BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-810. [PMID: 32211816 DOI: 10.1001/jamacardio.2020.0950] [Cited by in Crossref: 1702] [Cited by in F6Publishing: 1650] [Article Influence: 851.0] [Reference Citation Analysis]
Number Citing Articles
1 Churchill TW, Bertrand PB, Bernard S, Namasivayam M, Churchill J, Crousillat D, Davis EF, Hung J, Picard MH. Echocardiographic Features of COVID-19 Illness and Association with Cardiac Biomarkers. J Am Soc Echocardiogr 2020;33:1053-4. [PMID: 32580898 DOI: 10.1016/j.echo.2020.05.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
2 Wang N, Cao J, Lal S. COVID-19: getting to the heart of the matter. Eur J Heart Fail 2020;22:2216-8. [PMID: 32945558 DOI: 10.1002/ejhf.2007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Vitiello A, La Porta R, Ferrara F. Scientific hypothesis and rational pharmacological for the use of sacubitril/valsartan in cardiac damage caused by COVID-19. Med Hypotheses 2021;147:110486. [PMID: 33460992 DOI: 10.1016/j.mehy.2021.110486] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
4 Sánchez-Oro R, Fatahi Bandpey ML, García Martínez E, Edo Prades MÁ, Alonso Muñoz EM. Clinical and radiological findings for the new multisystem inflammatory syndrome in children associated with COVID-19. Radiologia 2021;63:334-44. [PMID: 33785227 DOI: 10.1016/j.rx.2021.03.001] [Reference Citation Analysis]
5 Sato K, Sinclair JE, Sadeghirad H, Fraser JF, Short KR, Kulasinghe A. Cardiovascular disease in SARS-CoV-2 infection. Clin Transl Immunology 2021;10:e1343. [PMID: 34512975 DOI: 10.1002/cti2.1343] [Reference Citation Analysis]
6 Koh HM, Chong PF, Tan JN, Chidambaram SK, Chua HJ. QT prolongation associated with hydroxychloroquine and protease inhibitors in COVID-19. J Clin Pharm Ther 2021;46:800-6. [PMID: 33768612 DOI: 10.1111/jcpt.13356] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shafi AMA, Shaikh SA, Shirke MM, Iddawela S, Harky A. Cardiac manifestations in COVID-19 patients-A systematic review. J Card Surg. 2020;35:1988-2008. [PMID: 32652713 DOI: 10.1111/jocs.14808] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 20.5] [Reference Citation Analysis]
8 Big Ten Cardiac Registry Steering Committee; Rink LD, Daniels CJ, Boersma D, Borchers J, Busch J, Kovan J, Kratochvil CJ, Rifat S, Rosenthal G, Chung EH. Competitive Sports, the Coronavirus Disease 2019 Pandemic, and Big Ten Athletics.Circ Cardiovasc Qual Outcomes. 2020;13:e007608. [PMID: 33125280 DOI: 10.1161/CIRCOUTCOMES.120.007608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wicik Z, Eyileten C, Jakubik D, Simões SN, Martins DC Jr, Pavão R, Siller-Matula JM, Postula M. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors. J Clin Med 2020;9:E3743. [PMID: 33233425 DOI: 10.3390/jcm9113743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
10 Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Recalde M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LYH, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology (Oxford) 2021;60:SI37-50. [PMID: 33725121 DOI: 10.1093/rheumatology/keab250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
11 Colon CM, Barrios JG, Chiles JW, Brown TM, Pogwizd SM, McElwee SK, Gandotra S, Russell DW, McElderry HT, Maddox WR. Atrial arrhythmia related outcomes in critically ill COVID-19 patients. Pacing Clin Electrophysiol 2021;44:814-23. [PMID: 33738812 DOI: 10.1111/pace.14221] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Coolen T, Lolli V, Sadeghi N, Rovai A, Trotta N, Taccone FS, Creteur J, Henrard S, Goffard JC, Dewitte O, Naeije G, Goldman S, De Tiège X. Early postmortem brain MRI findings in COVID-19 non-survivors. Neurology 2020;95:e2016-27. [PMID: 32546654 DOI: 10.1212/WNL.0000000000010116] [Cited by in Crossref: 92] [Cited by in F6Publishing: 67] [Article Influence: 46.0] [Reference Citation Analysis]
13 Qiu C, Li T, Wei G, Xu J, Yu W, Wu Z, Li D, He Y, Chen T, Zhang J, He X, Hu J, Fang J, Zhang H. Hemorrhage and venous thromboembolism in critically ill patients with COVID-19. SAGE Open Med 2021;9:20503121211020167. [PMID: 34104439 DOI: 10.1177/20503121211020167] [Reference Citation Analysis]
14 Sharma A, Bhatt NS, Hijano DR. Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients. Curr Opin Hematol 2021;28:394-400. [PMID: 34456224 DOI: 10.1097/MOH.0000000000000683] [Reference Citation Analysis]
15 Perico L, Benigni A, Casiraghi F, Ng LFP, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46-64. [PMID: 33077917 DOI: 10.1038/s41581-020-00357-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 42.5] [Reference Citation Analysis]
16 Stavileci B, Özdemir E, Özdemir B, Ereren E, Cengiz M. De-novo development of fragmented QRS during a six-month follow-up period in patients with COVID-19 disease and its cardiac effects. Journal of Electrocardiology 2022. [DOI: 10.1016/j.jelectrocard.2022.02.012] [Reference Citation Analysis]
17 Mousseaux E, Fayol A, Danchin N, Soulat G, Charpentier E, Livrozet M, Carves JB, Tea V, Salem FB, Chamandi C, Hulot JS, Puymirat E. Association between coronary artery calcifications and 6-month mortality in hospitalized patients with COVID-19. Diagn Interv Imaging 2021:S2211-5684(21)00169-8. [PMID: 34312110 DOI: 10.1016/j.diii.2021.06.007] [Reference Citation Analysis]
18 Suri JS, Puvvula A, Biswas M, Majhail M, Saba L, Faa G, Singh IM, Oberleitner R, Turk M, Chadha PS, Johri AM, Sanches JM, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Ahluwalia P, Kolluri R, Teji J, Maini MA, Agbakoba A, Dhanjil SK, Sockalingam M, Saxena A, Nicolaides A, Sharma A, Rathore V, Ajuluchukwu JNA, Fatemi M, Alizad A, Viswanathan V, Krishnan PR, Naidu S. COVID-19 pathways for brain and heart injury in comorbidity patients: A role of medical imaging and artificial intelligence-based COVID severity classification: A review. Comput Biol Med 2020;124:103960. [PMID: 32919186 DOI: 10.1016/j.compbiomed.2020.103960] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
19 Chamié D, Oliveira F, Braga S, Costa JR, Siqueira DAA, Staico R, Costa R, Maldonado G, Tanajura LFL, Centemero MP, Chaves ÁJ, Abizaid ACSL, Freitas RAP, Coelho NT, Ohe LN, Abboud C, Feres F. Adapted Catheterization Laboratory Practices during the COVID-19 Pandemic: The Instituto Dante Pazzanese de Cardiologia Protocol. Arq Bras Cardiol 2020;115:558-68. [PMID: 33027381 DOI: 10.36660/abc.20200489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhang R, Chen X, Zuo W, Ji Z, Qu Y, Su Y, Yang M, Zuo P, Ma G, Li Y. Inflammatory activation and immune cell infiltration are main biological characteristics of SARS-CoV-2 infected myocardium. Bioengineered 2022;13:2486-97. [PMID: 35037831 DOI: 10.1080/21655979.2021.2014621] [Reference Citation Analysis]
21 Strauss SA, Seo C, Carrier M, Jetty P. From cellular function to global impact: the vascular perspective on COVID-19. Can J Surg 2021;64:E289-97. [PMID: 33978563 DOI: 10.1503/cjs.023820] [Reference Citation Analysis]
22 Pasha SB, Swi A, Hammoud GM. Gastrointestinal and hepatic manifestations of COVID-19 infection: Lessons for practitioners. World J Meta-Anal 2020; 8(5): 348-374 [DOI: 10.13105/wjma.v8.i5.348] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Tassiopoulos AK, Mofakham S, Rubano JA, Labropoulos N, Bannazadeh M, Drakos P, Volteas P, Cleri NA, Alkadaa LN, Asencio AA, Oganov A, Hou W, Rutigliano DN, Singer AJ, Vosswinkel J, Talamini M, Mikell CB, Kaushansky K. D-Dimer-Driven Anticoagulation Reduces Mortality in Intubated COVID-19 Patients: A Cohort Study With a Propensity-Matched Analysis. Front Med (Lausanne) 2021;8:631335. [PMID: 33634153 DOI: 10.3389/fmed.2021.631335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
24 Oleszak F, Maryniak A, Botti E, Abrahim C, Salifu MO, Youssef M, Henglein VL, McFarlane SI. Myocarditis Associated With COVID-19. Am J Med Case Rep 2020;8:498-502. [PMID: 33088905 DOI: 10.12691/ajmcr-8-12-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
25 Bhandari M, Pradhan A, Vishwakarma P, Sethi R. Coronavirus and cardiovascular manifestations- getting to the heart of the matter. World J Cardiol 2021; 13(10): 556-565 [PMID: 34754400 DOI: 10.4330/wjc.v13.i10.556] [Reference Citation Analysis]
26 Adu-Amankwaah J, Mprah R, Adekunle AO, Ndzie Noah ML, Adzika GK, Machuki JO, Sun H. The cardiovascular aspect of COVID-19. Ann Med 2021;53:227-36. [PMID: 33345626 DOI: 10.1080/07853890.2020.1861644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
27 Soulat-Dufour L, Fauvel C, Weizman O, Barbe T, Pezel T, Mika D, Cellier J, Geneste L, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Duceau B, Sutter W, Chaumont C, Guilleminot P, Sagnard A, Pastier J, Trimaille A, Bonnet G, Canu M, Coisne A, Cohen A. Prognostic value of right ventricular dilatation in patients with COVID-19: a multicentre study. Eur Heart J Cardiovasc Imaging 2021:jeab067. [PMID: 34008835 DOI: 10.1093/ehjci/jeab067] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Vitiello A, Ferrara F. Physiopathology and prospectives for therapeutic treatment of pulmonary fibrotic state in COVID-19 patients. Curr Res Pharmacol Drug Discov 2021;2:100056. [PMID: 34870154 DOI: 10.1016/j.crphar.2021.100056] [Reference Citation Analysis]
29 Elias P, Poterucha TJ, Jain SS, Sayer G, Raikhelkar J, Fried J, Clerkin K, Griffin J, DeFilippis EM, Gupta A, Lawlor M, Madhavan M, Rosenblum H, Roth ZB, Natarajan K, Hripcsak G, Perotte A, Wan EY, Saluja A, Dizon J, Ehlert F, Morrow JP, Yarmohammadi H, Kumaraiah D, Redfors B, Gavin N, Kirtane A, Rabbani L, Burkhoff D, Moses J, Schwartz A, Leon M, Uriel N. The Prognostic Value of Electrocardiogram at Presentation to Emergency Department in Patients With COVID-19. Mayo Clin Proc 2020;95:2099-109. [PMID: 33012341 DOI: 10.1016/j.mayocp.2020.07.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
30 Panagides V, Vincent F, Weizman O, Jonveaux M, Trimaille A, Pommier T, Cellier J, Geneste L, Marsou W, Deney A, Attou S, Delmotte T, Fauvel C, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Karsenty C, Duceau B, Sutter W, Mika D, Pezel T, Waldmann V, Ternacle J, Cohen A, Bonnet G; Critical COVID-19 France Investigators. History of heart failure in patients with coronavirus disease 2019: Insights from a French registry. Arch Cardiovasc Dis 2021;114:415-25. [PMID: 34099379 DOI: 10.1016/j.acvd.2021.04.003] [Reference Citation Analysis]
31 Diller GP, Enders D, Lammers AE, Orwat S, Schmidt R, Radke RM, Gerss J, De Torres Alba F, Kaleschke G, Bauer UM, Marschall U, Baumgartner H. Mortality and morbidity in patients with congenital heart disease hospitalised for viral pneumonia. Heart 2020:heartjnl-2020-317706. [PMID: 33109710 DOI: 10.1136/heartjnl-2020-317706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
32 Bhatt AS, Jering KS, Vaduganathan M, Claggett BL, Cunningham JW, Rosenthal N, Signorovitch J, Thune JJ, Vardeny O, Solomon SD. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail 2021;9:65-73. [PMID: 33384064 DOI: 10.1016/j.jchf.2020.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
33 Baldi E, Primi R, Bendotti S, Currao A, Compagnoni S, Gentile FR, Sechi GM, Mare C, Palo A, Contri E, Ronchi V, Bergamini G, Reali F, Parogni P, Facchin F, Rizzi U, Bussi D, Ruggeri S, Campi S, Centineo P, De Ponti R, Oltrona Visconti L, Savastano S; all the Lombardia CARe researchers. Relationship between out-of-hospital cardiac arrests and COVID-19 during the first and second pandemic wave. The importance of monitoring COVID-19 incidence. PLoS One 2021;16:e0260275. [PMID: 34797840 DOI: 10.1371/journal.pone.0260275] [Reference Citation Analysis]
34 Chatzis DG, Magounaki KT, Pantazopoulos IN, Johnson EO, Tsioufis KP. COVID-19 pandemic and cardiovascular disease: where do we stand? Minerva Cardioangiol 2020;68:347-58. [PMID: 32472990 DOI: 10.23736/S0026-4725.20.05298-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
35 Giani AM, Chen S. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery. Stem Cell Res 2021;53:102207. [PMID: 33677394 DOI: 10.1016/j.scr.2021.102207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Trogen B, Gonzalez FJ, Shust GF. COVID-19-Associated Myocarditis in an Adolescent. Pediatric Infectious Disease Journal 2020;39:e204-5. [DOI: 10.1097/inf.0000000000002788] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 11.5] [Reference Citation Analysis]
37 Contini C, Enrica Gallenga C, Neri G, Maritati M, Conti P. A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application. Med Hypotheses 2020;144:109876. [PMID: 32562915 DOI: 10.1016/j.mehy.2020.109876] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
38 Li Y, Fang L, Zhu S, Xie Y, Wang B, He L, Zhang D, Zhang Y, Yuan H, Wu C, Li H, Sun W, Zhang Y, Li M, Cui L, Cai Y, Wang J, Yang Y, Lv Q, Zhang L, Johri AM, Xie M. Echocardiographic Characteristics and Outcome in Patients With COVID-19 Infection and Underlying Cardiovascular Disease. Front Cardiovasc Med 2021;8:642973. [PMID: 33796573 DOI: 10.3389/fcvm.2021.642973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Carretta DM, Silva AM, D'Agostino D, Topi S, Lovero R, Charitos IA, Wegierska AE, Montagnani M, Santacroce L. Cardiac Involvement in COVID-19 Patients: A Contemporary Review. Infect Dis Rep 2021;13:494-517. [PMID: 34206074 DOI: 10.3390/idr13020048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Crudo VL, Ahmed AI, Cowan EL, Shah DJ, Al-Mallah MH, Malahfji M. Acute and Subclinical Myocardial Injury in COVID-19. Methodist Debakey Cardiovasc J 2021;17:22-30. [PMID: 34992721 DOI: 10.14797/mdcvj.1038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Al-Kuraishy HM, Al-Gareeb AI, Welson NN, Batiha GE. Trimetazidine and COVID-19-induced acute cardiac injury: a missed key. Int J Clin Pharm 2022. [PMID: 35449348 DOI: 10.1007/s11096-022-01408-5] [Reference Citation Analysis]
42 Dayaramani C, De Leon J, Reiss AB. Cardiovascular Disease Complicating COVID-19 in the Elderly. Medicina (Kaunas) 2021;57:833. [PMID: 34441038 DOI: 10.3390/medicina57080833] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Tsolaki V, Zakynthinos GE. Are Patients with COVID-19 Dying of or with Cardiac Injury? Am J Respir Crit Care Med 2020;202:300-1. [PMID: 32432894 DOI: 10.1164/rccm.202004-1083LE] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Prasad A, Prasad M. Single Virus Targeting Multiple Organs: What We Know and Where We Are Heading? Front Med (Lausanne) 2020;7:370. [PMID: 32850890 DOI: 10.3389/fmed.2020.00370] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
45 Zhang Y, Coats AJ, Zheng Z, Adamo M, Ambrosio G, Anker SD, Butler J, Xu D, Mao J, Khan MS, Bai L, Mebazaa A, Ponikowski P, Tang Q, Ruschitzka F, Seferovic P, Tschöpe C, Zhang S, Gao C, Zhou S, Senni M, Zhang J, Metra M. Management of heart failure patients with COVID ‐19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:941-56. [DOI: 10.1002/ejhf.1915] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 19.0] [Reference Citation Analysis]
46 Gluckman TJ, Bhave NM, Allen LA, Chung EH, Spatz ES, Ammirati E, Baggish AL, Bozkurt B, Cornwell WK, Harmon KG, Kim JH, Lala A, Levine BD, Martinez MW, Onuma O, Phelan D, Puntmann VO, Rajpal S, Taub PR, Verma AK. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play. Journal of the American College of Cardiology 2022. [DOI: 10.1016/j.jacc.2022.02.003] [Reference Citation Analysis]
47 Baldassarre LA, Yang EH, Cheng RK, DeCara JM, Dent S, Liu JE, Rudski LG, Strom JB, Thavendiranathan P, Barac A, Zaha VG, Bucciarelli-Ducci C, Ellahham S, Deswal A, Lenneman C, Villarraga HR, Blaes AH, Ismail-Khan R, Ky B, Leja MJ, Scherrer-Crosbie M. Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst 2021;113:513-22. [PMID: 33179744 DOI: 10.1093/jnci/djaa177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
48 Glinsky GV. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells. Biomedicines 2020;8:E129. [PMID: 32455629 DOI: 10.3390/biomedicines8050129] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 26.0] [Reference Citation Analysis]
49 Baldi E, Sechi GM, Mare C, Canevari F, Brancaglione A, Primi R, Klersy C, Palo A, Contri E, Ronchi V, Beretta G, Reali F, Parogni P, Facchin F, Rizzi U, Bussi D, Ruggeri S, Oltrona Visconti L, Savastano S; Lombardia CARe researchers. COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests. Eur Heart J 2020;41:3045-54. [PMID: 32562486 DOI: 10.1093/eurheartj/ehaa508] [Cited by in Crossref: 87] [Cited by in F6Publishing: 70] [Article Influence: 43.5] [Reference Citation Analysis]
50 Sonsoz MR, Alp ME, Guven G, Guler A, Unsel M, Altuntas Aydin O. Increasing modified CHA2DS2-VASc risk score is associated with acute cardiac injury in hospitalised COVID-19 patients. Acta Cardiol 2021;:1-7. [PMID: 34275416 DOI: 10.1080/00015385.2021.1952000] [Reference Citation Analysis]
51 Baral R, Ali O, Brett I, Reinhold J, Vassiliou VS. COVID-19: a pan-organ pandemic. Oxf Med Case Reports. 2020;2020:omaa107. [PMID: 33304597 DOI: 10.1093/omcr/omaa107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Moreno-P O, Leon-Ramirez JM, Fuertes-Kenneally L, Perdiguero M, Andres M, Garcia-Navarro M, Ruiz-Torregrosa P, Boix V, Gil J, Merino E; COVID19-ALC Research Group. Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients. Int J Infect Dis 2020;100:449-54. [PMID: 32950739 DOI: 10.1016/j.ijid.2020.09.033] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
53 Afewerky HK. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Exp Biol Med (Maywood) 2020;245:1299-307. [PMID: 32635753 DOI: 10.1177/1535370220942126] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Correale P, Caracciolo M, Bilotta F, Conte M, Cuzzola M, Falcone C, Mangano C, Falzea AC, Iuliano E, Morabito A, Foti G, Armentano A, Caraglia M, De Lorenzo A, Sitkovsky M, Macheda S. Therapeutic effects of adenosine in high flow 21% oxygen aereosol in patients with Covid19-pneumonia. PLoS One 2020;15:e0239692. [PMID: 33031409 DOI: 10.1371/journal.pone.0239692] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
55 Maier SRDO, Rodrigues JPF, Sudré MRS, Dessotte CAM. Cardiac Complications in Patients with COVID-19: An Integrative Literature Review. Aquichan 2020;20:1-13. [DOI: 10.5294/aqui.2020.20.4.3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Cardiovasc Res 2021:cvab343. [PMID: 34864876 DOI: 10.1093/cvr/cvab343] [Reference Citation Analysis]
57 Wang Y, Zheng Y, Tong Q, Wang L, Lv G, Xi Z, Liu W. Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019. Front Cardiovasc Med 2020;7:147. [PMID: 33195443 DOI: 10.3389/fcvm.2020.00147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Nie SF, Yu M, Xie T, Yang F, Wang HB, Wang ZH, Li M, Gao XL, Lv BJ, Wang SJ, Zhang XB, He SL, Qiu ZH, Liao YH, Zhou ZH, Cheng X. Cardiac Troponin I Is an Independent Predictor for Mortality in Hospitalized Patients With COVID-19. Circulation. 2020;142:608-610. [PMID: 32539541 DOI: 10.1161/CIRCULATIONAHA.120.048789] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
59 Fathi M, Vakili K, Sayehmiri F, Mohamadkhani A, Hajiesmaeili M, Rezaei-Tavirani M, Eilami O. The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study. PLoS One 2021;16:e0246190. [PMID: 33592019 DOI: 10.1371/journal.pone.0246190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
60 Violi F, Pastori D, Cangemi R, Pignatelli P, Loffredo L. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost 2020;120:949-56. [PMID: 32349133 DOI: 10.1055/s-0040-1710317] [Cited by in Crossref: 105] [Cited by in F6Publishing: 91] [Article Influence: 52.5] [Reference Citation Analysis]
61 Yang K, Wen G, Wang J, Zhou S, Da W, Meng Y, Xue Y, Tao L. Complication and Sequelae of COVID-19: What Should We Pay Attention to in the Post-Epidemic Era. Front Immunol 2021;12:711741. [PMID: 34539642 DOI: 10.3389/fimmu.2021.711741] [Reference Citation Analysis]
62 Felsenstein S, Herbert JA, McNamara PS, Hedrich CM. COVID-19: Immunology and treatment options. Clin Immunol. 2020;215:108448. [PMID: 32353634 DOI: 10.1016/j.clim.2020.108448] [Cited by in Crossref: 254] [Cited by in F6Publishing: 222] [Article Influence: 127.0] [Reference Citation Analysis]
63 Uranga A, Villanueva A, Lafuente I, González N, Legarreta MJ, Aguirre U, Pablo España P, Quintana JM, García-Gutiérrez S; el grupo de trabajo COVID-19-Osakidetza. [Risk factors for clinical deterioration in patients admitted for COVID-19: a case-control study]. Rev Clin Esp 2021. [PMID: 34054133 DOI: 10.1016/j.rce.2021.04.007] [Reference Citation Analysis]
64 Gross A, Albrecht T. One year of COVID-19 pandemic: what we Radiologists have learned about imaging. Rofo 2021. [PMID: 34649291 DOI: 10.1055/a-1522-3155] [Reference Citation Analysis]
65 Eskander M, Razzaque MS. Can Maintaining Optimal Magnesium Balance Reduce the Disease Severity of COVID-19 Patients? Front Endocrinol 2022;13:843152. [DOI: 10.3389/fendo.2022.843152] [Reference Citation Analysis]
66 Akintayo AA, Addo B, Soleye SO, Patel D, Ahmad A, Tongia S. Diagnostic dilemma: COVID-19 related cardiomyopathy or peripartum cardiomyopathy? J Cardiol Cases 2021;24:206-9. [PMID: 34178185 DOI: 10.1016/j.jccase.2021.05.012] [Reference Citation Analysis]
67 Goerlich E, Minhas AS, Mukherjee M, Sheikh FH, Gilotra NA, Sharma G, Michos ED, Hays AG. Multimodality Imaging for Cardiac Evaluation in Patients with COVID-19. Curr Cardiol Rep 2021;23:44. [PMID: 33721125 DOI: 10.1007/s11886-021-01483-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
68 Purroy F, Arqué G. Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study. PLoS One 2021;16:e0252351. [PMID: 34106984 DOI: 10.1371/journal.pone.0252351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Uriel N, Sayer G, Clerkin KJ. Myocardial Injury in COVID-19 Patients: The Beginning or the End? J Am Coll Cardiol 2020;76:547-9. [PMID: 32731932 DOI: 10.1016/j.jacc.2020.06.045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
70 Dewland TA, Whitman IR, Win S, Sanchez JM, Olgin JE, Pletcher MJ, Santhosh L, Kumar U, Joyce S, Yang V, Hwang J, Ogomori K, Peyser N, Horner C, Wen D, Butcher X, Marcus GM. Prospective arrhythmia surveillance after a COVID-19 diagnosis. Open Heart 2022;9:e001758. [DOI: 10.1136/openhrt-2021-001758] [Reference Citation Analysis]
71 Kassam N, Aghan E, Aziz O, Mbithe H, Hameed K, Shah R, Surani S, Orwa J, Somji S. Factors Associated with Mortality Among Hospitalized Adults with COVID-19 Pneumonia at a Private Tertiary Hospital in Tanzania: A Retrospective Cohort Study. Int J Gen Med 2021;14:5431-40. [PMID: 34526810 DOI: 10.2147/IJGM.S330580] [Reference Citation Analysis]
72 Hinton J, Gabara L, Curzen N. Is the true clinical value of high-sensitivity troponins as a biomarker of risk? The concept that detection of high-sensitivity troponin 'never means nothing'. Expert Rev Cardiovasc Ther 2020;18:843-57. [PMID: 32966128 DOI: 10.1080/14779072.2020.1828063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Houshmand G, Ghorashi SM, Mirrazeghi F, Omidi N. Concomitant active inflammation of myocardium and thyroid, incidental finding in COVID-19 pandemic: A case report. Clin Case Rep 2021;9:e04998. [PMID: 34745619 DOI: 10.1002/ccr3.4998] [Reference Citation Analysis]
74 Lozahic C, Maddock H, Sandhu H. Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19. Front Cardiovasc Med 2021;8:634291. [PMID: 33969006 DOI: 10.3389/fcvm.2021.634291] [Reference Citation Analysis]
75 Grosse C, Grosse A, Salzer HJF, Dünser MW, Motz R, Langer R. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc Pathol 2020;49:107263. [PMID: 32784110 DOI: 10.1016/j.carpath.2020.107263] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
76 Rivetti L, Mantovan R, Sitta N, Marinigh R, Allocca G, Mohammed M, Pizzino F, Nucifora G. Management of Pacemaker Implantation during COVID-19 Infection. Case Rep Cardiol 2020;2020:8833660. [PMID: 33133701 DOI: 10.1155/2020/8833660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Karagodin I, Carvalho Singulane C, Woodward GM, Xie M, Tucay ES, Tude Rodrigues AC, Vasquez-Ortiz ZY, Alizadehasl A, Monaghan MJ, Ordonez Salazar BA, Soulat-Dufour L, Mostafavi A, Moreo A, Citro R, Narang A, Wu C, Descamps T, Addetia K, Lang RM, Asch FM; WASE-COVID Investigators. Echocardiographic Correlates of In-Hospital Death in Patients with Acute COVID-19 Infection: The World Alliance Societies of Echocardiography (WASE-COVID) Study. J Am Soc Echocardiogr 2021;34:819-30. [PMID: 34023454 DOI: 10.1016/j.echo.2021.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
78 Sharma YP, Agstam S, Yadav A, Gupta A, Gupta A. Cardiovascular manifestations of COVID-19: An evidence-based narrative review. Indian J Med Res 2021;153:7-16. [PMID: 33818464 DOI: 10.4103/ijmr.IJMR_2450_20] [Reference Citation Analysis]
79 Martínez-Rubio A, Ascoeta S, Taibi F, Soldevila JG. Coronavirus Disease 2019 and Cardiac Arrhythmias. Eur Cardiol 2020;15:e66. [PMID: 33294034 DOI: 10.15420/ecr.2020.23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 [DOI: 10.1101/2020.04.04.20053280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Younis NK, Zareef RO, Maktabi MAN, Mahfouz R. The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment. Genet Test Mol Biomarkers 2021;25:85-101. [PMID: 33596144 DOI: 10.1089/gtmb.2020.0227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Khan M, Shah N, Mushtaq H, Jehanzeb V. Profiling Laboratory Biomarkers Associated with COVID-19 Disease Progression: A Single-Center Experience. Int J Microbiol 2021;2021:6643333. [PMID: 33628256 DOI: 10.1155/2021/6643333] [Reference Citation Analysis]
83 Sostin OV, Rajapakse P, Cruser B, Wakefield D, Cruser D, Petrini J. A matched cohort study of convalescent plasma therapy for COVID-19. J Clin Apher 2021;36:523-32. [PMID: 33616257 DOI: 10.1002/jca.21888] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
84 Romero J, Alviz I, Parides M, Diaz JC, Briceno D, Gabr M, Gamero M, Patel K, Braunstein ED, Purkayastha S, Polanco D, Valencia CR, Della Rocca D, Velasco A, Yang R, Tarantino N, Zhang XD, Mohanty S, Bello J, Natale A, Jorde UP, Garcia M, Di Biase L. T-wave inversion as a manifestation of COVID-19 infection: a case series. J Interv Card Electrophysiol 2020;59:485-93. [PMID: 33128658 DOI: 10.1007/s10840-020-00896-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
85 [DOI: 10.1101/2020.05.01.20087114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
86 Michard F, Malbrain ML, Martin GS, Fumeaux T, Lobo S, Gonzalez F, Pinho-Oliveira V, Constantin JM. Haemodynamic monitoring and management in COVID-19 intensive care patients: an International survey. Anaesth Crit Care Pain Med 2020;39:563-9. [PMID: 32781167 DOI: 10.1016/j.accpm.2020.08.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
87 Normando PG, Araujo-Filho JA, Fonseca GA, Rodrigues REF, Oliveira VA, Hajjar LA, Almeida ALC, Bocchi EA, Salemi VMC, Melo M. Reduction in Hospitalization and Increase in Mortality Due to Cardiovascular Diseases during the COVID-19 Pandemic in Brazil. Arq Bras Cardiol 2021;116:371-80. [PMID: 33566937 DOI: 10.36660/abc.20200821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
88 Calvo-Fernández A, Izquierdo A, Subirana I, Farré N, Vila J, Durán X, García-Guimaraes M, Valdivielso S, Cabero P, Soler C, García-Ribas C, Rodríguez C, Llagostera M, Mojón D, Vicente M, Solé-González E, Sánchez-Carpintero A, Tevar C, Marrugat J, Vaquerizo B. [Markers of myocardial injury in the prediction of short-term COVID-19 prognosis]. Rev Esp Cardiol 2021;74:576-83. [PMID: 33262553 DOI: 10.1016/j.recesp.2020.09.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Li L, Hill J, Spratt JC, Jin Z. Myocardial injury in severe COVID-19: Identification and management. Resuscitation 2021;160:16-7. [PMID: 33450334 DOI: 10.1016/j.resuscitation.2020.11.040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
90 Echarte-Morales J, Minguito-Carazo C, Del Castillo-García S, Borrego-Rodríguez J, Rodríguez-Santamarta M, Sánchez-Muñoz E, Bergel-García R, González-Maniega C, Prieto-González S, Menéndez-Suarez P, Tundidor-Sanz E, Benito-González T, Fernández-Vázquez F. Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19. J Electrocardiol 2021;64:30-5. [PMID: 33307378 DOI: 10.1016/j.jelectrocard.2020.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Kirkbride RR, Rawal B, Mirsadraee S, Galperin-aizenberg M, Wechalekar K, Ridge CA, Litmanovich DE. Imaging of Cardiac Infections: A Comprehensive Review and Investigation Flowchart for Diagnostic Workup. Journal of Thoracic Imaging 2021;36:W70-88. [DOI: 10.1097/rti.0000000000000552] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Naeem KB, Hachim MY, Hachim IY, Chkhis A, Quadros R, Hannawi H, Al Salmi I, Alokaily F, Hannawi S. Acute cardiac injury is associated with adverse outcomes, including mortality in COVID-19 patients. A single-center experience. Saudi Med J 2020;41:1204-10. [PMID: 33130840 DOI: 10.15537/smj.2020.11.25466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Mei X, Ji Y, Qian Z, Ling Y, Zhu H, Zhao X, Shen F, Xu Q, Zhang Z, Cheng X, Liu Y, Guo H, Zou Y, Wang J, Zhang Y, Xu L, Lu H. Risk factors for myocardial injury at admission of 325 patients with coronavirus disease 2019 in Shanghai, China. Australas J Ageing 2021. [PMID: 34668629 DOI: 10.1111/ajag.13003] [Reference Citation Analysis]
94 Schiavone M, Gobbi C, Biondi-Zoccai G, D'Ascenzo F, Palazzuoli A, Gasperetti A, Mitacchione G, Viecca M, Galli M, Fedele F, Mancone M, Forleo GB. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties. J Clin Med 2020;9:E1683. [PMID: 32498230 DOI: 10.3390/jcm9061683] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
95 Jacob G, Aharon A, Brenner B. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations. Front Physiol 2020;11:596057. [PMID: 33391014 DOI: 10.3389/fphys.2020.596057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
96 Chen MY, Xiao FP, Kuai L, Zhou HB, Jia ZQ, Liu M, He H, Hong M. Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: A systematic review and meta-analysis. Am J Emerg Med 2021;50:661-9. [PMID: 34879483 DOI: 10.1016/j.ajem.2021.09.050] [Reference Citation Analysis]
97 Zhao S, Lin Y, Zhou C, Wang L, Chen X, Clifford SP, Akca O, Huang J, Chen X. Short-Term Outcomes of Patients With COVID-19 Undergoing Invasive Mechanical Ventilation: A Retrospective Observational Study From Wuhan, China. Front Med (Lausanne) 2020;7:571542. [PMID: 33117833 DOI: 10.3389/fmed.2020.571542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis 2021;21:855. [PMID: 34418980 DOI: 10.1186/s12879-021-06536-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Yu JS, Chen RD, Zeng LC, Yang HK, Li H. Myoglobin Offers Higher Accuracy Than Other Cardiac-Specific Biomarkers for the Prognosis of COVID-19. Front Cardiovasc Med 2021;8:686328. [PMID: 34458331 DOI: 10.3389/fcvm.2021.686328] [Reference Citation Analysis]
100 Pan C, Zhang Z, Luo L, Wu W, Jia T, Lu L, Liu WV, Qin Y, Hu F, Ding X, Qin P, Qian L, Chen J, Li S. Cardiac T1 and T2 Mapping Showed Myocardial Involvement in Recovered COVID-19 Patients Initially Considered Devoid of Cardiac Damage. J Magn Reson Imaging 2021;54:421-8. [PMID: 33590944 DOI: 10.1002/jmri.27534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
101 Coyle J, Igbinomwanhia E, Sanchez-Nadales A, Danciu S, Chu C, Shah N. A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001. JACC Case Rep 2020;2:1331-6. [PMID: 32368755 DOI: 10.1016/j.jaccas.2020.04.025] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 20.0] [Reference Citation Analysis]
102 Beitzke D, Salgado R, Francone M, Kreitner KF, Natale L, Bremerich J, Gutberlet M, Mousseaux E, Nikolaou K, Peebles C, Velthuis B, Vliegenthart R, Loewe C, Emrich T;  Executive Committee of the European Society of Cardiovascular Radiology (ESCR):; Luigi N, Matthias G, Rozemarijn V, Konstantin N, Marco F, Christian L, Brigitta V, Rodrigo S, Charles P, Ellie M. Cardiac imaging procedures and the COVID-19 pandemic: recommendations of the European Society of Cardiovascular Radiology (ESCR). Int J Cardiovasc Imaging. 2020;36:1801-1810. [PMID: 32451877 DOI: 10.1007/s10554-020-01892-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
103 Tabassum T, Rahman A, Araf Y, Ullah MA, Hosen MJ. Prospective selected biomarkers in COVID-19 diagnosis and treatment. Biomark Med 2021;15:1435-49. [PMID: 34538093 DOI: 10.2217/bmm-2021-0038] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Abdel-Haq N, Asmar BI. Fever in the Returned Pediatric Traveler. Glob Pediatr Health 2021;8:2333794X211026188. [PMID: 34423077 DOI: 10.1177/2333794X211026188] [Reference Citation Analysis]
105 Natarajan A, Su H, Heneghan C. Occurrence of Relative Bradycardia and Relative Tachycardia in Individuals Diagnosed With COVID-19. Front Physiol 2022;13:898251. [DOI: 10.3389/fphys.2022.898251] [Reference Citation Analysis]
106 Franks CE, Scott MG, Farnsworth CW. Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA. J Appl Lab Med 2020;5:1137-9. [PMID: 32484893 DOI: 10.1093/jalm/jfaa092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
107 Liu J, Liu Z, Jiang W, Wang J, Zhu M, Song J, Wang X, Su Y, Xiang G, Ye M, Li J, Zhang Y, Shen Q, Li Z, Yao D, Song Y, Yu K, Luo Z, Ye L. Clinical predictors of COVID-19 disease progression and death: Analysis of 214 hospitalised patients from Wuhan, China. Clin Respir J 2021;15:293-309. [PMID: 33090710 DOI: 10.1111/crj.13296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
108 Colombo C, Garatti L, Ferrante G, Casadei F, Montalto C, Crimi G, Cogliati C, Ammirati E, Savonitto S, Morici N. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people. J Geriatr Cardiol 2021;18:534-48. [PMID: 34404990 DOI: 10.11909/j.issn.1671-5411.2021.07.001] [Reference Citation Analysis]
109 Khan MS, Shahid I, Anker SD, Solomon SD, Vardeny O, Michos ED, Fonarow GC, Butler J. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med 2020;18:403. [PMID: 33334360 DOI: 10.1186/s12916-020-01816-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
110 Limanaqi F, Busceti CL, Biagioni F, Lazzeri G, Forte M, Schiavon S, Sciarretta S, Frati G, Fornai F. Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis.Antioxidants (Basel). 2020;9:1105. [PMID: 33182802 DOI: 10.3390/antiox9111105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
111 Ernzen K, Trask AJ, Peeples ME, Garg V, Zhao MT. Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System. Stem Cell Rev Rep 2021. [PMID: 34365591 DOI: 10.1007/s12015-021-10229-4] [Reference Citation Analysis]
112 Zhang R, Tang Y. Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs. Viral Immunol 2021;34:291-9. [PMID: 32614684 DOI: 10.1089/vim.2020.0027] [Reference Citation Analysis]
113 Zareini B, Rajan D, El-Sheikh M, Jensen MH, Højbjerg Lassen MC, Skaarup K, Hansen ML, Biering-Sørensen T, Jabbari R, Kirk O, Tfelt-Hansen J, Nielsen OW, Lindegaard B, Tønder N, Pedersen LK, Ulrik CS, Ellekvist P, Stæhr Jensen JU, Schou M, Gislason G, Lamberts M. Cardiac arrhythmias in patients hospitalized with COVID-19: The ACOVID study. Heart Rhythm O2 2021;2:304-8. [PMID: 34337582 DOI: 10.1016/j.hroo.2021.03.008] [Reference Citation Analysis]
114 Dimai S, Semmler L, Prabhu A, Stachelscheid H, Huettemeister J, Klaucke SC, Lacour P, Blaschke F, Kruse J, Parwani A, Boldt LH, Bullinger L, Pieske BM, Heinzel FR, Hohendanner F. COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab. PLoS One 2021;16:e0255976. [PMID: 34411149 DOI: 10.1371/journal.pone.0255976] [Reference Citation Analysis]
115 Wu X, Xu Y, Jin L, Wang X, Zhu H, Xie Y. Association of Preexisting Asthma and Other Allergic Diseases With Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:670744. [PMID: 34249969 DOI: 10.3389/fmed.2021.670744] [Reference Citation Analysis]
116 Mitacchione G, Schiavone M, Gasperetti A, Forleo GB. Ventricular tachycardia storm management in a COVID-19 patient: a case report. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33089046 DOI: 10.1093/ehjcr/ytaa217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
117 Alwaqfi NR, Ibrahim KS. COVID-19: an update and cardiac involvement. J Cardiothorac Surg 2020;15:239. [PMID: 32907637 DOI: 10.1186/s13019-020-01299-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
118 Patel VD, Patel KH, Lakhani DA, Desai R, Mehta D, Mody P, Pruthi S. Acute pericarditis in a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a case report and review of the literature on SARS-CoV-2 cardiological manifestations. AME Case Rep 2021;5:6. [PMID: 33634246 DOI: 10.21037/acr-20-90] [Reference Citation Analysis]
119 Kammerlander AA, Mascherbauer J. COVID-19: frequently asked questions to the cardiologist. Wien Klin Wochenschr 2020;132:690-2. [PMID: 32710220 DOI: 10.1007/s00508-020-01696-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
120 Feng YF, Wang KP, Mo JG, Xu YH, Wang LZ, Jin C, Chen X, Yi B. The spatiotemporal trend of renal involvement in COVID-19: A pooled analysis of 17 134 patients. Int J Infect Dis 2021;106:281-8. [PMID: 33823283 DOI: 10.1016/j.ijid.2021.03.082] [Reference Citation Analysis]
121 Hsu A, Weber W, Heins A, Josephson E, Kornberg R, Diaz R. A proposal for selective resuscitation of adult cardiac arrest patients in a pandemic. J Am Coll Emerg Physicians Open 2020. [PMID: 32838375 DOI: 10.1002/emp2.12096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
122 Peiró ÓM, Carrasquer A, Sánchez-Gimenez R, Lal-Trehan N, Del-Moral-Ronda V, Bonet G, Fort-Gallifa I, Picó-Plana E, Bastón-Paz N, Gutiérrez C, Bardaji A. Biomarkers and short-term prognosis in COVID-19. Biomarkers 2021;26:119-26. [PMID: 33426934 DOI: 10.1080/1354750X.2021.1874052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
123 Corica B, Marra AM, Basili S, Cangemi R, Cittadini A, Proietti M, Romiti GF. Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis. Sci Rep 2021;11:17774. [PMID: 34493763 DOI: 10.1038/s41598-021-96955-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Junapudi SS, Junapudi S, Ega K, Chidipi B. Major cardiac concerns in therapy and vaccinations for COVID-19. Metabol Open 2021;11:100102. [PMID: 34222851 DOI: 10.1016/j.metop.2021.100102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
125 Li Y, Renner DM, Comar CE, Whelan JN, Reyes HM, Cardenas-Diaz FL, Truitt R, Tan LH, Dong B, Alysandratos KD, Huang J, Palmer JN, Adappa ND, Kohanski MA, Kotton DN, Silverman RH, Yang W, Morrisey E, Cohen NA, Weiss SR. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes. bioRxiv 2020:2020. [PMID: 32995797 DOI: 10.1101/2020.09.24.312553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
126 Tarun T, Kumar S, Johnson J, Chockalingam A. A case report on transient cardiomyopathy with cytokine storm in SARS-CoV-2. Eur Heart J Case Rep 2021;5:ytaa519. [PMID: 33594344 DOI: 10.1093/ehjcr/ytaa519] [Reference Citation Analysis]
127 Maloberti A, Biolcati M, Giannattasio C. Troponin elevation in COVID-19 patients: An important stratification biomarker with still some open questions. Int J Cardiol 2021:S0167-5273(21)01194-3. [PMID: 34352353 DOI: 10.1016/j.ijcard.2021.07.049] [Reference Citation Analysis]
128 Alger HM, Rutan C, Williams JH 4th, Walchok JG, Bolles M, Hall JL, Bradley SM, Elkind MSV, Rodriguez F, Wang TY, Morrow DA, Das SR, de Lemos JA. American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines. Circ Cardiovasc Qual Outcomes 2020;13:e006967. [PMID: 32546000 DOI: 10.1161/CIRCOUTCOMES.120.006967] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
129 Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg 2020;35:1302-5. [PMID: 32306491 DOI: 10.1111/jocs.14538] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 28.5] [Reference Citation Analysis]
130 Fauvel C, Weizman O, Trimaille A, Mika D, Pommier T, Pace N, Douair A, Barbin E, Fraix A, Bouchot O, Benmansour O, Godeau G, Mecheri Y, Lebourdon R, Yvorel C, Massin M, Leblon T, Chabbi C, Cugney E, Benabou L, Aubry M, Chan C, Boufoula I, Barnaud C, Bothorel L, Duceau B, Sutter W, Waldmann V, Bonnet G, Cohen A, Pezel T; Critical Covid-19 France Investigators. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J 2020;41:3058-68. [PMID: 32656565 DOI: 10.1093/eurheartj/ehaa500] [Cited by in Crossref: 81] [Cited by in F6Publishing: 80] [Article Influence: 40.5] [Reference Citation Analysis]
131 Fox SE, Heide RSV. COVID-19: The Heart of the Matter-Pathological Changes and a Proposed Mechanism. J Cardiovasc Pharmacol Ther 2021;26:217-24. [PMID: 33703938 DOI: 10.1177/1074248421995356] [Reference Citation Analysis]
132 Demir E. The potential use of Drosophila as an in vivo model organism for COVID-19-related research: a review. Turk J Biol 2021;45:559-69. [PMID: 34803454 DOI: 10.3906/biy-2104-26] [Reference Citation Analysis]
133 Singh H, Kakkar AK, Chauhan P. Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges. Expert Rev Anti Infect Ther 2020;18:997-1003. [PMID: 32552044 DOI: 10.1080/14787210.2020.1782190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
134 Cappuccio FP, Siani A. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint. Nutr Metab Cardiovasc Dis 2020;30:1227-35. [PMID: 32595085 DOI: 10.1016/j.numecd.2020.05.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
135 Addison D, Campbell CM, Guha A, Ghosh AK, Dent SF, Jneid H. Cardio-Oncology in the Era of the COVID-19 Pandemic and Beyond. J Am Heart Assoc 2020;9:e017787. [PMID: 32713239 DOI: 10.1161/JAHA.120.017787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
136 Abdi A, AlOtaiby S, Badarin FA, Khraibi A, Hamdan H, Nader M. Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy. Biomed Pharmacother 2021;146:112518. [PMID: 34906770 DOI: 10.1016/j.biopha.2021.112518] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Lv Z, Wang W, Qiao B, Cui X, Feng Y, Chen L, Ma Q, Liu X. The prognostic value of general laboratory testing in patients with COVID-19. J Clin Lab Anal 2021;35:e23668. [PMID: 33314316 DOI: 10.1002/jcla.23668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
138 Badeti S, Tseng HC, Romanienko P, Yehia G, Liu D. Development of a Novel Human CD147 Transgenic NSG Mouse Model to test SARS-CoV-2 Infection and Immune Responses. Res Sq 2021:rs. [PMID: 33851148 DOI: 10.21203/rs.3.rs-396257/v1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Centurión OA, Miño LM, Scavenius KE. Severe Acute Respiratory Syndrome Coronavirus 2: The Importance of Prompt Detection of Cardiovascular Involvement. TOCMJ 2020;14:38-41. [DOI: 10.2174/18741924020140100038] [Reference Citation Analysis]
140 Jones ID. The impact of Covid-19 on cardiovascular health. Nurs Crit Care 2022;27:141-4. [PMID: 35384184 DOI: 10.1111/nicc.12756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Garau G, Joachim S, Duliere GL, Melissopoulou M, Boccar S, Fraipont V, Dugauquier C, Troisfontaines P, Hougrand O, Delvenne P, Hoffer E. Sudden cardiogenic shock mimicking fulminant myocarditis in a surviving teenager affected by severe acute respiratory syndrome coronavirus 2 infection. ESC Heart Fail 2021;8:766-73. [PMID: 33190387 DOI: 10.1002/ehf2.13049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Gill GS, Vlacancich R, Mehta N, Chaturvedi M, Papolos A. Spectrum of Cardiac Involvement in COVID-19. Cureus 2020;12:e8638. [PMID: 32685307 DOI: 10.7759/cureus.8638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Chang SH, Chen D, Paone D, Geraci TC, Scheinerman J, Bizekis C, Zervos M, Cerfolio RJ. Thoracic surgery outcomes for patients with Coronavirus Disease 2019. J Thorac Cardiovasc Surg 2021:S0022-5223(21)00168-9. [PMID: 33642100 DOI: 10.1016/j.jtcvs.2021.01.069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
144 Costa IBSDS, Rochitte CE, Campos CM, Barberato SH, Oliveira GMM, Lopes MACQ, Nomura CH, Abizaid AA, Cerri G, Kalil Filho R, Hajjar LA. Cardiovascular Imaging and Interventional Procedures in Patients with Novel Coronavirus Infection. Arq Bras Cardiol 2020;115:111-26. [PMID: 32813825 DOI: 10.36660/abc.20200370] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
145 Lisco G, De Tullio A, Stragapede A, Solimando AG, Albanese F, Capobianco M, Giagulli VA, Guastamacchia E, De Pergola G, Vacca A, Racanelli V, Triggiani V. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme. J Clin Med 2021;10:2920. [PMID: 34209964 DOI: 10.3390/jcm10132920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
146 Xia G, Qin B, Ma C, Zhu Y, Zheng Q. High-dose vitamin C ameliorates cardiac injury in COVID-19 pandemic: a retrospective cohort study. Aging (Albany NY) 2021;13:20906-14. [PMID: 34499050 DOI: 10.18632/aging.203503] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Okura H. Update of takotsubo syndrome in the era of COVID-19. J Cardiol 2021;77:361-9. [PMID: 33148469 DOI: 10.1016/j.jjcc.2020.10.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
148 Lombardi CM, Carubelli V, Iorio A, Inciardi RM, Bellasi A, Canale C, Camporotondo R, Catagnano F, Dalla Vecchia LA, Giovinazzo S, Maccagni G, Mapelli M, Margonato D, Monzo L, Nuzzi V, Oriecuia C, Peveri G, Pozzi A, Provenzale G, Sarullo F, Tomasoni D, Ameri P, Gnecchi M, Leonardi S, Merlo M, Agostoni P, Carugo S, Danzi GB, Guazzi M, La Rovere MT, Mortara A, Piepoli M, Porto I, Sinagra G, Volterrani M, Specchia C, Metra M, Senni M. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study.JAMA Cardiol. 2020;5:1274-1280. [PMID: 32845276 DOI: 10.1001/jamacardio.2020.3538] [Cited by in Crossref: 43] [Cited by in F6Publishing: 59] [Article Influence: 21.5] [Reference Citation Analysis]
149 Dou Q, Wei X, Zhou K, Yang S, Jia P. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. Trends Endocrinol Metab 2020;31:893-904. [PMID: 33172748 DOI: 10.1016/j.tem.2020.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
150 Seecheran R, Narayansingh R, Giddings S, Rampaul M, Furlonge K, Abdool K, Bhagwandass N, Seecheran NA. Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection. J Investig Med High Impact Case Rep 2020;8:2324709620925571. [PMID: 32370558 DOI: 10.1177/2324709620925571] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
151 Yang L, Han Y, Jaffré F, Nilsson-Payant BE, Bram Y, Wang P, Zhu J, Zhang T, Redmond D, Houghton S, Uhl S, Borczuk A, Huang Y, Richardson C, Chandar V, Acklin JA, Lim JK, Chen Z, Xiang J, Ho DD, tenOever BR, Schwartz RE, Evans T, Chen S. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts. Circ Res 2021;129:33-46. [PMID: 33853355 DOI: 10.1161/CIRCRESAHA.121.319060] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
152 Vedovati MC, Giustozzi M, Conti S, Becattini C. Shock and Diffuse ST-elevation in a Patient with Coronavirus Disease-2019 Disease. J Cardiovasc Echogr 2020;30:223-6. [PMID: 33828946 DOI: 10.4103/jcecho.jcecho_71_20] [Reference Citation Analysis]
153 Miranda Soriano RV, Rossi Neto JM, Finger MA, Santos CCD, Lin-Wang HT. COVID-19 in heart transplant patients: Case reports from Brazil. Clin Transplant 2021;:e14330. [PMID: 34028903 DOI: 10.1111/ctr.14330] [Reference Citation Analysis]
154 Doshi RN. The State of Atrial Fibrillation in 2020. J Innov Card Rhythm Manag 2021;12:4350-3. [PMID: 33520349 DOI: 10.19102/icrm.2021.120105] [Reference Citation Analysis]
155 Potere N, Valeriani E, Candeloro M, Tana M, Porreca E, Abbate A, Spoto S, Rutjes AWS, Di Nisio M. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care 2020;24:389. [PMID: 32616077 DOI: 10.1186/s13054-020-03022-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 28.0] [Reference Citation Analysis]
156 Juneja D, Savio RD, Srinivasan S, Pandit RA, Ramasubban S, Reddy PK, Singh M, Gopal PB, Chaudhry D, Govil D, Dixit S, Samavedam S. Basic Critical Care for Management of COVID-19 Patients: Position Paper of Indian Society of Critical Care Medicine, Part-I. Indian J Crit Care Med 2020;24:S244-53. [PMID: 33354048 DOI: 10.5005/jp-journals-10071-23601] [Reference Citation Analysis]
157 Yi Y, Xu Y, Jiang H, Wang J. Cardiovascular Disease and COVID-19: Insight From Cases With Heart Failure. Front Cardiovasc Med 2021;8:629958. [PMID: 33791346 DOI: 10.3389/fcvm.2021.629958] [Reference Citation Analysis]
158 Furqan MM, Verma BR, Cremer PC, Imazio M, Klein AL. Pericardial Diseases in COVID19: a Contemporary Review. Curr Cardiol Rep 2021;23:90. [PMID: 34081219 DOI: 10.1007/s11886-021-01519-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Kotecha T, Knight DS, Razvi Y, Kumar K, Vimalesvaran K, Thornton G, Patel R, Chacko L, Brown JT, Coyle C, Leith D, Shetye A, Ariff B, Bell R, Captur G, Coleman M, Goldring J, Gopalan D, Heightman M, Hillman T, Howard L, Jacobs M, Jeetley PS, Kanagaratnam P, Kon OM, Lamb LE, Manisty CH, Mathurdas P, Mayet J, Negus R, Patel N, Pierce I, Russell G, Wolff A, Xue H, Kellman P, Moon JC, Treibel TA, Cole GD, Fontana M. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J 2021;42:1866-78. [PMID: 33596594 DOI: 10.1093/eurheartj/ehab075] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 37.0] [Reference Citation Analysis]
160 Sharma JB, Sharma E, Sharma S, Singh J. Recommendations for prenatal, intrapartum, and postpartum care during COVID-19 pandemic in India. Am J Reprod Immunol 2020;84:e13336. [PMID: 32877014 DOI: 10.1111/aji.13336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
161 Goldraich LA, Silvestre OM, Gomes E, Biselli B, Montera MW. Emerging Topics in Heart Failure: COVID-19 and Heart Failure. Arq Bras Cardiol 2020;115:942-4. [PMID: 33295461 DOI: 10.36660/abc.20201081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
162 Sonsoz MR, Oncul A, Cevik E, Orta H, Yilmaz M, Ayduk Govdeli E, Nalbant A, Demirtakan ZG, Tonyali M, Durmus D, Anakli I, Polat O, Catma Y, Senkal N, Medetalibeyoglu A, Kose M, Emet S, Tukek T. Wide QRS Complex and Lateral ST-T Segment Abnormality Are Associated With Worse Clinical Outcomes in COVID-19 Patients. Am J Med Sci 2021;361:591-7. [PMID: 33581838 DOI: 10.1016/j.amjms.2020.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
163 Greenhalgh T, Knight M, A’court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. [DOI: 10.1136/bmj.m3026] [Cited by in Crossref: 311] [Cited by in F6Publishing: 259] [Article Influence: 155.5] [Reference Citation Analysis]
164 Consolazio D, Murtas R, Tunesi S, Gervasi F, Benassi D, Russo AG. Assessing the Impact of Individual Characteristics and Neighborhood Socioeconomic Status During the COVID-19 Pandemic in the Provinces of Milan and Lodi. Int J Health Serv 2021;51:311-24. [PMID: 33650453 DOI: 10.1177/0020731421994842] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
165 Çakmak Karaaslan Ö, Özilhan MO, Maden O, Tüfekçioğlu O. Prevalence of cardiac involvement in home-based recovered coronavirus disease 2019 (COVID-19) patients: a retrospective observational study. Ir J Med Sci 2021. [PMID: 34714493 DOI: 10.1007/s11845-021-02824-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Fernández Ibáñez JM, Morales Ballesteros MDC, Fernández Anguita MJ, Galindo Andúgar MÁ, Arias Arias Á, Barberá-Farré JR. Influence of influenza vaccine and comorbidity on the evolution of hospitalized COVID-19 patients. Med Clin (Barc) 2021:S0025-7753(21)00325-0. [PMID: 34304882 DOI: 10.1016/j.medcli.2021.06.003] [Reference Citation Analysis]
167 Zanin M, Papo D. Assessing functional propagation patterns in COVID-19. Chaos Solitons Fractals 2020;138:109993. [PMID: 32546901 DOI: 10.1016/j.chaos.2020.109993] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
168 Baguma S, Okot C, Alema NO, Apiyo P, Layet P, Acullu D, Oloya JN, Ochula D, Atim P, Olwedo PO, Okot SG, Oyat FWD, Oola J, Ikoona EN, Aloyo J, Kitara DL. Factors Associated With Mortality Among the COVID-19 Patients Treated at Gulu Regional Referral Hospital: A Retrospective Study. Front Public Health 2022;10:841906. [DOI: 10.3389/fpubh.2022.841906] [Reference Citation Analysis]
169 Jia X, Virani SS. Statins in COVID-19 infection: A rehash of old themes or truly a new hope? J Clin Lipidol 2021;15:399-401. [PMID: 33994121 DOI: 10.1016/j.jacl.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Shen Q, Li J, Zhang Z, Guo S, Wang Q, An X, Chang H. COVID-19: systemic pathology and its implications for therapy. Int J Biol Sci 2022;18:386-408. [PMID: 34975340 DOI: 10.7150/ijbs.65911] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Mussini C, Cozzi-Lepri A, Menozzi M, Meschiari M, Franceschini E, Rogati C, Cuomo G, Bedini A, Iadisernia V, Volpi S, Milic J, Tonelli R, Brugioni L, Pietrangelo A, Girardis M, Cossarizza A, Clini E, Guaraldi G; Modena Covid-19 Working Group (MoCo19)., Office of information and communication technologies of Policlinico di Modena. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect 2021;27:1137-44. [PMID: 33359539 DOI: 10.1016/j.cmi.2020.12.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
172 Shakaib B, Zohra T, Ikram A, Shakaib MB, Ali A, Bashir A, Salman M, Khan MA, Ansari J. A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come? Virol J 2021;18:120. [PMID: 34098986 DOI: 10.1186/s12985-021-01578-0] [Reference Citation Analysis]
173 Raffaello WM, Huang I, Budi Siswanto B, Pranata R. In-depth review of cardiopulmonary support in COVID-19 patients with heart failure. WJC 2021;13:299-309. [DOI: 10.4330/wjc.v13.i8.299] [Reference Citation Analysis]
174 Percy E, Luc JGY, Vervoort D, Hirji S, Ruel M, Coutinho T. Post-Discharge Cardiac Care in the Era of Coronavirus 2019: How Should We Prepare? Can J Cardiol 2020;36:956-60. [PMID: 32299750 DOI: 10.1016/j.cjca.2020.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
175 Zeng L, Wang S, Cai J, Sun S, Wang S, Li J, Sun L. Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis. Epidemiol Infect 2020;148:e266. [PMID: 33092664 DOI: 10.1017/S0950268820002587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
176 Batta Y, King C, Johnson J, Haddad N, Boueri M, Haddad G. Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems. Front Physiol 2022;12:748972. [DOI: 10.3389/fphys.2021.748972] [Reference Citation Analysis]
177 Climent FJ, Calvo C, García-Guereta L, Rodríguez-Álvarez D, Buitrago NM, Pérez-Martínez A. [Fatal outcome of COVID-19 disease in a 5-month infant with comorbidities]. Rev Esp Cardiol 2020;73:667-9. [PMID: 32834361 DOI: 10.1016/j.recesp.2020.04.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
178 Gemelli Against COVID-19 Post-Acute Care Study Group. Post-COVID-19 global health strategies: the need for an interdisciplinary approach. Aging Clin Exp Res 2020;32:1613-20. [PMID: 32529595 DOI: 10.1007/s40520-020-01616-x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 22.0] [Reference Citation Analysis]
179 Volis I, Livneh I, Hussein K, Raz-Pasteur A. COVID-19-Associated Suspected Myocarditis as the Etiology for Recurrent and Protracted Fever in an Otherwise Healthy Adult. Am J Med Sci 2021;361:522-5. [PMID: 33546881 DOI: 10.1016/j.amjms.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Lala A, Johnson KW, Russak AJ, Paranjpe I, Zhao S, Solani S, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Januzzi J, Mancini DM, Fuster V. Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection. medRxiv 2020:2020. [PMID: 32511658 DOI: 10.1101/2020.04.20.20072702] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
181 Luo S, Qiu XM, Zeng XJ, Zhang DY, Wan B, Li X, Tian RH, Wang JT, Wang MY, Zhu J, Zhang C, Yang R, Chen F, Liang Y, Fan B, Jiang HJ, Wang XM, Chen W, Xu K, Gao JB, Du C, Zhang LN, Yang Y, Jia SJ, Ren H, Zu ZY, Xu PP, Zhong J, Yang YT, Zhou CS, Zhang W, Liu XX, Zhang QR, Xia F, Qi L, Lu MJ, Zhang LJ, Liu YX, Lu GM. Coronary artery calcification and risk of mortality and adverse outcomes in patients with COVID-19: a Chinese multicenter retrospective cohort study. Chin J Acad Radiol 2021;:1-9. [PMID: 34222797 DOI: 10.1007/s42058-021-00072-4] [Reference Citation Analysis]
182 Vahidy FS, Nicolas JC, Meeks JR, Khan O, Pan A, Jones SL, Masud F, Sostman HD, Phillips R, Andrieni JD, Kash BA, Nasir K. Racial and ethnic disparities in SARS-CoV-2 pandemic: analysis of a COVID-19 observational registry for a diverse US metropolitan population. BMJ Open 2020;10:e039849. [PMID: 32784264 DOI: 10.1136/bmjopen-2020-039849] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 38.0] [Reference Citation Analysis]
183 Lü M, Qiu L, Jia G, Guo R, Leng Q. Single-cell expression profiles of ACE2 and TMPRSS2 reveals potential vertical transmission and fetus infection of SARS-CoV-2. Aging (Albany NY) 2020;12:19880-97. [PMID: 33104520 DOI: 10.18632/aging.104015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
184 Kunal S, Sharma SM, Sharma SK, Gautam D, Bhatia H, Mahla H, Sharma S, Bhandari S. Cardiovascular complications and its impact on outcomes in COVID-19. Indian Heart J 2020;72:593-8. [PMID: 33357651 DOI: 10.1016/j.ihj.2020.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
185 Feldman C, Anderson R. Brief review: Cardiac complications and platelet activation in COVID-19 infection. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235425 DOI: 10.7196/AJTCCM.2020.v26i3.107] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
186 Zuin M, Rigatelli G, Bilato C, Zuliani G, Roncon L. Heart failure as a complication of COVID-19 infection: systematic review and meta-analysis. Acta Cardiol 2021;:1-7. [PMID: 34080948 DOI: 10.1080/00015385.2021.1890925] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Shah JZ, Kumar SA, Patel AA. Myocarditis and Pericarditis in Patients with COVID-19. Heart Views 2020;21:209-14. [PMID: 33688413 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_154_20] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
188 Beni ZN, Beni AN, Samani FR, Dayani MA, Beni FN, Radmehr H, Noorshargh P. Multivariable analysis of clinical and laboratory data manifestations predicting severity and mortality risk in patients with Coronavirus disease 2019 in the mountainous west of Iran: a retrospective single-center study. Asian Biomedicine 2022;16:31-42. [DOI: 10.2478/abm-2022-0005] [Reference Citation Analysis]
189 Augustine R, S A, Nayeem A, Salam SA, Augustine P, Dan P, Maureira P, Mraiche F, Gentile C, Hansbro PM, McClements L, Hasan A. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Chem Biol Interact 2021;351:109738. [PMID: 34740598 DOI: 10.1016/j.cbi.2021.109738] [Reference Citation Analysis]
190 Heo E, Oh SJ, Lee HW, Lee JK, Kim DK, Park SW. Veno-arterial extracorporeal membrane oxygenation may be useful in critically ill COVID-19 patients with suspected cardiac injury. Acute Crit Care 2020;35:223-5. [PMID: 32772036 DOI: 10.4266/acc.2020.00262] [Reference Citation Analysis]
191 Narvel H, Sayed A, Narvel N, Yakkali S, Katchi T. Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019? J Clin Med Res 2021;13:195-203. [PMID: 34007357 DOI: 10.14740/jocmr4254] [Reference Citation Analysis]
192 Shang Y, Pan C, Yang X, Zhong M, Shang X, Wu Z, Yu Z, Zhang W, Zhong Q, Zheng X, Sang L, Jiang L, Zhang J, Xiong W, Liu J, Chen D. Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China. Ann Intensive Care 2020;10:73. [PMID: 32506258 DOI: 10.1186/s13613-020-00689-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 27.0] [Reference Citation Analysis]
193 Niazi I, Khan M. Arrhythmias in the Age of Coronavirus Disease 2019. J Innov Card Rhythm Manag 2021;12:4345-8. [PMID: 33520348 DOI: 10.19102/icrm.2021.120107] [Reference Citation Analysis]
194 Pranata R, Huang I, Raharjo SB. Incidence and impact of cardiac arrhythmias in coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Indian Pacing Electrophysiol J 2020;20:193-8. [PMID: 32814094 DOI: 10.1016/j.ipej.2020.08.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
195 Gupta R, Charron J, Stenger CL, Painter J, Steward H, Cook TW, Faber W, Frisch A, Lind E, Bauss J, Li X, Sirpilla O, Soehnlen X, Underwood A, Hinds D, Morris M, Lamb N, Carcillo JA, Bupp C, Uhal BD, Rajasekaran S, Prokop JW. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics. J Biol Chem 2020;295:11742-53. [PMID: 32587094 DOI: 10.1074/jbc.RA120.014873] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
196 Li Y, Xu Y, Shi P, Zhu Y, Hu W, Chen C. Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e21380. [PMID: 32769869 DOI: 10.1097/MD.0000000000021380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
197 Cui N, Jiang C, Yang C, Zhang L, Feng X. Comparison of deep vein thrombosis risks in acute respiratory distress syndrome caused by COVID-19 and bacterial pneumonia: a retrospective cohort study. Thromb J 2022;20:27. [PMID: 35538488 DOI: 10.1186/s12959-022-00386-y] [Reference Citation Analysis]
198 Spaccarotella C, Mazzitelli M, Migliarino S, Curcio A, De Rosa S, Torti C, Indolfi C. Therapy with RAS inhibitors during the COVID-19 pandemic. J Cardiovasc Med (Hagerstown) 2021;22:329-34. [PMID: 33795584 DOI: 10.2459/JCM.0000000000001160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
199 Baker SM, Leedy DJ, Klafter JA, Zhang Y, Secrest KM, Osborn TR, Cheng RK, Judson SD, Merel SE, Mikacenic C, Bhatraju PK, Liles WC. Clinical presentation, complications, and outcomes of hospitalized COVID-19 patients in an academic center with a centralized palliative care consult service. Health Sci Rep 2021;4:e423. [PMID: 34754946 DOI: 10.1002/hsr2.423] [Reference Citation Analysis]
200 Schiavone M, Gasperetti A, Gherbesi E, Bergamaschi L, Arosio R, Mitacchione G, Viecca M, Forleo GB. Arrhythmogenic Risk and Mechanisms of QT-Prolonging Drugs to Treat COVID-19. Cardiac Electrophysiology Clinics 2021. [DOI: 10.1016/j.ccep.2021.10.009] [Reference Citation Analysis]
201 Wu CL, Jules-Elysee KM, Kirksey MA, Liguori GA. Perioperative Nonsteroidal Anti-Inflammatory Agents in the COVID-19 Orthopedic Patient. HSS J 2020;:1-5. [PMID: 32952464 DOI: 10.1007/s11420-020-09783-3] [Reference Citation Analysis]
202 Ruscica M, Macchi C, Iodice S, Tersalvi G, Rota I, Ghidini S, Terranova L, Valenti L, Amati F, Aliberti S, Corsini A, Blasi F, Carugo S, Bollati V, Vicenzi M. Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience. Eur J Clin Invest 2021;51:e13629. [PMID: 34184268 DOI: 10.1111/eci.13629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
203 Sarzani R, Giulietti F, Di Pentima C, Giordano P, Spannella F. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury. Am J Physiol Lung Cell Mol Physiol 2020;319:L325-36. [PMID: 32639866 DOI: 10.1152/ajplung.00189.2020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
204 Petersen-Uribe A, Avdiu A, Martus P, Witzel K, Jaeger P, Zdanyte M, Heinzmann D, Tavlaki E, Warm V, Geisler T, Müller K, Gawaz M, Rath D. Impaired Myocardial Function Is Prognostic for Severe Respiratory Failure in the Course of COVID-19 Infection. Front Cardiovasc Med 2021;8:584108. [PMID: 34150860 DOI: 10.3389/fcvm.2021.584108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
205 Vrettou AR, Parissis J, Ikonomidis I. The Dual Role of Echocardiography in the Diagnosis of Acute Cardiac Complications and Treatment Monitoring for Coronavirus Disease 2019 (COVID-19). Front Cardiovasc Med. 2020;7:129. [PMID: 32984405 DOI: 10.3389/fcvm.2020.00129] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
206 Murugan C, Ramamoorthy S, Kuppuswamy G, Murugan RK, Sivalingam Y, Sundaramurthy A. COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks. Int J Biol Macromol 2021:S0141-8130(21)02301-1. [PMID: 34710479 DOI: 10.1016/j.ijbiomac.2021.10.144] [Reference Citation Analysis]
207 Mariani S, De Piero ME, Ravaux JM, Saelmans A, Kawczynski MJ, van Bussel BCT, Di Mauro M, Willers A, Swol J, Kowalewski M, Li T, Delnoij TSR, van der Horst ICC, Maessen J, Lorusso R. Temporary mechanical circulatory support for COVID‐19 patients: A systematic review of literature. Artificial Organs. [DOI: 10.1111/aor.14261] [Reference Citation Analysis]
208 Gupta YS, Finkelstein M, Manna S, Toussie D, Bernheim A, Little BP, Concepcion J, Maron SZ, Jacobi A, Chung M, Kukar N, Voutsinas N, Cedillo MA, Fernandes A, Eber C, Fayad ZA, Hota P. Coronary artery calcification in COVID-19 patients: an imaging biomarker for adverse clinical outcomes. Clin Imaging 2021;77:1-8. [PMID: 33601125 DOI: 10.1016/j.clinimag.2021.02.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
209 Khaksarinejad R, Arabpour Z, RezaKhani L, Parvizpour F, Rasmi Y. Biomarker based biosensors: An opportunity for diagnosis of COVID-19. Rev Med Virol 2022;:e2356. [PMID: 35478470 DOI: 10.1002/rmv.2356] [Reference Citation Analysis]
210 Dzik S. COVID-19 Convalescent Plasma: Now Is the Time for Better Science. Transfus Med Rev. 2020;. [PMID: 32359789 DOI: 10.1016/j.tmrv.2020.04.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
211 Samuel RM, Majd H, Richter MN, Ghazizadeh Z, Zekavat SM, Navickas A, Ramirez JT, Asgharian H, Simoneau CR, Bonser LR, Koh KD, Garcia-Knight M, Tassetto M, Sunshine S, Farahvashi S, Kalantari A, Liu W, Andino R, Zhao H, Natarajan P, Erle DJ, Ott M, Goodarzi H, Fattahi F. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. Cell Stem Cell 2020;27:876-889.e12. [PMID: 33232663 DOI: 10.1016/j.stem.2020.11.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 48] [Article Influence: 19.0] [Reference Citation Analysis]
212 Tedeschi D, Rizzi A, Biscaglia S, Tumscitz C. Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19. Catheter Cardiovasc Interv 2021;97:272-7. [PMID: 32767631 DOI: 10.1002/ccd.29179] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
213 Barrantes FJ. While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs? Front Physiol 2020;11:820. [PMID: 32719619 DOI: 10.3389/fphys.2020.00820] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
214 Ma L, Song K, Huang Y. Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications. J Cardiothorac Vasc Anesth 2021;35:1860-5. [PMID: 32451271 DOI: 10.1053/j.jvca.2020.04.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
215 Lim W, Suhail M, Diaz K. Diagnostic Challenges of Pneumocystis Pneumonia during the COVID-19 Pandemic: A Case of a Young Patient with Ground Glass Opacities and Pulmonary Embolism on Chest CT. Case Rep Infect Dis 2021;2021:5669543. [PMID: 34373796 DOI: 10.1155/2021/5669543] [Reference Citation Analysis]
216 Arnold RH, Tideman PA, Devlin GP, Carroll GE, Elder A, Lowe H, Macdonald PS, Bannon PG, Juergens C, McGuire M, Mariani JA, Coffey S, Faddy S, Brown A, Inglis S, Wang WYS. Rural and Remote Cardiology During the COVID-19 Pandemic: Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement. Heart Lung Circ 2020;29:e88-93. [PMID: 32487432 DOI: 10.1016/j.hlc.2020.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
217 Luchian ML, Lochy S, Motoc A, Belsack D, Magne J, Roosens B, de Mey J, Tanaka K, Scheirlynck E, Boeckstaens S, Van den Bussche K, De Potter T, von Kemp B, Galloo X, François C, Weytjens C, Droogmans S, Cosyns B. Prognostic Value of Coronary Artery Calcium Score in Hospitalized COVID-19 Patients. Front Cardiovasc Med 2021;8:684528. [PMID: 34307498 DOI: 10.3389/fcvm.2021.684528] [Reference Citation Analysis]
218 Li C, Jiang J, Wang F, Zhou N, Veronese G, Moslehi JJ, Ammirati E, Wang DW. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol 2020;147:74-87. [PMID: 32827510 DOI: 10.1016/j.yjmcc.2020.08.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
219 Golpour A, Patriki D, Hanson PJ, McManus B, Heidecker B. Epidemiological Impact of Myocarditis. J Clin Med 2021;10:603. [PMID: 33562759 DOI: 10.3390/jcm10040603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
220 Liu J, Virani SS, Alam M, Denktas AE, Hamzeh I, Khalid U. Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Rev Med Virol 2021;31:e2172. [PMID: 32959951 DOI: 10.1002/rmv.2172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Manka R, Karolyi M, Polacin M, Holy EW, Nemeth J, Steiger P, Schuepbach RA, Zinkernagel AS, Alkadhi H, Mehra MR, Ruschitzka F. Myocardial edema in COVID-19 on cardiac MRI. J Heart Lung Transplant 2020;39:730-2. [PMID: 32650881 DOI: 10.1016/j.healun.2020.04.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
222 Hasan MZ, Islam S, Matsumoto K, Kawai T. SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs. Sci Rep 2021;11:16814. [PMID: 34413339 DOI: 10.1038/s41598-021-96110-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
223 Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 [PMID: 34630865 DOI: 10.4252/wjsc.v13.i9.1318] [Reference Citation Analysis]
224 Wang M, Jiang N, Li C, Wang J, Yang H, Liu L, Tan X, Chen Z, Gong Y, Yin X, Zong Q, Xiong N, Zhang G. Sex-Disaggregated Data on Clinical Characteristics and Outcomes of Hospitalized Patients With COVID-19: A Retrospective Study. Front Cell Infect Microbiol 2021;11:680422. [PMID: 34123876 DOI: 10.3389/fcimb.2021.680422] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Rex DAB, Arun Kumar ST, Modi PK, Keshava Prasad TS. Broadening COVID-19 Interventions to Drug Innovation: Neprilysin Pathway as a Friend, Foe, or Promising Molecular Target? OMICS 2021;25:408-16. [PMID: 34191617 DOI: 10.1089/omi.2021.0080] [Reference Citation Analysis]
226 Kumar V. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us. Int Rev Immunol 2021;40:5-53. [PMID: 32744465 DOI: 10.1080/08830185.2020.1800688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
227 Rastogi A, Tewari P. Covid 19 and its cardiovascular effects. Ann Card Anaesth 2020;23:401-8. [PMID: 33109794 DOI: 10.4103/aca.aca_237_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
228 Bahrami A, Ferns GA. Genetic and pathogenic characterization of SARS-CoV-2: a review. Future Virology 2020;15:533-49. [DOI: 10.2217/fvl-2020-0129] [Cited by in Crossref: 7] [Article Influence: 3.5] [Reference Citation Analysis]
229 Kashour T, Halwani R, Arabi YM, Sohail MR, O'Horo JC, Badley AD, Tleyjeh IM. Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility. Immunopharmacol Immunotoxicol 2021;43:37-50. [PMID: 33406943 DOI: 10.1080/08923973.2020.1863984] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
230 Bartolomucci A, Sapolsky RM. Psychosocial Risk Factors, Noncommunicable Diseases, and Animal Models for COVID-19. Biol Psychiatry 2021;89:e67-71. [PMID: 33487440 DOI: 10.1016/j.biopsych.2020.12.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
231 Rey JR, Caro-Codón J, Poveda Pineda D, Merino JL, Iniesta ÁM, López-Sendón JL; investigadores CARD-COVID. [Arterial thrombotic complications in hospitalized patients with COVID-19]. Rev Esp Cardiol 2020;73:769-71. [PMID: 32834364 DOI: 10.1016/j.recesp.2020.05.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
232 Barochiner J, Martínez R. Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis. J Clin Pharm Ther 2020;45:1244-52. [PMID: 32767823 DOI: 10.1111/jcpt.13246] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
233 Amin A, Eftekhar SP, Ziaie N, Roudbari S, Salehi P, Jalali F, Jafaripour I, Ghaffari S, Mohseni Salehi M, Ebadi R. Clinically suspected myocarditis in COVID-19 patients: Case series and review of the literature. Clin Case Rep 2021;9:e05236. [PMID: 34963812 DOI: 10.1002/ccr3.5236] [Reference Citation Analysis]
234 Bleakley C, Singh S, Garfield B, Morosin M, Surkova E, Mandalia MS, Dias B, Androulakis E, Price LC, McCabe C, Wort SJ, West C, Li W, Khattar R, Senior R, Patel BV, Price S. Right ventricular dysfunction in critically ill COVID-19 ARDS. Int J Cardiol 2021;327:251-8. [PMID: 33242508 DOI: 10.1016/j.ijcard.2020.11.043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
235 Biscetti F, Rando MM, Nardella E, Cecchini AL, Bruno P, Landolfi R, Flex A. Cardiovascular Disease and SARS-CoV-2: the Role of Host Immune Response Versus Direct Viral Injury. Int J Mol Sci 2020;21:E8141. [PMID: 33143371 DOI: 10.3390/ijms21218141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
236 Garg A, Seeliger B, Derda AA, Xiao K, Gietz A, Scherf K, Sonnenschein K, Pink I, Hoeper MM, Welte T, Bauersachs J, David S, Bär C, Thum T. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur J Heart Fail 2021;23:468-75. [PMID: 33421274 DOI: 10.1002/ejhf.2096] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
237 Crook RL, Williams H, Green M, Brown S, Morris R, Fletcher H, Walters S, Walsh C, Price A, King S, McAloon CJ. Prospective multicentre cohort study of transthoracic echocardiography provision in the South West of the UK during the first wave of SARS-CoV-2 pandemic. Open Heart 2021;8:e001409. [PMID: 33504630 DOI: 10.1136/openhrt-2020-001409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Zhang L, Xu J, Qi X, Tao Z, Yang Z, Chen W, Wang X, Pan T, Dai Y, Tian R, Chen Y, Tang B, Liu Z, Tan R, Qu H, Yu Y, Liu J. Development and Validation of a Nomogram for Predicting the Risk of Coronavirus-Associated Acute Respiratory Distress Syndrome: A Retrospective Cohort Study. IDR 2022;Volume 15:2371-81. [DOI: 10.2147/idr.s348278] [Reference Citation Analysis]
239 Shah P, Doshi R, Chenna A, Owens R, Cobb A, Ivey H, Newton S, Mccarley K. Prognostic Value of Elevated Cardiac Troponin I in Hospitalized Covid-19 Patients.Am J Cardiol. 2020;135:150-153. [PMID: 32861733 DOI: 10.1016/j.amjcard.2020.08.041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
240 Brojakowska A, Eskandari A, Bisserier M, Bander J, Garikipati VNS, Hadri L, Goukassian DA, Fish KM. Comorbidities, sequelae, blood biomarkers and their associated clinical outcomes in the Mount Sinai Health System COVID-19 patients. PLoS One 2021;16:e0253660. [PMID: 34228746 DOI: 10.1371/journal.pone.0253660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Rea IM, Alexander HD. Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing. Ageing Res Rev 2021;73:101494. [PMID: 34688926 DOI: 10.1016/j.arr.2021.101494] [Reference Citation Analysis]
242 Shi C, Wang L, Ye J, Gu Z, Wang S, Xia J, Xie Y, Li Q, Xu R, Lin N. Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infect Dis 2021;21:663. [PMID: 34238232 DOI: 10.1186/s12879-021-06369-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
243 Berg N, Ilonze O, Bajpai V, Guglin M, Rao R. Acute Biventricular Heart Failure After COVID-19 Infection in an Orthotropic Heart Transplant Patient: A Case Report. Transplant Proc 2021;53:1224-6. [PMID: 33892935 DOI: 10.1016/j.transproceed.2021.03.013] [Reference Citation Analysis]
244 Jin S, Jin Y, Xu B, Hong J, Yang X. Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis. Thromb Haemost 2020;120:1524-35. [PMID: 32679593 DOI: 10.1055/s-0040-1714369] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
245 [DOI: 10.1101/2020.05.12.20095885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
246 Garg N, McClafferty B, Ramgobin D, Golamari R, Jain R, Jain R. Cardiology and COVID-19: do we have sufficient information? Future Cardiol 2021;17:705-11. [PMID: 33124920 DOI: 10.2217/fca-2020-0126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Sharma A, Garcia G Jr, Wang Y, Plummer JT, Morizono K, Arumugaswami V, Svendsen CN. Human iPSC-Derived Cardiomyocytes Are Susceptible to SARS-CoV-2 Infection. Cell Rep Med 2020;1:100052. [PMID: 32835305 DOI: 10.1016/j.xcrm.2020.100052] [Cited by in Crossref: 89] [Cited by in F6Publishing: 105] [Article Influence: 44.5] [Reference Citation Analysis]
248 Tucker NR, Chaffin M, Bedi KC Jr, Papangeli I, Akkad AD, Arduini A, Hayat S, Eraslan G, Muus C, Bhattacharyya RP, Stegmann CM;  Human Cell Atlas Lung Biological Network; Margulies KB, Ellinor PT;  Human Cell Atlas Lung Biological Network Consortium Members. Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2-Mediated Myocarditis. Circulation. 2020;142:708-710. [PMID: 32795091 DOI: 10.1161/circulationaha.120.047911] [Cited by in Crossref: 9] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
249 Arévalos V, Ortega-Paz L, Rodríguez-Arias JJ, Calvo López M, Castrillo-Golvano L, Salazar-Rodríguez A, Sabaté-Tormos M, Spione F, Sabaté M, Brugaletta S. Acute and Chronic Effects of COVID-19 on the Cardiovascular System. J Cardiovasc Dev Dis 2021;8:128. [PMID: 34677197 DOI: 10.3390/jcdd8100128] [Reference Citation Analysis]
250 Lewis MJ, Anderson BR, Fremed M, Argenio M, Krishnan U, Weller R, Levasseur S, Sommer R, Lytrivi ID, Bacha EA, Vincent J, Chung WK, Rosenzweig EB, Starc TJ, Rosenbaum M; CUIMC Pediatric/Adult Congenital Heart Research Collaborative ‡. Impact of Coronavirus Disease 2019 (COVID-19) on Patients With Congenital Heart Disease Across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City. J Am Heart Assoc 2020;9:e017580. [PMID: 33196343 DOI: 10.1161/JAHA.120.017580] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
251 Thakkar S, Arora S, Kumar A, Jaswaney R, Faisaluddin M, Ammad Ud Din M, Shariff M, Barssoum K, Patel HP, Nirav A, Jani C, Patel K, Savani S, DeSimone C, Mulpuru S, Deshmukh A. A Systematic Review of the Cardiovascular Manifestations and Outcomes in the Setting of Coronavirus-19 Disease. Clin Med Insights Cardiol 2020;14:1179546820977196. [PMID: 33312009 DOI: 10.1177/1179546820977196] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
252 Gómez-Mesa JE, Galindo-Coral S, Montes MC, Alarco W, Barisani JL, Magaña A, Perna ER, Romero A, Speranza M, Mendoza I, Wyss F. Latin-American Registry of Cardiovascular Disease and COVID-19: Rationale and Design of the CARDIO COVID 19-20 Registry. Glob Heart 2021;16:14. [PMID: 33833938 DOI: 10.5334/gh.925] [Reference Citation Analysis]
253 Noda T, Tada H. COVID-19 and AV block: An Unusual Manifestation. Intern Med 2021;60:2525-6. [PMID: 34148953 DOI: 10.2169/internalmedicine.7083-21] [Reference Citation Analysis]
254 Lehrich BM, Goshtasbi K, Raad RA, Ganti A, Papagiannopoulos P, Tajudeen BA, Kuan EC. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses. Otolaryngol Head Neck Surg 2020;163:156-61. [PMID: 32423285 DOI: 10.1177/0194599820929278] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
255 Buckley BJR, Harrison SL, Fazio-Eynullayeva E, Underhill P, Lane DA, Lip GYH. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest 2021;51:e13679. [PMID: 34516657 DOI: 10.1111/eci.13679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
256 Xia J, Wu T, Zhou L. Sharing of Verified Information about COVID-19 on Social Network Sites: A Social Exchange Theory Perspective. Int J Environ Res Public Health 2021;18:1260. [PMID: 33572493 DOI: 10.3390/ijerph18031260] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Narula S, Yusuf S, Chong M, Ramasundarahettige C, Rangarajan S, Bangdiwala SI, van Eikels M, Leineweber K, Wu A, Pigeyre M, Paré G. Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis. Lancet 2020;396:968-76. [PMID: 33010842 DOI: 10.1016/S0140-6736(20)31964-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
258 Hasan MR, Suleiman M, Pérez-López A. Metabolomics in the Diagnosis and Prognosis of COVID-19. Front Genet 2021;12:721556. [PMID: 34367265 DOI: 10.3389/fgene.2021.721556] [Reference Citation Analysis]
259 Marchiano S, Hsiang TY, Khanna A, Higashi T, Whitmore LS, Bargehr J, Davaapil H, Chang J, Smith E, Ong LP, Colzani M, Reinecke H, Yang X, Pabon L, Sinha S, Najafian B, Sniadecki NJ, Bertero A, Gale M Jr, Murry CE. SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical Function. Stem Cell Reports 2021;16:478-92. [PMID: 33657418 DOI: 10.1016/j.stemcr.2021.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
260 Ding J, Liu W, Guan H, Feng Y, Bao Y, Li H, Wang X, Zhou Z, Chen Z. Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy. Medicine (Baltimore) 2021;100:e26538. [PMID: 34260531 DOI: 10.1097/MD.0000000000026538] [Reference Citation Analysis]
261 Bhatia RT, Marwaha S, Malhotra A, Iqbal Z, Hughes C, Börjesson M, Niebauer J, Pelliccia A, Schmied C, Serratosa L, Papadakis M, Sharma S. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol 2020;27:1242-51. [PMID: 32475157 DOI: 10.1177/2047487320930596] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 18.0] [Reference Citation Analysis]
262 Suri JS, Agarwal S, Gupta SK, Puvvula A, Biswas M, Saba L, Bit A, Tandel GS, Agarwal M, Patrick A, Faa G, Singh IM, Oberleitner R, Turk M, Chadha PS, Johri AM, Miguel Sanches J, Khanna NN, Viskovic K, Mavrogeni S, Laird JR, Pareek G, Miner M, Sobel DW, Balestrieri A, Sfikakis PP, Tsoulfas G, Protogerou A, Misra DP, Agarwal V, Kitas GD, Ahluwalia P, Teji J, Al-Maini M, Dhanjil SK, Sockalingam M, Saxena A, Nicolaides A, Sharma A, Rathore V, Ajuluchukwu JNA, Fatemi M, Alizad A, Viswanathan V, Krishnan PK, Naidu S. A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. Comput Biol Med 2021;130:104210. [PMID: 33550068 DOI: 10.1016/j.compbiomed.2021.104210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
263 Li C, Wang DW, Zhao C. Cardiovascular Involvement in Patients with 2019 Novel Coronavirus Disease. J Transl Int Med 2021;9:152-60. [PMID: 34900625 DOI: 10.2478/jtim-2021-0016] [Reference Citation Analysis]
264 Possari RY, Andrade-Gomes HJ, Mello VC, Galdeano EA, Aguiar-Filho LF, Bittencourt MS, Ponte EV, Bertoche LR, Caio LRS, Rodrigues JD, Alcantara FB, Freitas MAC, Sarinho JCGC, Cervigne NK, Rodrigues WM, Aprahamian I. Association of coronary calcification with prognosis of Covid-19 patients without known heart disease. Braz J Med Biol Res 2021;54:e11681. [PMID: 34878066 DOI: 10.1590/1414-431X2021e11681] [Reference Citation Analysis]
265 Vaidya A, Golbus JR, Vedage NA, Mazurek J, Raza F, Forfia PR. Virtual echocardiography screening tool to differentiate hemodynamic profiles in pulmonary hypertension. Pulm Circ 2020;10:2045894020950225. [PMID: 32994924 DOI: 10.1177/2045894020950225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
266 Zylla MM, Merle U, Vey JA, Korosoglou G, Hofmann E, Müller M, Herth F, Schmidt W, Blessing E, Göggelmann C, Weidner N, Fiedler MO, Weigand MA, Kälble F, Morath C, Leiner J, Kieser M, Katus HA, Thomas D. Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19. J Clin Med 2021;10:E133. [PMID: 33401735 DOI: 10.3390/jcm10010133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
267 Mohamed MO, Banerjee A, Clarke S, de Belder M, Patwala A, Goodwin AT, Kwok CS, Rashid M, Gale CP, Curzen N, Mamas MA. Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality. Eur Heart J Qual Care Clin Outcomes 2021;7:247-56. [PMID: 33079204 DOI: 10.1093/ehjqcco/qcaa079] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
268 Kavsak PA, Hammarsten O, Worster A, Smith SW, Apple FS. Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results. Clin Chem 2021;67:107-13. [PMID: 33045044 DOI: 10.1093/clinchem/hvaa225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
269 Bieber S, Kraechan A, Hellmuth JC, Muenchhoff M, Scherer C, Schroeder I, Irlbeck M, Kaeaeb S, Massberg S, Hausleiter J, Grabmaier U, Orban M, Weckbach LT. Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury. Infection 2021;49:491-500. [PMID: 33515390 DOI: 10.1007/s15010-020-01572-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
270 Tersalvi G, Veronese G, Winterton D. Emerging evidence of myocardial injury in COVID-19: A path through the smoke. Theranostics 2020;10:9888-9. [PMID: 32863965 DOI: 10.7150/thno.50788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
271 Vidovich MI, Fischman DL, Bates ER. COVID-19 STEMI 2020: It's Not What You Know, It's How You Think. JACC Case Rep 2020;2:1289-90. [PMID: 32342050 DOI: 10.1016/j.jaccas.2020.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
272 Gerstein NS, Venkataramani R, Goumas AM, Chapman NN, Deriy L. COVID-19-Related Cardiovascular Disease and Practical Considerations for Perioperative Clinicians. Semin Cardiothorac Vasc Anesth 2020;24:293-303. [PMID: 32706293 DOI: 10.1177/1089253220943019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
273 Maev IV, Shpektor AV, Vasilyeva EY, Manchurov VN, Andreev DN. [Novel coronavirus infection COVID-19: extrapulmonary manifestations]. Ter Arkh 2020;92:4-11. [PMID: 33346454 DOI: 10.26442/00403660.2020.08.000767] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
274 Perez-Bermejo JA, Kang S, Rockwood SJ, Simoneau CR, Joy DA, Silva AC, Ramadoss GN, Flanigan WR, Fozouni P, Li H, Chen PY, Nakamura K, Whitman JD, Hanson PJ, McManus BM, Ott M, Conklin BR, McDevitt TC. SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19. Sci Transl Med 2021;13:eabf7872. [PMID: 33723017 DOI: 10.1126/scitranslmed.abf7872] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
275 Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A, Kutys B, Guo L, Cornelissen A, Mori M, Sato Y, Pescetelli I, Brivio M, Romero M, Guagliumi G, Virmani R, Finn AV. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week. J Am Coll Cardiol 2021;77:314-25. [PMID: 33478655 DOI: 10.1016/j.jacc.2020.11.031] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 39.0] [Reference Citation Analysis]
276 Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E. A comprehensive review of COVID-19 characteristics. Biol Proced Online 2020;22:19. [PMID: 32774178 DOI: 10.1186/s12575-020-00128-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 37.0] [Reference Citation Analysis]
277 Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 2020;131:110678. [PMID: 32861070 DOI: 10.1016/j.biopha.2020.110678] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
278 Rocha ASCD, Volschan A, Campos LAA, Coelho RPDS, Thielmann DCDA, Ferreira CALC, Colafranceschi AS. Predictive Value of Myocardial injury in Patients with COVID-19 Admitted to a Quaternary Hospital in the City of Rio de Janeiro. International Journal of Cardiovascular Sciences 2021. [DOI: 10.36660/ijcs.20200352] [Reference Citation Analysis]
279 Jin H, Yang S, Yang F, Zhang L, Weng H, Liu S, Fan F, Li H, Zheng X, Yang H, Zhang Y, Zhou J, Li J. Elevated resting heart rates are a risk factor for mortality among patients with coronavirus disease 2019 in Wuhan, China. Journal of Translational Internal Medicine 2021;9:285-93. [DOI: 10.2478/jtim-2021-0042] [Reference Citation Analysis]
280 Calvo-Fernández A, Izquierdo A, Subirana I, Farré N, Vila J, Durán X, García-Guimaraes M, Valdivielso S, Cabero P, Soler C, García-Ribas C, Rodríguez C, Llagostera M, Mojón D, Vicente M, Solé-González E, Sánchez-Carpintero A, Tevar C, Marrugat J, Vaquerizo B. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis. Rev Esp Cardiol (Engl Ed) 2021;74:576-83. [PMID: 33153955 DOI: 10.1016/j.rec.2020.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
281 Ramírez-Soto MC, Arroyo-Hernández H, Ortega-Cáceres G. Sex differences in the incidence, mortality, and fatality of COVID-19 in Peru. PLoS One 2021;16:e0253193. [PMID: 34125851 DOI: 10.1371/journal.pone.0253193] [Reference Citation Analysis]
282 Haslbauer JD, Tzankov A, Mertz KD, Schwab N, Nienhold R, Twerenbold R, Leibundgut G, Stalder AK, Matter M, Glatz K. Characterisation of cardiac pathology in 23 autopsies of lethal COVID-19. J Pathol Clin Res 2021;7:326-37. [PMID: 33837673 DOI: 10.1002/cjp2.212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
283 Leong A, Cole JB, Brenner LN, Meigs JB, Florez JC, Mercader JM. Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis. PLoS Med 2021;18:e1003553. [PMID: 33661905 DOI: 10.1371/journal.pmed.1003553] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
284 Bamgboje A, Hong J, Mushiyev S, Pekler G. A 61-Year-Old Man with SARS-CoV-2 Infection and Venous Thrombosis Presenting with Painful Swelling and Gangrene of the Lower Limb Consistent with Phlegmasia Cerulea Dolens. Am J Case Rep 2020;21:e928342. [PMID: 33323917 DOI: 10.12659/AJCR.928342] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
285 Melillo F, Napolano A, Loffi M, Regazzoni V, Boccellino A, Danzi GB, Cappelletti AM, Rovere-Querini P, Landoni G, Ingallina G, Stella S, Ancona F, Dagna L, Scarpellini P, Ripa M, Castagna A, Tresoldi M, Zangrillo A, Ciceri F, Agricola E. Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19. Eur J Clin Invest 2021;:e13703. [PMID: 34706062 DOI: 10.1111/eci.13703] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
286 Díaz JJS, Rincon JM, López MAR, Zuleta MB, Castellanos N, Saavedra ZS, Rodríguez HC, Barrera DFH, Parra JE, Fernández JJD. Echocardiographic 60-day mortality markers in patients hospitalized in intensive care for COVID-19. Heart Lung 2022;52:123-9. [PMID: 35016107 DOI: 10.1016/j.hrtlng.2021.12.007] [Reference Citation Analysis]
287 Haseeb S, Gul EE, Çinier G, Bazoukis G, Alvarez-Garcia J, Garcia-Zamora S, Lee S, Yeung C, Liu T, Tse G, Baranchuk A; International Society of Electrocardiology Young Community (ISE-YC). Value of electrocardiography in coronavirus disease 2019 (COVID-19). J Electrocardiol 2020;62:39-45. [PMID: 32805546 DOI: 10.1016/j.jelectrocard.2020.08.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
288 Patti G, Lio V, Cavallari I, Gragnano F, Riva L, Calabrò P, Di Pasquale G, Pengo V, Rubboli A; Italian Study Group on Atherosclerosis, Thrombosis, Vascular Biology. Questions and Answers on Practical Thrombotic Issues in SARS-CoV-2 Infection: A Guidance Document from the Italian Working Group on Atherosclerosis, Thrombosis and Vascular Biology. Am J Cardiovasc Drugs 2020;20:559-70. [PMID: 33145698 DOI: 10.1007/s40256-020-00446-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
289 Abutaleb A, Nathan S. COVID-19 infection-associated coagulopathy: Pathophysiology and clinical implications. Interv Neuroradiol 2021;27:6-12. [PMID: 34747644 DOI: 10.1177/15910199211035894] [Reference Citation Analysis]
290 Magleby R, Westblade LF, Trzebucki A, Simon MS, Rajan M, Park J, Goyal P, Safford MM, Satlin MJ. Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019. Clin Infect Dis. 2020;. [PMID: 32603425 DOI: 10.1093/cid/ciaa851] [Cited by in Crossref: 135] [Cited by in F6Publishing: 127] [Article Influence: 67.5] [Reference Citation Analysis]
291 Ciaffi J, Meliconi R, Ruscitti P, Berardicurti O, Giacomelli R, Ursini F. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol 2020;4:65. [PMID: 33123675 DOI: 10.1186/s41927-020-00165-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
292 Kwee TC, Kwee RM. Chest CT in COVID-19: What the Radiologist Needs to Know. Radiographics. 2020;40:1848-1865. [PMID: 33095680 DOI: 10.1148/rg.2020200159] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 29.5] [Reference Citation Analysis]
293 Halpin-Veszeleiova K, Hatfield SM. Therapeutic Targeting of Hypoxia-A2-Adenosinergic Pathway in COVID-19 Patients. Physiology (Bethesda) 2022;37:46-52. [PMID: 34486395 DOI: 10.1152/physiol.00010.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Yonter SJ, Alter K, Bartels MN, Bean JF, Brodsky MB, González-Fernández M, Henderson DK, Hoenig H, Russell H, Needham DM, Kumble S, Chan L. What Now for Rehabilitation Specialists? Coronavirus Disease 2019 Questions and Answers. Arch Phys Med Rehabil 2020;101:2233-42. [PMID: 32966809 DOI: 10.1016/j.apmr.2020.09.368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
295 Xia F, Zhang M, Cui B, An W, Chen M, Yang P, Qin T, Zhou X, Liao Y, Xu X, Liu S, Li K, Zhou Q, Wang K, Hu G, Du M, Chen S, Zhang Y, Wei W, Xiang M, Zhang J. COVID-19 patients with hypertension are at potential risk of worsened organ injury. Sci Rep 2021;11:3779. [PMID: 33580165 DOI: 10.1038/s41598-021-83295-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Clouston SAP, Luft BJ, Sun E. Clinical risk factors for mortality in an analysis of 1375 patients admitted for COVID treatment. Sci Rep 2021;11:23414. [PMID: 34862487 DOI: 10.1038/s41598-021-02920-w] [Reference Citation Analysis]
297 Salerno JA, Torquato T, Temerozo JR, Goto-Silva L, Karmirian K, Mendes MA, Sacramento CQ, Fintelman-Rodrigues N, Souza LRQ, Ornelas IM, Veríssimo CP, Aragão LGHS, Vitória G, Pedrosa CSG, da Silva Gomes Dias S, Cardoso Soares V, Puig-Pijuan T, Salazar V, Dariolli R, Biagi D, Furtado DR, Barreto Chiarini L, Borges HL, Bozza PT, Zaluar P Guimarães M, Souza TML, Rehen SK. Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating. PeerJ 2021;9:e12595. [PMID: 35036128 DOI: 10.7717/peerj.12595] [Reference Citation Analysis]
298 Chowdhury D, Fremed MA, Dean P, Glickstein JS, Robinson J, Rellosa N, Thacker D, Soma D, Briskin SM, Asplund C, Johnson J, Snyder C. Return to Activity After SARS-CoV-2 Infection: Cardiac Clearance for Children and Adolescents. Sports Health 2021;:19417381211039746. [PMID: 34427496 DOI: 10.1177/19417381211039746] [Reference Citation Analysis]
299 An PJ, Zhu YZ, Yang LP. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications. Pharmacol Res 2020;159:104946. [PMID: 32450346 DOI: 10.1016/j.phrs.2020.104946] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
300 Shalash AO, Hussein WM, Skwarczynski M, Toth I. Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative. Adv Sci (Weinh) 2021;8:e2100985. [PMID: 34176237 DOI: 10.1002/advs.202100985] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
301 Venditto VJ, Haydar D, Abdel-Latif A, Gensel JC, Anstead MI, Pitts MG, Creameans J, Kopper TJ, Peng C, Feola DJ. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19. Front Immunol 2021;12:574425. [PMID: 33643308 DOI: 10.3389/fimmu.2021.574425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
302 Rosoff DB, Yoo J, Lohoff FW. Smoking is significantly associated with increased risk of COVID-19 and other respiratory infections. Commun Biol 2021;4:1230. [PMID: 34711921 DOI: 10.1038/s42003-021-02685-y] [Reference Citation Analysis]
303 Ielapi N, Licastro N, Provenzano M, Andreucci M, Franciscis S, Serra R. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis. Biomark Med 2020;14:713-6. [PMID: 32426991 DOI: 10.2217/bmm-2020-0201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
304 Keller KG, Reangsing C, Schneider JK. Clinical presentation and outcomes of hospitalized adults with COVID-19: A systematic review. J Adv Nurs 2020;76:3235-57. [PMID: 32881050 DOI: 10.1111/jan.14558] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
305 Johnson JE, McGuone D, Xu ML, Jane-Wit D, Mitchell RN, Libby P, Pober JS. Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis: Correlation with Neutrophil but Not Endothelial Activation. Am J Pathol 2021:S0002-9440(21)00429-6. [PMID: 34599881 DOI: 10.1016/j.ajpath.2021.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Sandoval Y, Januzzi JL Jr, Jaffe AS. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol 2020;76:1244-58. [PMID: 32652195 DOI: 10.1016/j.jacc.2020.06.068] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 50.0] [Reference Citation Analysis]
307 Cihakova D, Streiff MB, Menez SP, Chen TK, Gilotra NA, Michos ED, Marr KA, Karaba AH, Robinson ML, Blair PW, Dioverti MV, Post WS, Cox AL, R Antar AA. High-value laboratory testing for hospitalized COVID-19 patients: a review. Future Virol 2021. [PMID: 34567235 DOI: 10.2217/fvl-2020-0316] [Reference Citation Analysis]
308 Shi W, Lv J, Lin L. Coagulopathy in COVID-19: Focus on vascular thrombotic events. J Mol Cell Cardiol 2020;146:32-40. [PMID: 32681845 DOI: 10.1016/j.yjmcc.2020.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
309 Mahajan K, Chand Negi P, Ganju N, Sondhi S, Gaur N, Somendra R. Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts. Int J Hypertens 2020;2020:1025913. [PMID: 33145103 DOI: 10.1155/2020/1025913] [Reference Citation Analysis]
310 Higgins V, Sohaei D, Diamandis EP, Prassas I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci 2021;58:297-310. [PMID: 33347790 DOI: 10.1080/10408363.2020.1860895] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
311 Vrsalovic M, Vrsalovic Presecki A. Cardiac troponins predict mortality in patients with COVID-19: A meta-analysis of adjusted risk estimates. J Infect 2020;81:e99-e100. [PMID: 32416124 DOI: 10.1016/j.jinf.2020.05.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
312 Niu W, Wu F, Cui H, Cao W, Chao Y, Wu Z, Fan M, Liang C. Network Pharmacology Analysis to Identify Phytochemicals in Traditional Chinese Medicines That May Regulate ACE2 for the Treatment of COVID-19. Evid Based Complement Alternat Med 2020;2020:7493281. [PMID: 33204291 DOI: 10.1155/2020/7493281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
313 Megiorni F, Pontecorvi P, Gerini G, Anastasiadou E, Marchese C, Ceccarelli S. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19. Biomolecules 2022;12:21. [DOI: 10.3390/biom12010021] [Reference Citation Analysis]
314 Gordon JS, Drazner MH. Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review. Curr Heart Fail Rep 2021;18:163-8. [PMID: 33666855 DOI: 10.1007/s11897-021-00505-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Chen S, Yang L, Nilsson-Payant B, Han Y, Jaffré F, Zhu J, Wang P, Zhang T, Redmond D, Houghton S, Møller R, Hoagland D, Horiuchi S, Acklin J, Lim J, Bram Y, Richardson C, Chandar V, Borczuk A, Huang Y, Xiang J, Ho D, Schwartz R, tenOever B, Evans T. SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2. Res Sq 2020:rs. [PMID: 33236003 DOI: 10.21203/rs.3.rs-94634/v1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
316 Oséas JM, Oliveira WSD, Oliveira BA, Miranda JM, Barros RGV, Oliveira NRD. Takotsubo Syndrome as a Complication of Mild COVID-19: A Case Report. International Journal of Cardiovascular Sciences 2021. [DOI: 10.36660/ijcs.20200398] [Reference Citation Analysis]
317 Licu R, Blîndu E, Benedek I, Benedek T. Decrease of Cardiovascular Emergencies During the COVID-19 Pandemic. Journal Of Cardiovascular Emergencies 2020;6:59-62. [DOI: 10.2478/jce-2020-0011] [Reference Citation Analysis]
318 Caiado LDC, Azevedo NC, Azevedo RRC, Caiado BR. Cardiac involvement in patients recovered from COVID-19 identified using left ventricular longitudinal strain. J Echocardiogr 2021. [PMID: 34648149 DOI: 10.1007/s12574-021-00555-4] [Reference Citation Analysis]
319 Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, Madhur MS, Tomaszewski M, Maffia P, D'Acquisto F, Nicklin SA, Marian AJ, Nosalski R, Murray EC, Guzik B, Berry C, Touyz RM, Kreutz R, Wang DW, Bhella D, Sagliocco O, Crea F, Thomson EC, McInnes IB. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020;116:1666-87. [PMID: 32352535 DOI: 10.1093/cvr/cvaa106] [Cited by in Crossref: 487] [Cited by in F6Publishing: 433] [Article Influence: 243.5] [Reference Citation Analysis]
320 Verma AK, Vader JM. Building Experience and Evidence: COVID-19 and Myocardial Injury. Circ Cardiovasc Imaging 2021;14:e012220. [PMID: 33461305 DOI: 10.1161/CIRCIMAGING.120.012220] [Reference Citation Analysis]
321 Coto E, Avanzas P, Gómez J. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019. Eur Cardiol 2021;16:e07. [PMID: 33737961 DOI: 10.15420/ecr.2020.30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
322 Liaqat A, Ali-Khan RS, Asad M, Rafique Z. Evaluation of myocardial injury patterns and ST changes among critical and non-critical patients with coronavirus-19 disease. Sci Rep 2021;11:4828. [PMID: 33649391 DOI: 10.1038/s41598-021-84467-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
323 Ma H, Cassedy A, O'Kennedy R. The role of antibody-based troponin detection in cardiovascular disease: A critical assessment. J Immunol Methods 2021;:113108. [PMID: 34329690 DOI: 10.1016/j.jim.2021.113108] [Reference Citation Analysis]
324 Singh M, Bansal V, Feschotte C. A single-cell RNA expression map of human coronavirus entry factors. bioRxiv 2020:2020. [PMID: 32511375 DOI: 10.1101/2020.05.08.084806] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 8.5] [Reference Citation Analysis]
325 Li J, Zhang Y, Wang F, Liu B, Li H, Tang G, Chang Z, Liu A, Fu C, Lv Y, Gao J, Li J. Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19). BMC Cardiovasc Disord 2020;20:479. [PMID: 33167876 DOI: 10.1186/s12872-020-01758-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
326 Garcia G Jr, Sharma A, Ramaiah A, Sen C, Purkayastha A, Kohn DB, Parcells MS, Beck S, Kim H, Bakowski MA, Kirkpatrick MG, Riva L, Wolff KC, Han B, Yuen C, Ulmert D, Purbey PK, Scumpia P, Beutler N, Rogers TF, Chatterjee AK, Gabriel G, Bartenschlager R, Gomperts B, Svendsen CN, Betz UAK, Damoiseaux RD, Arumugaswami V. Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication. Cell Rep 2021;35:108940. [PMID: 33784499 DOI: 10.1016/j.celrep.2021.108940] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
327 O'Shea PM, Lee GR, Griffin TP, Tormey V, Hayat A, Costelloe SJ, Griffin DG, Srinivasan S, O'Kane M, Burke CM, Faul J, Thompson CJ, Curley G, Tormey WP. COVID-19 in adults: test menu for hospital blood science laboratories. Ir J Med Sci 2020;189:1147-52. [PMID: 32424603 DOI: 10.1007/s11845-020-02252-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
328 Benzano D, Ornell F, Schuch JB, Pechansky F, Sordi AO, von Diemen L, Kessler FHP. Clinical vulnerability for severity and mortality by COVID-19 among users of alcohol and other substances. Psychiatry Res 2021;300:113915. [PMID: 33836472 DOI: 10.1016/j.psychres.2021.113915] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
329 Rezabakhsh A, Sadat-Ebrahimi SR, Ala A, Nabavi SM, Banach M, Ghaffari S. A close-up view of dynamic biomarkers in the setting of COVID-19: Striking focus on cardiovascular system. J Cell Mol Med 2021. [PMID: 34894069 DOI: 10.1111/jcmm.17122] [Reference Citation Analysis]
330 Liu C, Ferrari VA, Han Y. Cardiovascular Magnetic Resonance Imaging and Heart Failure. Curr Cardiol Rep 2021;23:35. [PMID: 33686516 DOI: 10.1007/s11886-021-01464-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
331 Chen X, Gao W, Li J, You D, Yu Z, Zhang M, Shao F, Wei Y, Zhang R, Lange T, Wang Q, Chen F, Lu X, Zhao Y. A predictive paradigm for COVID-19 prognosis based on the longitudinal measure of biomarkers. Brief Bioinform 2021:bbab206. [PMID: 34081102 DOI: 10.1093/bib/bbab206] [Reference Citation Analysis]
332 Aciksari G, Cetinkal G, Kocak M, Cag Y, Atici A, Altunal LN, Barman HA, Aydın M, Kocas BB, Cam G, Guclu KG, Caliskan M. Evaluation of Modified ATRIA Risk Score in Predicting Mortality in Hospitalized Patients with COVID-19. Am J Med Sci 2021:S0002-9629(21)00214-7. [PMID: 34107275 DOI: 10.1016/j.amjms.2021.06.001] [Reference Citation Analysis]
333 Mohamed S, Abo El-Hassan O, Rizk M, Ismail JH, Baioumy A. Death due to Cardiac Arrest in a Young Female With Highly Suspected COVID-19: A Case Report. Cureus. 2020;12:e10127. [PMID: 33005541 DOI: 10.7759/cureus.10127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
334 Bellis A, Mauro C, Barbato E, Trimarco B, Morisco C. The Rationale for Angiotensin Receptor Neprilysin Inhibitors in a Multi-Targeted Therapeutic Approach to COVID-19. Int J Mol Sci 2020;21:E8612. [PMID: 33203141 DOI: 10.3390/ijms21228612] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
335 Siddiqi HK, Libby P, Ridker PM. COVID-19 - A vascular disease. Trends Cardiovasc Med. 2021;31:1-5. [PMID: 33068723 DOI: 10.1016/j.tcm.2020.10.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 21.0] [Reference Citation Analysis]
336 Kostova D, Richter P, Van Vliet G, Mahar M, Moolenaar RL. The Role of Noncommunicable Diseases in the Pursuit of Global Health Security. Health Secur 2021;19:288-301. [PMID: 33961498 DOI: 10.1089/hs.2020.0121] [Reference Citation Analysis]
337 Sorrentino S, Cacia M, Leo I, Polimeni A, Sabatino J, Spaccarotella CAM, Mongiardo A, De Rosa S, Indolfi C. B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis. J Clin Med 2020;9:E2957. [PMID: 32932743 DOI: 10.3390/jcm9092957] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
338 Bevilacqua M, De Togni P, Cattazzo F, Dell'Atti D, Dalbeni A, Mazzaferri F, Tacconelli E, Farzaneh-Far A, Fava C, Minuz P, Romano S. Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19-Related Disease. Am J Cardiol 2021:S0002-9149(21)01110-3. [PMID: 34895871 DOI: 10.1016/j.amjcard.2021.10.046] [Reference Citation Analysis]
339 Choi JH, Park JH. Things You Should Know in the Performing Echocardiographic Examination in Patients with COVID-19. J Cardiovasc Imaging 2021;29:20-30. [PMID: 33511797 DOI: 10.4250/jcvi.2020.0128] [Reference Citation Analysis]
340 Bargehr J, Rericha P, Petchey A, Colzani M, Moule G, Malgapo MC, Rassl D, Tarkin J, Mellor G, Sampaziotis F, Brevini T, Gambardella L, Bennett MR, Sinha S. Cardiovascular ACE2 receptor expression in patients undergoing heart transplantation. ESC Heart Fail 2021. [PMID: 34390216 DOI: 10.1002/ehf2.13528] [Reference Citation Analysis]
341 Çınar T, Şaylık F, Akbulut T, Asal S, Selçuk M, Çiçek V, Kılıç Ş, Orhan AL. One-Year Outcomes of Invasively Managed Acute Coronary Syndrome Patients with COVID-19. Heart & Lung 2022. [DOI: 10.1016/j.hrtlng.2022.01.012] [Reference Citation Analysis]
342 Dan S, Pant M, Upadhyay SK. The Case Fatality Rate in COVID-19 Patients With Cardiovascular Disease: Global Health Challenge and Paradigm in the Current Pandemic. Curr Pharmacol Rep 2020;:1-10. [PMID: 32953401 DOI: 10.1007/s40495-020-00239-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
343 Tomasoni D, Inciardi RM, Lombardi CM, Tedino C, Agostoni P, Ameri P, Barbieri L, Bellasi A, Camporotondo R, Canale C, Carubelli V, Carugo S, Catagnano F, Dalla Vecchia LA, Danzi GB, Di Pasquale M, Gaudenzi M, Giovinazzo S, Gnecchi M, Iorio A, La Rovere MT, Leonardi S, Maccagni G, Mapelli M, Margonato D, Merlo M, Monzo L, Mortara A, Nuzzi V, Piepoli M, Porto I, Pozzi A, Sarullo F, Sinagra G, Volterrani M, Zaccone G, Guazzi M, Senni M, Metra M. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study.Eur J Heart Fail. 2020;22:2238-2247. [PMID: 33179839 DOI: 10.1002/ejhf.2052] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
344 Roy-Gash F, De Mesmay M, Devys JM, Vespignani H, Blanc R, Engrand N. COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features. Crit Care 2020;24:419. [PMID: 32653019 DOI: 10.1186/s13054-020-03131-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
345 Park J, Kim Y, Pereira J, Hennessey KC, Faridi KF, McNamara RL, Velazquez EJ, Hur DJ, Sugeng L, Agarwal V. Understanding the role of left and right ventricular strain assessment in patients hospitalized with COVID-19. Am Heart J Plus 2021;6:100018. [PMID: 34095889 DOI: 10.1016/j.ahjo.2021.100018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
346 Nemer DM, Wilner BR, Burkle A, Aguilera J, Adewumi J, Gillombardo C, Wazni O, Menon V, Pengel S, Foxx M, Petre M, Hamilton AC, Cantillon DJ. Clinical Characteristics and Outcomes of Non-ICU Hospitalization for COVID-19 in a Nonepicenter, Centrally Monitored Healthcare System. J Hosp Med 2021;16:7-14. [PMID: 33147132 DOI: 10.12788/jhm.3510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
347 Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR, White A, Salvo GD, Sade LE, Pearce K, Newby DE, Popescu BA, Donal E, Cosyns B, Edvardsen T, Mills NL, Haugaa K. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging 2020;21:949-58. [PMID: 32556199 DOI: 10.1093/ehjci/jeaa178] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 53.5] [Reference Citation Analysis]
348 Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, Laouali N, Peiffer-Smadja N, Aune D, Severi G. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open 2021;11:e052777. [PMID: 34697120 DOI: 10.1136/bmjopen-2021-052777] [Reference Citation Analysis]
349 Soares RA, Vedovello RS, de Medeiros SCG, Nunes CZ, Sian CA, Jorge PDM. COVID-19 diagnosis in a patient with critical limb ischemia: complications and clinical outcomes. J Vasc Bras 2020;19:e20200071. [PMID: 34211520 DOI: 10.1590/1677-5449.200071] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
350 Perl L, Ben Avraham B, Vaknin-Assa H, Ben Gal T, Kornowski R. A rise in left atrial pressure detected by the V-LAP™ system for patients with heart failure during the coronavirus disease 2019 pandemic. ESC Heart Fail 2020. [PMID: 32965779 DOI: 10.1002/ehf2.13033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
351 Alqahtani MS, Abbas M, Alsabaani A, Alqarni A, Almohiy HM, Alsawqaee E, Alshahrani R, Alshahrani S. The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System. Infect Drug Resist 2022;15:1175-89. [PMID: 35345472 DOI: 10.2147/IDR.S351318] [Reference Citation Analysis]
352 Yu WL, Toh HS, Liao CT, Chang WT. Cardiovascular Complications of COVID-19 and Associated Concerns: A Review. Acta Cardiol Sin 2021;37:9-17. [PMID: 33488023 DOI: 10.6515/ACS.202101_37(1).20200913A] [Reference Citation Analysis]
353 Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Relcade M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LY, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D. Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis. medRxiv 2020:2020. [PMID: 33269355 DOI: 10.1101/2020.11.24.20236802] [Reference Citation Analysis]
354 Armentano GM, Carneiro-Ramos MS. Effect of COVID-19 on cardiorenal axis: known or unknown universe? Braz J Med Biol Res 2022;55:e11932. [PMID: 35319675 DOI: 10.1590/1414-431X2022e11932] [Reference Citation Analysis]
355 Bonny V, Maillard A, Mousseaux C, Plaçais L, Richier Q. [COVID-19: Pathogenesis of a multi-faceted disease]. Rev Med Interne 2020;41:375-89. [PMID: 32507520 DOI: 10.1016/j.revmed.2020.05.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
356 Case BC, Yerasi C, Forrestal BJ, Shea C, Rappaport H, Medranda GA, Zhang C, Satler LF, Ben-Dor I, Hashim H, Rogers T, Waksman R. Comparison of Characteristics and Outcomes of Patients With Acute Myocardial Infarction With Versus Without Coronarvirus-19. Am J Cardiol 2021;144:8-12. [PMID: 33385357 DOI: 10.1016/j.amjcard.2020.12.059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
357 Kaur N, Oskotsky B, Butte AJ, Hu Z. Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patients. Genome Biol 2022;23:15. [PMID: 35012625 DOI: 10.1186/s13059-021-02589-4] [Reference Citation Analysis]
358 Li X, Pan X, Li Y, An N, Xing Y, Yang F, Tian L, Sun J, Gao Y, Shang H, Xing Y. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Crit Care. 2020;24:468. [PMID: 32723362 DOI: 10.1186/s13054-020-03183-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
359 Kazory A, Ronco C, McCullough PA. SARS-CoV-2 (COVID-19) and intravascular volume management strategies in the critically ill. Proc (Bayl Univ Med Cent) 2020;0:1-6. [PMID: 32336959 DOI: 10.1080/08998280.2020.1754700] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
360 Nie L, Dai K, Wu J, Zhou X, Hu J, Zhang C, Zhan Y, Song Y, Fan W, Hu Z, Yang H, Yang Q, Wu D, Li F, Li D, Nie R. Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study. Thorac Cancer 2021;12:57-65. [PMID: 33142039 DOI: 10.1111/1759-7714.13710] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
361 Salbach C, Mueller-Hennessen M, Biener M, Stoyanov K, Preusch M, Kihm L, Merle U, Schnitzler P, Katus HA, Giannitsis E. Interpretation of myocardial injury subtypes in COVID-19 disease per fourth version of Universal Definition of Myocardial Infarction. Biomarkers 2021;26:401-9. [PMID: 33998352 DOI: 10.1080/1354750X.2021.1921031] [Reference Citation Analysis]
362 Thrupthi K, Ganti A, Acherjee T, Mehmood MA, Vakde T. A Rare Case of Acute Pericarditis Due to SARS-CoV-2 Managed With Aspirin and Colchicine. Cureus 2021;13:e12534. [PMID: 33564532 DOI: 10.7759/cureus.12534] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Benhamou D, Keita H, Ducloy-Bouthors AS; Obstetric Anaesthesia and Critical Care Club Working Group. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients. Anaesth Crit Care Pain Med 2020;39:351-3. [PMID: 32437961 DOI: 10.1016/j.accpm.2020.05.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
364 Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martinèz-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C; GRECCO-19 investigators. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open 2020;3:e2013136. [PMID: 32579195 DOI: 10.1001/jamanetworkopen.2020.13136] [Cited by in Crossref: 150] [Cited by in F6Publishing: 146] [Article Influence: 75.0] [Reference Citation Analysis]
365 Park JF, Banerjee S, Umar S. In the eye of the storm: the right ventricle in COVID-19. Pulm Circ 2020;10:2045894020936660. [PMID: 32655856 DOI: 10.1177/2045894020936660] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
366 Platt DE, Parida L, Zalloua P. Lies, Gosh Darn Lies, and not enough good statistics: why epidemic model parameter estimation fails. Sci Rep 2021;11:408. [PMID: 33432032 DOI: 10.1038/s41598-020-79745-6] [Reference Citation Analysis]
367 Dorobisz K, Dorobisz T, Janczak D, Zatoński T. Doxycycline in the Coronavirus Disease 2019 Therapy. Ther Clin Risk Manag 2021;17:1023-6. [PMID: 34584416 DOI: 10.2147/TCRM.S314923] [Reference Citation Analysis]
368 Almeida Junior GLG, Braga F, Jorge JK, Nobre GF, Kalichsztein M, Faria PMP, Bussade B, Penna GL, Alves VO, Pereira MA, Gorgulho PC, Faria MRDSE, Drumond LE, Carpinete FBS, Neno ACLB, Neno ACA. Prognostic Value of Troponin-T and B-Type Natriuretic Peptide in Patients Hospitalized for COVID-19. Arq Bras Cardiol 2020;115:660-6. [PMID: 33111866 DOI: 10.36660/abc.20200385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
369 Torabi AJ, Villegas-Galaviz J, Guglin M, Frick K, Rao R. Cardiogenic shock following cardiac tamponade and Takotsubo in COVID-19. Future Cardiol 2021;17:631-5. [PMID: 33078963 DOI: 10.2217/fca-2020-0115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
370 Pfeifer M, Hamer OW. [COVID-19 pneumonia]. Internist (Berl) 2020;61:793-803. [PMID: 32728817 DOI: 10.1007/s00108-020-00854-5] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
371 Xie Y, Wang L, Li M, Li H, Zhu S, Wang B, He L, Zhang D, Zhang Y, Yuan H, Wu C, Sun W, Zhang Y, Cui L, Cai Y, Wang J, Yang Y, Lv Q, Xie M, Li Y, Zhang L. Biventricular Longitudinal Strain Predict Mortality in COVID-19 Patients. Front Cardiovasc Med 2020;7:632434. [PMID: 33537350 DOI: 10.3389/fcvm.2020.632434] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
372 Souza CDF, Leal TC, Santos LG. Circulatory System Diseases in Patients with COVID-19: Description of Clinical and Epidemiological Profile of 197 Deaths. Arq Bras Cardiol 2020;115:281-3. [PMID: 32876198 DOI: 10.36660/abc.20200453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
373 Roy S, Sharma B, Mazid MI, Akhand RN, Das M, Marufatuzzahan M, Chowdhury TA, Azim KF, Hasan M. Identification and host response interaction study of SARS-CoV-2 encoded miRNA-like sequences: an in silico approach. Comput Biol Med 2021;134:104451. [PMID: 34020131 DOI: 10.1016/j.compbiomed.2021.104451] [Reference Citation Analysis]
374 Chatrath N, Kaza N, Pabari PA, Fox K, Mayet J, Barton C, Cole GD, Plymen CM. The effect of concomitant COVID-19 infection on outcomes in patients hospitalized with heart failure. ESC Heart Fail 2020. [PMID: 33040480 DOI: 10.1002/ehf2.13059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
375 Lopez RA, Padilla LA, Sorabella RA, Cleveland DC, Rhodes LA, Dabal RJ. Tachyarrhythmia as a possible symptom of coronavirus in a neonate diagnosed with transposition of the great arteries. J Card Surg 2021;36:2578-81. [PMID: 33861465 DOI: 10.1111/jocs.15574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
376 Ferrari F, Martins VM, Fuchs FD, Stein R. Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review. Clinics (Sao Paulo) 2021;76:e2342. [PMID: 33852652 DOI: 10.6061/clinics/2021/e2342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
377 Huang Z, Huang P, Du B, Kong L, Zhang W, Zhang Y, Dong J. Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2021;31:2-13. [PMID: 33229199 DOI: 10.1016/j.numecd.2020.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
378 Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol 2020;148:25-33. [PMID: 32835666 DOI: 10.1016/j.yjmcc.2020.08.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
379 Mansueto G, Niola M, Napoli C. Can COVID 2019 induce a specific cardiovascular damage or it exacerbates pre-existing cardiovascular diseases? Pathol Res Pract 2020;216:153086. [PMID: 32825954 DOI: 10.1016/j.prp.2020.153086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
380 Raad M, Dabbagh M, Gorgis S, Yan J, Chehab O, Dagher C, Jamoor K, Hussein IH, Cook B, Van Harn M, Singh G, McCord J, Parikh S. Cardiac Injury Patterns and Inpatient Outcomes Among Patients Admitted With COVID-19.Am J Cardiol. 2020;133:154-161. [PMID: 32829913 DOI: 10.1016/j.amjcard.2020.07.040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
381 Duckheim M, Schreieck J. COVID-19 and Cardiac Arrhythmias. Hamostaseologie 2021;41:372-8. [PMID: 34695853 DOI: 10.1055/a-1581-6881] [Reference Citation Analysis]
382 Tudoran M, Tudoran C, Lazureanu VE, Marinescu AR, Pop GN, Pescariu AS, Enache A, Cut TG. Alterations of Left Ventricular Function Persisting during Post-Acute COVID-19 in Subjects without Previously Diagnosed Cardiovascular Pathology. J Pers Med 2021;11:225. [PMID: 33809873 DOI: 10.3390/jpm11030225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
383 Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, Levantovsky R, Malle L, Moreira A, Park MD, Pia L, Risson E, Saffern M, Salomé B, Esai Selvan M, Spindler MP, Tan J, van der Heide V, Gregory JK, Alexandropoulos K, Bhardwaj N, Brown BD, Greenbaum B, Gümüş ZH, Homann D, Horowitz A, Kamphorst AO, Curotto de Lafaille MA, Mehandru S, Merad M, Samstein RM; Sinai Immunology Review Project. Immunology of COVID-19: Current State of the Science. Immunity 2020;52:910-41. [PMID: 32505227 DOI: 10.1016/j.immuni.2020.05.002] [Cited by in Crossref: 731] [Cited by in F6Publishing: 635] [Article Influence: 365.5] [Reference Citation Analysis]
384 Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol 2020;95:1578-89. [PMID: 32857878 DOI: 10.1002/ajh.25982] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
385 Li J, Sun L, Wang F, Liu B, Li H, Tang G, Chang Z, Liu A, Fu C, Lv Y, Gao J, Li J. Relation between Cardiac Injury and Elevated Levels of Inflammatory Biomarkers in Patients with Severe COVID-19. Cardiovascular Innovations and Applications 2021;5:165-72. [DOI: 10.15212/cvia.2019.1264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Tersalvi G, Winterton D, Cioffi GM, Ghidini S, Roberto M, Biasco L, Pedrazzini G, Dauw J, Ameri P, Vicenzi M. Telemedicine in Heart Failure During COVID-19: A Step Into the Future. Front Cardiovasc Med 2020;7:612818. [PMID: 33363223 DOI: 10.3389/fcvm.2020.612818] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
387 Pourafkari L, Mirza-Aghzadeh-Attari M, Zarrintan A, Mousavi-Aghdas SA. Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study. Iran J Med Sci 2021;46:1-14. [PMID: 33487787 DOI: 10.30476/ijms.2020.87233.1730] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
388 Luetkens JA, Isaak A, Öztürk C, Mesropyan N, Monin M, Schlabe S, Reinert M, Faron A, Heine A, Velten M, Dabir D, Boesecke C, Strassburg CP, Attenberger U, Zimmer S, Duerr GD, Nattermann J. Cardiac MRI in Suspected Acute COVID-19 Myocarditis. Radiol Cardiothorac Imaging 2021;3:e200628. [PMID: 33969316 DOI: 10.1148/ryct.2021200628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
389 Hatami F, Valizadeh N, Ansari Ramandi MM. Emerging mechanisms for the new coronavirus-related myocardial injury and ischemia: A review of the literature. Anatol J Cardiol 2020;24:7-12. [PMID: 32628143 DOI: 10.14744/AnatolJCardiol.2020.68166] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
390 Toth G, Spiotta AM, Hirsch JA, Fiorella D. Misinformation in the COVID-19 era. J Neurointerv Surg 2020;12:829-30. [PMID: 32801141 DOI: 10.1136/neurintsurg-2020-016683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
391 Seid S, Adane H, Mekete G. Patterns of presentation, prevalence and associated factors of mortality in ICU among adult patients during the pandemic of COVID 19: A retrospective cross-sectional study. Annals of Medicine and Surgery 2022;77:103618. [DOI: 10.1016/j.amsu.2022.103618] [Reference Citation Analysis]
392 Carver C, Jones N. Cardiac injury, ARDS and COVID-19 meta-analysis validity - Correspondence in response to Santoso et al. Am J Emerg Med 2021;42:252. [PMID: 32641263 DOI: 10.1016/j.ajem.2020.06.028] [Reference Citation Analysis]
393 Wei ZY, Qiao R, Chen J, Huang J, Wang WJ, Yu H, Xu J, Wu H, Wang C, Gu CH, Li HJ, Li M, Liu C, Yang J, Ding HM, Lu MJ, Yin WH, Wang Y, Li KW, Shi HF, Qian HY, Yang WX, Geng YJ. Pre-existing Health Conditions and Epicardial Adipose Tissue Volume: Potential Risk Factors for Myocardial Injury in COVID-19 Patients. Front Cardiovasc Med 2020;7:585220. [PMID: 33505992 DOI: 10.3389/fcvm.2020.585220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
394 Chatterjee NA, Cheng RK. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment. Heart 2020;106:1119-21. [PMID: 32451360 DOI: 10.1136/heartjnl-2020-317110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
395 Yenerçağ M, Arslan U, Doğduş M, Günal Ö, Öztürk ÇE, Aksan G, Erdoğan G, Gül S, Yontar OC, Şen A. Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19. J Electrocardiol 2020;62:5-9. [PMID: 32731139 DOI: 10.1016/j.jelectrocard.2020.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
396 Gupta A, Marzook H, Ahmad F. Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview. Clin Exp Med 2022. [PMID: 35362771 DOI: 10.1007/s10238-022-00821-4] [Reference Citation Analysis]
397 Thakore A, Nguyen J, Pollack S, Muehlbauer S, Chi B, Knight D, Mehrotra B, Stern J, Cao JJ, Lucore C, Levine J. Electrocardiographic manifestations of COVID-19: Effect on cardiac activation and repolarization. EClinicalMedicine 2021;39:101057. [PMID: 34377967 DOI: 10.1016/j.eclinm.2021.101057] [Reference Citation Analysis]
398 Asokan I, Rabadia SV, Yang EH. The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population. Curr Oncol Rep 2020;22:60. [PMID: 32462289 DOI: 10.1007/s11912-020-00945-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
399 Zwaenepoel B, Dhont S, Schaubroeck H, Gevaert S. The use of cardiac troponins and B-type natriuretic peptide in COVID-19. Acta Cardiol 2021;:1-6. [PMID: 34459705 DOI: 10.1080/00015385.2021.1970403] [Reference Citation Analysis]
400 Sami R, Fathi F, Eskandari N, Ahmadi M, ArefNezhad R, Motedayyen H. Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? Cytokine 2021;140:155439. [PMID: 33524886 DOI: 10.1016/j.cyto.2021.155439] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
401 Shao MJ, Shang LX, Luo JY, Shi J, Zhao Y, Li XM, Yang YN. Myocardial injury is associated with higher mortality in patients with coronavirus disease 2019: a meta-analysis. J Geriatr Cardiol 2020;17:224-8. [PMID: 32362922 DOI: 10.11909/j.issn.1671-5411.2020.04.009] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
402 Fan H, Zhang L, Huang B, Zhu M, Zhou Y, Zhang H, Tao X, Cheng S, Yu W, Zhu L, Chen J. Cardiac injuries in patients with coronavirus disease 2019: Not to be ignored. Int J Infect Dis 2020;96:294-7. [PMID: 32437935 DOI: 10.1016/j.ijid.2020.05.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
403 Gopinathannair R, Merchant FM, Lakkireddy DR, Etheridge SP, Feigofsky S, Han JK, Kabra R, Natale A, Poe S, Saha SA, Russo AM. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol 2020;59:329-36. [PMID: 32494896 DOI: 10.1007/s10840-020-00789-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 20.5] [Reference Citation Analysis]
404 Williams V, Dash N, Suthar R, Mohandoss V, Jaiswal N, Kavitha T, Nallasamy K, Angurana SK. Clinicolaboratory Profile, Treatment, Intensive Care Needs, and Outcome of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2: A Systematic Review and Meta-analysis. J Pediatr Intensive Care. [DOI: 10.1055/s-0040-1719173] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
405 Tang H, Tu C, Xiong F, Sun X, Tian JB, Dong JW, Wang XH, Lei CT, Liu J, Zhao Z, Qiu Y, Miao XP, Zhang C. Risk factors for the mortality of hemodialysis patients with COVID-19: A multicenter study from the overall hemodialysis population in Wuhan. Semin Dial 2021. [PMID: 34137080 DOI: 10.1111/sdi.12995] [Reference Citation Analysis]
406 Nader Marta G, Colombo Bonadio R, Nicole Encinas Sejas O, Watarai G, Mathias Machado MC, Teixeira Frasson L, Motta Venchiarutti Moniz C, de Luca Ito RK, Peixoto D, Oliveira Hoff C, Menegatti Anastacio V, Ribeiro U Jr, Pereira J, Rocha V, Abdala E, Del Pilar Estevez-Diz M, Hoff PM. Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19. JCO Glob Oncol 2021;7:1084-92. [PMID: 34228508 DOI: 10.1200/GO.21.00087] [Reference Citation Analysis]
407 Liu J, Zhang Y, Han L, Guo S, Wu S, Doud EH, Wang C, Chen H, Rubart-von der Lohe M, Wan J, Yang L. Genome-wide analyses reveal the detrimental impacts of SARS-CoV-2 viral gene Orf9c on human pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports 2022:S2213-6711(22)00058-3. [PMID: 35180394 DOI: 10.1016/j.stemcr.2022.01.014] [Reference Citation Analysis]
408 Chojecka D, Pytlos J, Zawadka M, Andruszkiewicz P, Szarpak Ł, Dzieciątkowski T, Jaguszewski MJ, Filipiak KJ, Gąsecka A. How to Maintain Safety and Maximize the Efficacy of Cardiopulmonary Resuscitation in COVID-19 Patients: Insights from the Recent Guidelines. J Clin Med 2021;10:5667. [PMID: 34884368 DOI: 10.3390/jcm10235667] [Reference Citation Analysis]
409 Drewry AM, Hotchkiss R, Kulstad E. Response to "Body temperature correlates with mortality in COVID-19 patients". Crit Care 2020;24:460. [PMID: 32709253 DOI: 10.1186/s13054-020-03186-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
410 Rombolà G, Brunini F. COVID-19 and dialysis: why we should be worried. J Nephrol 2020;33:401-3. [PMID: 32323202 DOI: 10.1007/s40620-020-00737-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
411 Cetinkal G, Kocas BB, Ser OS, Kilci H, Keskin K, Ozcan SN, Verdi Y, Zeren MI, Demir T, Kilickesmez K. Assessment of the Modified CHA2DS2VASc Risk Score in Predicting Mortality in Patients Hospitalized With COVID-19. Am J Cardiol 2020;135:143-9. [PMID: 32861734 DOI: 10.1016/j.amjcard.2020.08.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
412 Chen L, Hu W, Guo X, Zhao P, Tang J, Gu Y, Huang N, Wang C, Cui A, Zhang D, Hu L, Feng Y, Hu S, Chen M, Duru F, Xiong C. Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19. Sci Rep 2021;11:4432. [PMID: 33627696 DOI: 10.1038/s41598-021-83822-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
413 Wei ZY, Geng YJ, Huang J, Qian HY. Pathogenesis and management of myocardial injury in coronavirus disease 2019. Eur J Heart Fail 2020;22:1994-2006. [PMID: 32683753 DOI: 10.1002/ejhf.1967] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
414 Cho JH, Namazi A, Shelton R, Ramireddy A, Ehdaie A, Shehata M, Wang X, Marbán E, Chugh SS, Cingolani E. Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States. PLoS One 2020;15:e0244533. [PMID: 33370347 DOI: 10.1371/journal.pone.0244533] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
415 Kelham M, Choudry FA, Hamshere S, Beirne AM, Rathod KS, Baumbach A, Ahluwalia A, Mathur A, Jones DA. Therapeutic Implications of COVID-19 for the Interventional Cardiologist. J Cardiovasc Pharmacol Ther 2021;26:203-16. [PMID: 33331160 DOI: 10.1177/1074248420982736] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
416 Parsamanesh N, Karami-Zarandi M, Banach M, Penson PE, Sahebkar A. Effects of statins on myocarditis: A review of underlying molecular mechanisms. Prog Cardiovasc Dis 2021;67:53-64. [PMID: 33621589 DOI: 10.1016/j.pcad.2021.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
417 Pfeifer M, Ewig S, Voshaar T, Randerath WJ, Bauer T, Geiseler J, Dellweg D, Westhoff M, Windisch W, Schönhofer B, Kluge S, Lepper PM. Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19. Respiration 2020;99:521-42. [PMID: 32564028 DOI: 10.1159/000509104] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 12.5] [Reference Citation Analysis]
418 Gu T, Chu Q, Yu Z, Fa B, Li A, Xu L, Wu R, He Y. History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case-control study. BMJ Open 2020;10:e038976. [PMID: 32948572 DOI: 10.1136/bmjopen-2020-038976] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
419 Dehghani P, Davidson LJ, Grines CL, Nayak K, Saw J, Kaul P, Bagai A, Garberich R, Schmidt C, Ly HQ, Giri J, Meraj P, Shah B, Garcia S, Sharkey S, Wood DA, Welt FG, Mahmud E, Henry TD. North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications. Am Heart J 2020;227:11-8. [PMID: 32425198 DOI: 10.1016/j.ahj.2020.05.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
420 Knight DS, Kotecha T, Razvi Y, Chacko L, Brown JT, Jeetley PS, Goldring J, Jacobs M, Lamb LE, Negus R, Wolff A, Moon JC, Xue H, Kellman P, Patel N, Fontana M. COVID-19: Myocardial Injury in Survivors. Circulation 2020;142:1120-2. [PMID: 32673505 DOI: 10.1161/CIRCULATIONAHA.120.049252] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 20.5] [Reference Citation Analysis]
421 Liu C, Mu C, Zhang Q, Yang X, Yan H, Jiao H. Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review. Med Sci Monit 2021;27:e930168. [PMID: 34193809 DOI: 10.12659/MSM.930168] [Reference Citation Analysis]
422 Rando HM, MacLean AL, Lee AJ, Lordan R, Ray S, Bansal V, Skelly AN, Sell E, Dziak JJ, Shinholster L, D'Agostino McGowan L, Ben Guebila M, Wellhausen N, Knyazev S, Boca SM, Capone S, Qi Y, Park Y, Mai D, Sun Y, Boerckel JD, Brueffer C, Byrd JB, Kamil JP, Wang J, Velazquez R, Szeto GL, Barton JP, Goel RR, Mangul S, Lubiana T, Gitter A, Greene CS; COVID-19 Review Consortium Vikas Bansal, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Das, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang, Nils Wellhausen, . Pathogenesis, Symptomatology, and Transmission of SARS-CoV-2 through Analysis of Viral Genomics and Structure. mSystems 2021;6:e0009521. [PMID: 34698547 DOI: 10.1128/mSystems.00095-21] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
423 Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med 2020;38:1504-7. [PMID: 32317203 DOI: 10.1016/j.ajem.2020.04.048] [Cited by in Crossref: 275] [Cited by in F6Publishing: 221] [Article Influence: 137.5] [Reference Citation Analysis]
424 Schnaubelt S, Breyer MK, Siller-Matula J, Domanovits H. Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report. Eur Heart J Case Rep 2020;4:1-6. [PMID: 33089045 DOI: 10.1093/ehjcr/ytaa166] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
425 Sheng CC, Sahoo D, Dugar S, Prada RA, Wang TKM, Abou Hassan OK, Brennan D, Culver DA, Rajendram P, Duggal A, Lincoff AM, Nissen SE, Menon V, Cremer PC. Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study). Clin Cardiol 2020;43:1055-63. [PMID: 32830894 DOI: 10.1002/clc.23451] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
426 Elkholy KO, Mirashi E, Malyshev Y, Charles G, Sahni S. Wellens' Syndrome in the Setting of the 2019 Novel Coronavirus (COVID-19). Cureus 2021;13:e13290. [PMID: 33728223 DOI: 10.7759/cureus.13290] [Reference Citation Analysis]
427 Wang T, Tang R, Ruan H, Chen R, Zhang Z, Sang L, Su X, Yi S, Ni Z, Hu Y, Liu L, Shan H, Lei C, Peng Y, Liu C, Li J, Hong C, Zhang N, Zhong N, Li S; China Medical Treatment Expert Group for COVID-19. Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China. Clin Respir J 2021;15:915-24. [PMID: 33942518 DOI: 10.1111/crj.13382] [Reference Citation Analysis]
428 Gąsecka A, Borovac JA, Guerreiro RA, Giustozzi M, Parker W, Caldeira D, Chiva-Blanch G. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment. Cardiovasc Drugs Ther 2021;35:215-29. [PMID: 33074525 DOI: 10.1007/s10557-020-07084-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
429 Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS One 2020;15:e0238215. [PMID: 32845926 DOI: 10.1371/journal.pone.0238215] [Cited by in Crossref: 123] [Cited by in F6Publishing: 115] [Article Influence: 61.5] [Reference Citation Analysis]
430 Othman F, Abid AR, Alibrahim M, Abdulkarim S, Abdelaty MA, Aboukamar M, Arafah S. Non-ST Segment Elevation Myocardial Infarction in a Patient with COVID-19. Heart Views 2020;21:215-9. [PMID: 33688414 DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_151_20] [Reference Citation Analysis]
431 Saba L, Gerosa C, Wintermark M, Hedin U, Fanni D, Suri JS, Balestrieri A, Faa G. Can COVID19 trigger the plaque vulnerability-a Kounis syndrome warning for "asymptomatic subjects". Cardiovasc Diagn Ther. 2020;10:1352-1355. [PMID: 33224760 DOI: 10.21037/cdt-20-561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
432 Linares L, Cofan F, Diekmann F, Herrera S, Marcos MA, Castel MA, Farrero M, Colmenero J, Ruiz P, Crespo G, Llopis J, Garcia-Vidal C, Soriano À, Moreno A, Bodro M; Hospital Clínic COVID-19 research group. A propensity score-matched analysis of mortality in solid organ transplant patients with COVID-19 compared to non-solid organ transplant patients. PLoS One 2021;16:e0247251. [PMID: 33657157 DOI: 10.1371/journal.pone.0247251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
433 Feldman C. Cardiac complications in community-acquired pneumonia and COVID-19. Afr J Thorac Crit Care Med 2020;26. [PMID: 34235421 DOI: 10.7196/AJTCCM.2020.v26i2.077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
434 Caro-Codón J, Rey JR, Buño A, Iniesta AM, Rosillo SO, Castrejon-Castrejon S, Merino C, Marco I, Martinez LA, Garcia-Veas JM, Martin-Polo L, Rodriguez-Sotelo L, Martinez-Cossiani M, Gonzalez-Valle L, Herrero A, López-de-Sá E, Merino JL; CARD-COVID Investigators. Characterization of myocardial injury in a cohort of patients with SARS-CoV-2 infection. Med Clin (Engl Ed) 2021;157:274-80. [PMID: 34568576 DOI: 10.1016/j.medcle.2021.02.008] [Reference Citation Analysis]
435 Salabei JK, Asnake ZT, Ismail ZH, Charles K, Stanger G, Abdullahi AH, Abraham AT, Okonoboh P. COVID-19 and the Cardiovascular System: An Update. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2022.01.022] [Reference Citation Analysis]
436 Ishigami J, Kou M, Ding N, Matsushita K. Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention. Curr Epidemiol Rep 2021;:1-8. [PMID: 33425654 DOI: 10.1007/s40471-020-00261-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
437 Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV 3rd, Kwon DH, Singh T, Tilton JC, Tsai EJ, Tucker NR, Barnard J, Loscalzo J. COVID-19 and Cardiovascular Disease: From Bench to Bedside. Circ Res 2021;128:1214-36. [PMID: 33856918 DOI: 10.1161/CIRCRESAHA.121.317997] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
438 Shang Y, Liu T, Wei Y, Li J, Shao L, Liu M, Zhang Y, Zhao Z, Xu H, Peng Z, Zhou F, Wang X. Scoring systems for predicting mortality for severe patients with COVID-19. EClinicalMedicine 2020;24:100426. [PMID: 32766541 DOI: 10.1016/j.eclinm.2020.100426] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 20.5] [Reference Citation Analysis]
439 Sharma K, Desai HD, Patoliya JV, Jadeja DM, Gadhiya D. Takotsubo Syndrome a Rare Entity in COVID-19: a Systemic Review-Focus on Biomarkers, Imaging, Treatment, and Outcome. SN Compr Clin Med 2021;:1-11. [PMID: 33458567 DOI: 10.1007/s42399-021-00743-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
440 Cameli M, Pastore MC, Soliman Aboumarie H, Mandoli GE, D'Ascenzi F, Cameli P, Bigio E, Franchi F, Mondillo S, Valente S. Usefulness of echocardiography to detect cardiac involvement in COVID-19 patients. Echocardiography 2020;37:1278-86. [PMID: 32654210 DOI: 10.1111/echo.14779] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
441 Lam K, McClelland S, Dallo MJ. ECG: essential in care of patients with COVID-19. Med J Aust 2020;213:476-476.e1. [PMID: 33098111 DOI: 10.5694/mja2.50841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
442 Oltean PB, Kovács I, Hodas R, Rat N, Benedek T. Acute Coronary Syndrome and Arrhytmia Induced by SARS-CoV-2 Infection in a Patient with Non-Significant LAD Lesion. A Case Report. Journal of Interdisciplinary Medicine 2021;6:43-7. [DOI: 10.2478/jim-2021-0010] [Reference Citation Analysis]
443 [DOI: 10.1101/2020.08.30.274464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
444 Cheah IK, Halliwell B. Could Ergothioneine Aid in the Treatment of Coronavirus Patients? Antioxidants (Basel) 2020;9:E595. [PMID: 32646061 DOI: 10.3390/antiox9070595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
445 Tomasoni D, Italia L, Adamo M, Inciardi RM, Lombardi CM, Solomon SD, Metra M. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020;22:957-966. [PMID: 32412156 DOI: 10.1002/ejhf.1871] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 42.0] [Reference Citation Analysis]
446 Carmona A, Marchandot B, Matsushita K, Morel O. Letter by Carmona et al Regarding Article, "Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: a National Population-Based Cohort Study". Arterioscler Thromb Vasc Biol 2021;41:e280-1. [PMID: 33881925 DOI: 10.1161/ATVBAHA.121.316224] [Reference Citation Analysis]
447 Ambrosino P, Calcaterra I, Molino A, Moretta P, Lupoli R, Spedicato GA, Papa A, Motta A, Maniscalco M, Di Minno MND. Persistent Endothelial Dysfunction in Post-Acute COVID-19 Syndrome: A Case-Control Study. Biomedicines 2021;9:957. [PMID: 34440161 DOI: 10.3390/biomedicines9080957] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
448 Hekimian G, Frere C, Collet JP. [COVID-19 and mechanical circulatory support]. Ann Cardiol Angeiol (Paris) 2020;69:360-4. [PMID: 33092785 DOI: 10.1016/j.ancard.2020.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
449 Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis 2020;100:327-32. [PMID: 32920235 DOI: 10.1016/j.ijid.2020.09.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 23.5] [Reference Citation Analysis]
450 Morris G, Bortolasci CC, Puri BK, Olive L, Marx W, O'Neil A, Athan E, Carvalho A, Maes M, Walder K, Berk M. Preventing the development of severe COVID-19 by modifying immunothrombosis. Life Sci 2021;264:118617. [PMID: 33096114 DOI: 10.1016/j.lfs.2020.118617] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
451 Giagulli VA, Guastamacchia E, Magrone T, Jirillo E, Lisco G, De Pergola G, Triggiani V. Worse progression of COVID-19 in men: Is testosterone a key factor? Andrology 2021;9:53-64. [PMID: 32524732 DOI: 10.1111/andr.12836] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
452 Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, Ceirano A, Espinosa F, Saavedra E, Sanguine V, Tassara A, Cid C, Catalano HN, Agarwal A, Foroutan F, Rada G. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One 2020;15:e0241955. [PMID: 33201896 DOI: 10.1371/journal.pone.0241955] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 35.5] [Reference Citation Analysis]
453 Smyk W, Janik MK, Portincasa P, Milkiewicz P, Lammert F, Krawczyk M. COVID-19: Focus on the lungs but do not forget the gastrointestinal tract. Eur J Clin Invest. 2020;50:e13276. [PMID: 32406522 DOI: 10.1111/eci.13276] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
454 Chow J, Alhussaini A, Calvillo-Argüelles O, Billia F, Luk A. Cardiovascular Collapse in COVID-19 Infection: The Role of Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO). CJC Open 2020;2:273-7. [PMID: 32363334 DOI: 10.1016/j.cjco.2020.04.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
455 Gencer S, Lacy M, Atzler D, van der Vorst EPC, Döring Y, Weber C. Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19. Thromb Haemost 2020;120:1629-41. [PMID: 33124029 DOI: 10.1055/s-0040-1718735] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
456 Ricke DO. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies. Front Immunol 2021;12:640093. [PMID: 33717193 DOI: 10.3389/fimmu.2021.640093] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
457 Lafuse WP, Wozniak DJ, Rajaram MVS. Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair. Cells 2020;10:E51. [PMID: 33396359 DOI: 10.3390/cells10010051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
458 Nascimento CRD, Leão SC, Barbosa RHA, Tenório PP. Cardiovascular damage due to COVID-19: what do we need to know? Rev Assoc Med Bras (1992) 2021;67Suppl 1:121-6. [PMID: 34406302 DOI: 10.1590/1806-9282.67.Suppl1.20200706] [Reference Citation Analysis]
459 Cappannoli L, Scacciavillani R, Iannaccone G, Anastasia G, DI Giusto F, Crea F. 2019 novel Coronavirus: current knowledge, cardiovascular implications and management. Minerva Cardiol Angiol 2021;69:377-88. [PMID: 32472991 DOI: 10.23736/S2724-5683.20.05311-6] [Reference Citation Analysis]
460 McVaney KE, Pepe PE, Maloney LM, Bronsky ES, Crowe RP, Augustine JJ, Gilliam SO, Asaeda GH, Eckstein M, Mattu A, Fumagalli R, Aufderheide TP, Osterholm MT; Writing group on behalf of the Metropolitan EMS Medical Directors Global Alliance. The relationship of large city out-of-hospital cardiac arrests and the prevalence of COVID-19. EClinicalMedicine 2021;34:100815. [PMID: 33997730 DOI: 10.1016/j.eclinm.2021.100815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
461 Magnocavallo M, Vetta G, Della Rocca DG, Gianni C, Mohanty S, Bassiouny M, Di Lullo L, Del Prete A, Cirone D, Lavalle C, Chimenti C, Al-ahmad A, Burkhardt JD, Gallinghouse GJ, Sanchez JE, Horton RP, Di Biase L, Natale A. Prevalence, Management, and Outcome of Atrial Fibrillation and Other Supraventricular Arrhythmias in COVID-19 Patients. Cardiac Electrophysiology Clinics 2022. [DOI: 10.1016/j.ccep.2021.10.001] [Reference Citation Analysis]
462 Kim IC, Song JE, Lee HJ, Park JH, Hyun M, Lee JY, Kim HA, Kwon YS, Park JS, Youn JC, Hwang J, Lee CH, Cho YK, Park HS, Yoon HJ, Nam CW, Han S, Hur SH, Eisen HJ, Kim H. The Implication of Cardiac Injury Score on In-hospital Mortality of Coronavirus Disease 2019. J Korean Med Sci 2020;35:e349. [PMID: 33045772 DOI: 10.3346/jkms.2020.35.e349] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
463 Brojakowska A, Narula J, Shimony R, Bander J. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week. J Am Coll Cardiol 2020;75:3085-95. [PMID: 32305401 DOI: 10.1016/j.jacc.2020.04.028] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 34.0] [Reference Citation Analysis]
464 Šikić J, Planinić Z, Matišić V, Friščić T, Molnar V, Jagačić D, Vujičić L, Tudorić N, Postružin Gršić L, Ljubičić Đ, Primorac D. COVID-19: The Impact on Cardiovascular System. Biomedicines 2021;9:1691. [PMID: 34829920 DOI: 10.3390/biomedicines9111691] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
465 Lao N, Lim J, Bashir H, Mahalwar G, Adebolu O, Mangira C, Courson J, Hegde V. Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019. J Cardiol 2021:S0914-5087(21)00305-1. [PMID: 34848117 DOI: 10.1016/j.jjcc.2021.10.025] [Reference Citation Analysis]
466 Fox SE, Li G, Akmatbekov A, Harbert JL, Lameira FS, Brown JQ, Vander Heide RS. Unexpected Features of Cardiac Pathology in COVID-19 Infection. Circulation 2020;142:1123-5. [PMID: 32689809 DOI: 10.1161/CIRCULATIONAHA.120.049465] [Cited by in Crossref: 53] [Cited by in F6Publishing: 37] [Article Influence: 26.5] [Reference Citation Analysis]
467 Davidson SM, Lukhna K, Gorog DA, Salama AD, Castillo AR, Giesz S, Golforoush P, Kalkhoran SB, Lecour S, Imamdin A, do Carmo HRP, Bovi TG, Perroud MW Jr, Ntsekhe M, Sposito AC, Yellon DM. RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19. Cardiovasc Drugs Ther 2021. [PMID: 34169381 DOI: 10.1007/s10557-021-07221-y] [Reference Citation Analysis]
468 Zhou X, Chen D, Wang L, Zhao Y, Wei L, Chen Z, Yang B. Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical. Biosci Rep 2020:BSR20202690. [PMID: 33252122 DOI: 10.1042/BSR20202690] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
469 Saleh A, Matsumori A, Abdelrazek S, Eltaweel S, Salous A, Neumann FJ, Antz M. Myocardial involvement in coronavirus disease 19. Herz 2020;45:719-25. [PMID: 33216154 DOI: 10.1007/s00059-020-05001-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
470 Zinellu A, Sotgia S, Carru C, Mangoni AA. B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression. Front Cardiovasc Med 2021;8:690790. [PMID: 34250044 DOI: 10.3389/fcvm.2021.690790] [Reference Citation Analysis]
471 Ben Ammar H, Bouguira E, Brahmi L, Hamdi G, Bouallagui A, Khelifa E, Mnif L. Simultaneous occurrence of a Takotsubo syndrome and paranoia delirium, related to Covid-19 pandemic: A case report. Clin Case Rep 2021;9:e05026. [PMID: 34765206 DOI: 10.1002/ccr3.5026] [Reference Citation Analysis]
472 Katkat F, Kalyoncuoğlu M, Karahan S, Abanus H, Turhan Çağlar FN, Karabulut D, Varol S, Şahin İ, Erkalp K, Okuyan E. Does coexistence of fragmented QRS and cardiovascular disease have the ability to predict the mortality in hospitalized, critically ill patients with COVID-19? Anatol J Cardiol 2021;25:803-10. [PMID: 34734814 DOI: 10.5152/AnatolJCardiol.2021.13611] [Reference Citation Analysis]
473 Hasselbach L, Weidner J, Elsässer A, Theilmeier G. Heart Failure Relapses in Response to Acute Stresses – Role of Immunological and Inflammatory Pathways. Front Cardiovasc Med 2022;9:809935. [DOI: 10.3389/fcvm.2022.809935] [Reference Citation Analysis]
474 Rosoff DB, Yoo J, Lohoff FW. A genetically-informed study disentangling the relationships between tobacco smoking, cannabis use, alcohol consumption, substance use disorders and respiratory infections, including COVID-19. medRxiv 2021:2021. [PMID: 33594380 DOI: 10.1101/2021.02.11.21251581] [Reference Citation Analysis]
475 Mitrani RD, Dabas N, Goldberger JJ. COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020;17:1984-1990. [PMID: 32599178 DOI: 10.1016/j.hrthm.2020.06.026] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 39.5] [Reference Citation Analysis]
476 Boukhris M, Hillani A, Moroni F, Annabi MS, Addad F, Ribeiro MH, Mansour S, Zhao X, Ybarra LF, Abbate A, Vilca LM, Azzalini L. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective. Can J Cardiol 2020;36:1068-80. [PMID: 32425328 DOI: 10.1016/j.cjca.2020.05.018] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 34.0] [Reference Citation Analysis]
477 Sideris GA, Nikolakea M, Karanikola A, Konstantinopoulou S, Giannis D, Modahl L. Imaging in the COVID-19 era: Lessons learned during a pandemic. WJR 2021;13:193-223. [DOI: 10.4329/wjr.v13.i6.193] [Reference Citation Analysis]
478 Rodríguez-Santamarta M, Minguito-Carazo C, Echarte-Morales JC, Del Castillo-García S, Valdivia-Ruiz J, Fernández-Vázquez F. [Echocardiographic findings in critical patients with COVID-19]. Rev Esp Cardiol 2020;73:861-3. [PMID: 32836661 DOI: 10.1016/j.recesp.2020.06.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
479 Turgay Yıldırım Ö, Kaya Ş. The atherogenic index of plasma as a predictor of mortality in patients with COVID-19. Heart Lung 2021;50:329-33. [PMID: 33524862 DOI: 10.1016/j.hrtlng.2021.01.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
480 Siripanthong B, Hanff TC, Levin MG, Vidula MK, Khanji MY, Nazarian S, Chahal CAA. Coronavirus disease 2019 is delaying the diagnosis and management of chest pain, acute coronary syndromes, myocarditis and heart failure. Future Cardiol 2021;17:3-6. [PMID: 32608242 DOI: 10.2217/fca-2020-0088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
481 Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z, Ye D, Liu J, Wan J. Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed Pharmacother 2020;127:110230. [PMID: 32428835 DOI: 10.1016/j.biopha.2020.110230] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
482 De Simone B, Chouillard E, Sartelli M, Biffl WL, Di Saverio S, Moore EE, Kluger Y, Abu-Zidan FM, Ansaloni L, Coccolini F, Leppänemi A, Peitzmann AB, Pagani L, Fraga GP, Paolillo C, Picetti E, Valentino M, Pikoulis E, Baiocchi GL, Catena F. The management of surgical patients in the emergency setting during COVID-19 pandemic: the WSES position paper. World J Emerg Surg 2021;16:14. [PMID: 33752721 DOI: 10.1186/s13017-021-00349-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
483 Puthiyedath R, Kataria S, Payyappallimana U, Mangalath P, Nampoothiri V, Sharma P, Singh MK, Kumar K, Trehan N. Ayurvedic clinical profile of COVID-19 - A preliminary report. J Ayurveda Integr Med 2020:S0975-9476(20)30039-5. [PMID: 32624376 DOI: 10.1016/j.jaim.2020.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
484 Porzionato A, Emmi A, Barbon S, Boscolo-Berto R, Stecco C, Stocco E, Macchi V, De Caro R. Sympathetic activation: a potential link between comorbidities and COVID-19. FEBS J 2020;287:3681-8. [PMID: 32779891 DOI: 10.1111/febs.15481] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
485 Loghin C, Chauhan S, Lawless SM. Pseudo-Acute Myocardial Infarction in a Young COVID-19 Patient. JACC Case Rep 2020;2:1284-8. [PMID: 32342049 DOI: 10.1016/j.jaccas.2020.04.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
486 Werba JP, Veglia F. Moving Safely to Phase 2 of the COVID-19 Pandemic: What Is More Pressing, Dates or Data? Glob Heart 2020;15:39. [PMID: 32923333 DOI: 10.5334/gh.813] [Reference Citation Analysis]
487 [DOI: 10.1101/2020.04.12.20062869] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
488 Sanghvi SK, Schwarzman LS, Nazir NT. Cardiac MRI and Myocardial Injury in COVID-19: Diagnosis, Risk Stratification and Prognosis. Diagnostics (Basel) 2021;11:130. [PMID: 33467705 DOI: 10.3390/diagnostics11010130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
489 Ramzy M, Montrief T, Gottlieb M, Brady WJ, Singh M, Long B. COVID-19 cardiac arrest management: A review for emergency clinicians. Am J Emerg Med 2020;38:2693-702. [PMID: 33041141 DOI: 10.1016/j.ajem.2020.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
490 Rasmi Y, Mosa OF, Alipour S, Heidari N, Javanmard F, Golchin A, Gholizadeh-ghaleh Aziz S. Significance of Cardiac Troponins as an Identification Tool in COVID-19 Patients Using Biosensors: An Update. Front Mol Biosci 2022;9:821155. [DOI: 10.3389/fmolb.2022.821155] [Reference Citation Analysis]
491 Fathi F, Sami R, Mozafarpoor S, Hafezi H, Motedayyen H, Arefnezhad R, Eskandari N. Immune system changes during COVID-19 recovery play key role in determining disease severity. Int J Immunopathol Pharmacol 2020;34:2058738420966497. [PMID: 33076729 DOI: 10.1177/2058738420966497] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
492 Primorac D, Matišić V, Molnar V, Bahtijarević Z, Polašek O. Pre-season football preparation in the era of COVID-19: Croatian Football Association Model. J Glob Health 2020;10:010352. [PMID: 32426120 DOI: 10.7189/jogh.10.010352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
493 Sabayan B, Moghadami M, Assarzadegan F, Komachali SH, Poorsaadat L, Babaeepour Z, Ebrahimzadeh SA, Hamidi A, Hasheminejad ZS, Mohammadi-Vosough E, Mirkarimi HR, Paybast S, Rahimian N, Safari A, Sepehrnia M, Nematollahi R, Shahripour RB, Batra A, Sorond F, Borhani-Haghighi A. COVID-19 Respiratory Illness and Subsequent Cerebrovascular Events, the Initial Iranian Experience. J Stroke Cerebrovasc Dis 2021;30:105454. [PMID: 33212340 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
494 Siddiqi HK, Weber B, Zhou G, Regan J, Fajnzylber J, Coxen K, Corry H, Yu XG, DiCarli M, Li JZ, Bhatt DL. Increased Prevalence of Myocardial Injury in Patients with SARS-CoV-2 Viremia. Am J Med 2021;134:542-6. [PMID: 33181107 DOI: 10.1016/j.amjmed.2020.09.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
495 Chukwunyere U, Sehirli AO, Abacioglu N. COVID-19-related arrhythmias and the possible effects of ranolazine. Med Hypotheses 2021;149:110545. [PMID: 33636586 DOI: 10.1016/j.mehy.2021.110545] [Reference Citation Analysis]
496 Tehrani DM, Wang X, Rafique AM, Hayek SS, Herrmann J, Neilan TG, Desai P, Morgans A, Lopez-Mattei J, Parikh RV, Yang EH. Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry. Cardiooncology 2021;7:28. [PMID: 34372948 DOI: 10.1186/s40959-021-00113-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
497 Wibowo A, Pranata R, Akbar MR, Purnomowati A, Martha JW. Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression. Int J Infect Dis 2021;105:312-8. [PMID: 33667694 DOI: 10.1016/j.ijid.2021.02.113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
498 Ky B, Mann DL. COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities. JACC Basic Transl Sci 2020;5:501-17. [PMID: 32309679 DOI: 10.1016/j.jacbts.2020.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
499 [DOI: 10.1101/2020.04.21.20074591] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
500 Uranga A, Villanueva A, Lafuente I, González N, Legarreta MJ, Aguirre U, España PP, Quintana JM, García-Gutiérrez S; COVID-19-Osakidetza working group. Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study. Rev Clin Esp (Barc) 2021:S2254-8874(21)00149-1. [PMID: 34556435 DOI: 10.1016/j.rceng.2021.04.009] [Reference Citation Analysis]
501 Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. Front Public Health 2020;8:582932. [PMID: 33520910 DOI: 10.3389/fpubh.2020.582932] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
502 Abu Ghosh Z, Zwas DR, Keren A, Elbaz-Greener G, Israeli V, Amir O, Gotsman I. The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure. J Clin Med 2021;10:5577. [PMID: 34884277 DOI: 10.3390/jcm10235577] [Reference Citation Analysis]
503 Arévalos V, Ortega-Paz L, Brugaletta S. Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes. Med Clin (Barc) 2021:S0025-7753(21)00294-3. [PMID: 34147251 DOI: 10.1016/j.medcli.2021.05.006] [Reference Citation Analysis]
504 Yang C, Liu F, Liu W, Cao G, Liu J, Huang S, Zhu M, Tu C, Wang J, Xiong B. Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia. Int J Cardiol. 2020;. [PMID: 32979425 DOI: 10.1016/j.ijcard.2020.09.048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
505 Utebay D, Seeger H, Müller AMS, David S. Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case report. Eur Heart J Case Rep 2021;5:ytab386. [PMID: 34661055 DOI: 10.1093/ehjcr/ytab386] [Reference Citation Analysis]
506 Varghese GM, John R, Manesh A, Karthik R, Abraham OC. Clinical management of COVID-19. Indian J Med Res 2020;151:401-10. [PMID: 32611911 DOI: 10.4103/ijmr.IJMR_957_20] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
507 Nan J, Jin YB, Myo Y, Zhang G. Hypoxia in acute cardiac injury of coronavirus disease 2019: lesson learned from pathological studies. J Geriatr Cardiol. 2020;17:221-223. [PMID: 32362921 DOI: 10.11909/j.issn.1671-5411.2020.04.010] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
508 Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes Metab Syndr 2020;14:1043-51. [PMID: 32640416 DOI: 10.1016/j.dsx.2020.06.056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
509 Zheng X, Zhao Y, Yang L. Acute Kidney Injury in COVID-19: The Chinese Experience. Semin Nephrol 2020;40:430-42. [PMID: 33334457 DOI: 10.1016/j.semnephrol.2020.09.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
510 Han Y, Chen T, Bryant J, Bucciarelli-Ducci C, Dyke C, Elliott MD, Ferrari VA, Friedrich MG, Lawton C, Manning WJ, Ordovas K, Plein S, Powell AJ, Raman SV, Carr J. Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic. J Cardiovasc Magn Reson 2020;22:26. [PMID: 32340614 DOI: 10.1186/s12968-020-00628-w] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
511 Stockenhuber A, Vrettos A, Androschuck V, George M, Robertson C, Bowers N, Clifford P, Firoozan S. A pilot study on right ventricular longitudinal strain as a predictor of outcome in COVID‐19 patients with evidence of cardiac involvement. Echocardiography 2021;38:222-9. [DOI: 10.1111/echo.14966] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
512 Guimarães PO, de Souza FR, Lopes RD, Bittar C, Cardozo FA, Caramelli B, Calderaro D, Albuquerque CP, Drager LF, Feres F, Baracioli L, Feitosa Filho G, Barbosa RR, Ribeiro HB, Ribeiro E, Alves RJ, Soeiro A, Faillace B, Figueiredo E, Damiani LP, do Val RM, Huemer N, Nicolai LG, Hajjar LA, Abizaid A, Kalil Filho R. High risk coronavirus disease 2019: The primary results of the CoronaHeart multi-center cohort study. Int J Cardiol Heart Vasc 2021;36:100853. [PMID: 34345648 DOI: 10.1016/j.ijcha.2021.100853] [Reference Citation Analysis]
513 Patil M, Singh S, Henderson J, Krishnamurthy P. Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link? J Cell Physiol 2021;236:3366-82. [PMID: 33078408 DOI: 10.1002/jcp.30109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
514 Escobedo RA, Kaushal D, Singh DK. Insights Into the Changing Landscape of Coronavirus Disease 2019. Front Cell Infect Microbiol 2021;11:761521. [PMID: 35083164 DOI: 10.3389/fcimb.2021.761521] [Reference Citation Analysis]
515 Barzkar F, Ranjbar M, Sioofy-Khojine AB, Khajehazad M, Vesal Azad R, Moradi Y, Baradaran HR. Efficacy and safety of chloroquine and hydroxychloroquine for COVID-19: A comprehensive evidence synthesis of clinical, animal, and in vitro studies. Med J Islam Repub Iran 2020;34:171. [PMID: 33816370 DOI: 10.47176/mjiri.34.171] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
516 Ippolito M, Catalisano G, Marino C, Fucà R, Giarratano A, Baldi E, Einav S, Cortegiani A. Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis. Resuscitation 2021;164:122-9. [PMID: 33964332 DOI: 10.1016/j.resuscitation.2021.04.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
517 Ghazizadeh Z, Majd H, Richter M, Samuel R, Zekavat SM, Asgharian H, Farahvashi S, Kalantari A, Ramirez J, Zhao H, Natarajan P, Goodarzi H, Fattahi F. Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. bioRxiv 2020:2020. [PMID: 32511360 DOI: 10.1101/2020.05.12.091082] [Cited by in Crossref: 19] [Article Influence: 9.5] [Reference Citation Analysis]
518 Pedicelli A, Valente I, Pilato F, Distefano M, Colosimo C. Stroke priorities during COVID-19 outbreak: acting both fast and safe. J Stroke Cerebrovasc Dis 2020;29:104922. [PMID: 32417235 DOI: 10.1016/j.jstrokecerebrovasdis.2020.104922] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
519 Mutinelli-Szymanski P, Hude I, Merle E, Lombardi Y, Seris P, Abtahi M, Azeroual L, Bourgain C, Ensergueix G, Katerinis I, Kolko A, Kolta A, Maheas C, Mehrbanian S, Morel P, Ossman R, de Préneuf H, Roux A, Saltiel C, Vendé F, Verhoeven AS, Viron B, Laplanche S, Le Monnier A, Ridel C, Ureña-Torres P, Touzot M. Neutrophil:lymphocyte ratio predicts short-term outcome of COVID-19 in haemodialysis patients. Clin Kidney J 2021;14:124-31. [PMID: 33558835 DOI: 10.1093/ckj/sfaa194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
520 Braude P, Carter B, Short R, Vilches-Moraga A, Verduri A, Pearce L, Price A, Quinn TJ, Stechman M, Collins J, Bruce E, Einarsson A, Rickard F, Mitchell E, Holloway M, Hesford J, Barlow-Pay F, Clini E, Myint PK, Moug S, McCarthy K, Hewitt J. The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19. Int J Cardiol Heart Vasc 2020;31:100660. [PMID: 33083516 DOI: 10.1016/j.ijcha.2020.100660] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
521 Wu Y, Hou B, Liu J, Chen Y, Zhong P. Risk Factors Associated With Long-Term Hospitalization in Patients With COVID-19: A Single-Centered, Retrospective Study. Front Med (Lausanne) 2020;7:315. [PMID: 32582749 DOI: 10.3389/fmed.2020.00315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
522 Bascuñana A, Mijaylova A, Vega A, Macías N, Verde E, Rodríguez-Ferrero ML, Delgado A, Carbayo J, Goicoechea M. Thrombotic Microangiopathy in a Kidney Transplant Patient With COVID-19. Kidney Med 2021;3:124-7. [PMID: 33319192 DOI: 10.1016/j.xkme.2020.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
523 Morales DR, Conover MM, You SC, Pratt N, Kostka K, Duarte-Salles T, Fernández-Bertolín S, Aragón M, DuVall SL, Lynch K, Falconer T, van Bochove K, Sung C, Matheny ME, Lambert CG, Nyberg F, Alshammari TM, Williams AE, Park RW, Weaver J, Sena AG, Schuemie MJ, Rijnbeek PR, Williams RD, Lane JCE, Prats-Uribe A, Zhang L, Areia C, Krumholz HM, Prieto-Alhambra D, Ryan PB, Hripcsak G, Suchard MA. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health 2021;3:e98-e114. [PMID: 33342753 DOI: 10.1016/S2589-7500(20)30289-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
524 Kwan JM, Henry ML, Christophers B, Tamirisa K, Thamman R, Sadler D, Aggarwal NR, Cheng R, Parwani P, Dent S, Ismail-Khan R, Fradley MG, Brown SA. The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic. Curr Oncol Rep 2021;23:99. [PMID: 34259950 DOI: 10.1007/s11912-021-01081-3] [Reference Citation Analysis]
525 Rahman MA, Shanjana Y, Tushar MI, Mahmud T, Rahman GMS, Milan ZH, Sultana T, Chowdhury AMLH, Bhuiyan MA, Islam MR, Reza HM. Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh. PLoS One 2021;16:e0255379. [PMID: 34314447 DOI: 10.1371/journal.pone.0255379] [Reference Citation Analysis]
526 Qeadan F, Tingey B, Bern R, Porucznik CA, English K, Saeed AI, Madden EF. Opioid use disorder and health service utilization among COVID-19 patients in the US: A nationwide cohort from the Cerner Real-World Data. EClinicalMedicine 2021;37:100938. [PMID: 34109308 DOI: 10.1016/j.eclinm.2021.100938] [Reference Citation Analysis]
527 Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 2021;5:rkaa081. [PMID: 33615129 DOI: 10.1093/rap/rkaa081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
528 Stefanini GG, Chiarito M, Ferrante G, Cannata F, Azzolini E, Viggiani G, De Marco A, Briani M, Bocciolone M, Bragato R, Corrada E, Gasparini GL, Marconi M, Monti L, Pagnotta PA, Panico C, Pini D, Regazzoli D, My I, Kallikourdis M, Ciccarelli M, Badalamenti S, Aghemo A, Reimers B, Condorelli G; Humanitas COVID-19 Task Force. Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19. Heart 2020;106:1512-8. [PMID: 32817312 DOI: 10.1136/heartjnl-2020-317322] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
529 Stokes KA, Jones B, Bennett M, Close GL, Gill N, Hull JH, Kasper AM, Kemp SPT, Mellalieu SD, Peirce N, Stewart B, Wall BT, West SW, Cross M. Returning to Play after Prolonged Training Restrictions in Professional Collision Sports. Int J Sports Med 2020;41:895-911. [PMID: 32483768 DOI: 10.1055/a-1180-3692] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 10.5] [Reference Citation Analysis]
530 Qiang Z, Wang B, Garrett BC, Rainey RP, Superko HR. Coronavirus disease 2019: a comprehensive review and meta-analysis on cardiovascular biomarkers. Curr Opin Cardiol 2021;36:367-73. [PMID: 33709980 DOI: 10.1097/HCO.0000000000000851] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
531 Arutyunov GP, Tarlovskaya EI, Arutyunov AG, Belenkov YN, Konradi AO, Lopatin YM, Rebrov AP, Tereshchenko SN, Chesnikova AI, Hayrapetyan HG, Babin AP, Bakulin IG, Bakulina NV, Balykova LA, Blagonravova AS, Boldina MV, Vaisberg AR, Galyavich AS, Gomonova VV, Grigorieva NY, Gubareva IV, Demko IV, Evzerikhina AV, Zharkov AV, Kamilova UK, Kim ZF, Kuznetsova TY, Lareva NV, Makarova EV, Malchikova SV, Nedogoda SV, Petrova MM, Pochinka IG, Protasov KV, Protsenko DN, Ruzanau DY, Sayganov SA, Sarybaev AS, Selezneva NM, Sugraliev AB, Fomin IV, Khlynova OV, Chizhova OY, Shaposhnik II, Sh'ukarev DA, Abdrahmanova АK, Avetisian SA, Avoyan HG, Azarian KK, Aimakhanova GT, Ayipova DA, Akunov AC, Alieva MK, Aparkina AV, Aruslanova OR, Ashina EY, Badina OY, Barisheva OY, Batchayeva AS, Bitieva AM, Bikhteyev IU, Borodulina NA, Bragin MV, Budu AM, Bykova GM, Vagapova KR, Varlamova DD, Vezikova NN, Verbitskaya EA, Vilkova OE, Vinnikova EA, Vustina VV, Galova EA, Genkel VV, Gorshenina EI, Gostishev RV, Grigorieva EV, Gubareva EY, Dabylova GM, Demchenko AI, Dolgikh OY, Duyshobayev MY, Evdokimov DS, Egorova KE, Ermilova AN, Zheldybayeva AE, Zarechnova NV, Zimina YD, Ivanova SY, Ivanchenko EY, Ilina MV, Kazakovtseva MV, Kazymova EV, Kalinina YS, Kamardina NA, Karachenova AM, Karetnikov IA, Karoli NA, Karsiev MK, Кaskaeva DS, Kasymova KF, Kerimbekova ZB, Kerimova AS, Kim ES, Kiseleva NV, Klimenko DA, Klimova AV, Kovalishena OV, Kolmakova EV, Kolchinskaya TP, Kolyadich MI, Kondriakova OV, Konoval MP, Konstantinov DY, Konstantinova EA, Kordukova VA, Koroleva EV, Kraposhina AY, Kriukova TV, Kuznetsova AS, Kuzmina TY, Kuzmichev KV, Kulchoroevna CK, Kuprina TV, Kouranova IM, Kurenkova LV, Kurchugina NY, Kushubakova NA, Levankova VI, Lyubavina NA, Magdeyeva NA, Mazalov KV, Majseenko VI, Makarova AS, Maripov AM, Marusina AA, Melnikov ES, Moiseenko NB, Muradova FN, Muradyan RG, Musaelian SN, Myshak AO, Nekaeva ES, Nikitina NM, Ogurlieva BB, Odegova AA, Omarova YV, Omurzakova NA, Ospanova SO, Pahomova EV, Petrov LD, Plastinina SS, Pogrebetskaya VA, Polyakov DS, Ponomarenko EV, Popova LL, Prokofeva NA, Pudova IA, Rakov NA, Rahimov AN, Rozanova NA, Serikbolkyzy S, Simonov AA, Skachkova VV, Soloveva DV, Soloveva IA, Subbotin AK, Sukhomlinova IM, Sushilova AG, Tagayeva DR, Titojkina YV, Tikhonova EP, Tokmin DS, Tolmacheva AA, Torgunakova MS, Trenogina KV, Trostianetckaia NA, Trofimov DA, Tulichev AA, Tursunova AT, Ulanova ND, Fatenkov OV, Fedorishina OV, Fil TS, Fomina IY, Fominova IS, Frolova IA, Tsvinger SM, Tsoma VV, Cholponbaeva MB, Chudinovskikh TI, Shevchenko OA, Sheshina TV, Shishkina EA, Shishkov KY, Sherbakov SY, Yausheva EA. ACTIV SARS-CoV-2 registry (Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients). Assessment of impact of combined original comorbid diseases in patients with COVID-19 on the prognosis. Terapevticheskii arkhiv 2022;94:32-47. [DOI: 10.26442/00403660.2022.01.201320] [Reference Citation Analysis]
532 Tanwar V, Adelstein JM, Wold LE. Double trouble: combined cardiovascular effects of particulate matter exposure and coronavirus disease 2019. Cardiovasc Res 2021;117:85-95. [PMID: 33084879 DOI: 10.1093/cvr/cvaa293] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
533 Kaliyaperumal D, Bhargavi K, Ramaraju K, Nair KS, Ramalingam S, Alagesan M. Electrocardiographic Changes in COVID-19 Patients: A Hospital-based Descriptive Study. Indian Journal of Critical Care Medicine 2022;26:43-8. [DOI: 10.5005/jp-journals-10071-24045] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
534 Pavo N, Prausmüller S, Spinka G, Goliasch G, Bartko PE, Wurm R, Arfsten H, Strunk G, Poglitsch M, Domenig O, Mascherbauer J, Uyanik-Ünal K, Hengstenberg C, Zuckermann A, Hülsmann M. Myocardial Angiotensin Metabolism in End-Stage Heart Failure. J Am Coll Cardiol 2021;77:1731-43. [PMID: 33832600 DOI: 10.1016/j.jacc.2021.01.052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
535 Wu L, Baylan U, van der Leeden B, Schurink B, Roos E, Schalkwijk CG, Bugiani M, van der Valk P, van Rossum AC, Zeerleder SS, Heunks LMA, Boon RA, de Boer OJ, van der Wal AC, Niessen HWM, Krijnen PAJ. Cardiac inflammation and microvascular procoagulant changes are decreased in second wave compared to first wave deceased COVID-19 patients. Int J Cardiol 2021:S0167-5273(21)01970-7. [PMID: 34871622 DOI: 10.1016/j.ijcard.2021.11.079] [Reference Citation Analysis]
536 Hajouli S. A 29-Year-Old Man with COVID-19 Pneumonia, Heart Failure-Reduced Ejection Fraction, and Atrial Fibrillation with a Father and 2 Grandparents Who Were Positive for SARS-CoV-2 Infection. Am J Case Rep 2021;22:e933163. [PMID: 34294675 DOI: 10.12659/AJCR.933163] [Reference Citation Analysis]
537 Chen K, Lei Y, He Y, Xiao F, Yu Y, Lai X, Liu Y, Wang J, Dai H. Clinical outcomes of hospitalized COVID-19 patients with renal injury: a multi-hospital observational study from Wuhan. Sci Rep 2021;11:15205. [PMID: 34312430 DOI: 10.1038/s41598-021-94570-1] [Reference Citation Analysis]
538 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: 32651579 DOI: 10.1038/s41591-020-0968-3] [Cited by in Crossref: 770] [Cited by in F6Publishing: 675] [Article Influence: 385.0] [Reference Citation Analysis]
539 Sobh E, Abuarrah E, Abdelsalam KG, Awad SS, Badawy MA, Fathelbab MA, Aboulfotouh MA, Awadallah MF. Novel coronavirus disease 2019 (COVID-19) non-respiratory involvement. Egypt J Bronchol 2020;14. [DOI: 10.1186/s43168-020-00030-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
540 Martins-Filho PR, Barreto-Filho JAS, Santos VS. Myocardial Injury Biomarkers and Cardiac Complications Associated with Mortality in Patients with COVID-19. Arq Bras Cardiol 2020;115:273-7. [PMID: 32876196 DOI: 10.36660/abc.20200372] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
541 Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, Raparelli V, Pezzotti P, Riccardo F, Bella A, Fabiani M, D'Ancona FP, Vaianella L, Tiple D, Colaizzo E, Palmer K, Rezza G, Piccioli A, Brusaferro S, Onder G; Italian National Institute of Health COVID-19 Mortality Group. Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci 2020;75:1796-800. [PMID: 32506122 DOI: 10.1093/gerona/glaa146] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 33.0] [Reference Citation Analysis]
542 Jafarzadeh A, Jafarzadeh S, Nozari P, Mokhtari P, Nemati M. Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms. Scand J Immunol 2021;93:e12967. [PMID: 32875598 DOI: 10.1111/sji.12967] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
543 DeFilippis EM, Stefanescu Schmidt AC, Reza N. Adapting the Educational Environment for Cardiovascular Fellows-in-Training During the COVID-19 Pandemic. J Am Coll Cardiol 2020;75:2630-4. [PMID: 32304798 DOI: 10.1016/j.jacc.2020.04.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 16.0] [Reference Citation Analysis]
544 Khaleghi M, Aziz-Ahari A, Rezaeian N, Asadian S, Mounesi Sohi A, Motamedi O, Azhdeh S. The Valuable Role of Imaging Modalities in the Diagnosis of the Uncommon Presentations of COVID-19: An Educative Case Series. Case Rep Med 2021;2021:7213627. [PMID: 34691187 DOI: 10.1155/2021/7213627] [Reference Citation Analysis]
545 Bennett CE, Anavekar NS, Gulati R, Singh M, Kane GC, Sandoval Y, Foley TA, Jaffe AS, Sandhu GS, Bell MR, Askew JW. ST-segment Elevation, Myocardial Injury, and Suspected or Confirmed COVID-19 Patients: Diagnostic and Treatment Uncertainties. Mayo Clin Proc 2020;95:1107-11. [PMID: 32414550 DOI: 10.1016/j.mayocp.2020.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
546 Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, Sutherland A, Puri S, Srivastava A, Leonberg-Yoo A, Shehata AM, Flythe JE, Rashidi A, Schenck EJ, Goyal N, Hedayati SS, Dy R, Bansal A, Athavale A, Nguyen HB, Vijayan A, Charytan DM, Schulze CE, Joo MJ, Friedman AN, Zhang J, Sosa MA, Judd E, Velez JCQ, Mallappallil M, Redfern RE, Bansal AD, Neyra JA, Liu KD, Renaghan AD, Christov M, Molnar MZ, Sharma S, Kamal O, Boateng JO, Short SAP, Admon AJ, Sise ME, Wang W, Parikh CR, Leaf DE; STOP-COVID Investigators. AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. J Am Soc Nephrol 2021;32:161-76. [PMID: 33067383 DOI: 10.1681/ASN.2020060897] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 23.0] [Reference Citation Analysis]
547 Wang Z, Yang L. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts. J Ethnopharmacol 2021;270:113869. [PMID: 33485973 DOI: 10.1016/j.jep.2021.113869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
548 Wetterslev M, Jacobsen PK, Hassager C, Jøns C, Risum N, Pehrson S, Bastiansen A, Andreasen AS, Tjelle Kristiansen K, Bestle MH, Mohr T, Møller-Sørensen H, Perner A. Cardiac arrhythmias in critically ill patients with coronavirus disease 2019: A retrospective population-based cohort study. Acta Anaesthesiol Scand 2021;65:770-7. [PMID: 33638870 DOI: 10.1111/aas.13806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
549 Cure E, Cumhur Cure M. Comment on "Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade". Nephron 2020;144:251-2. [PMID: 32311696 DOI: 10.1159/000507786] [Reference Citation Analysis]
550 Maino A, Di Stasio E, Grimaldi MC, Cappannoli L, Rocco E, Vergallo R, Biscetti F, Baroni S, Urbani A, Landolfi R, Biasucci LM. Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin. Int J Cardiol 2021;338:278-85. [PMID: 34157355 DOI: 10.1016/j.ijcard.2021.06.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
551 Li N, Zhu L, Sun L, Shao G. The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries. Stem Cell Res 2021;51:102168. [PMID: 33485182 DOI: 10.1016/j.scr.2021.102168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
552 Vera-Pineda R, Francisco Carrizales-Sepulveda E, Camacho-Ortiz A, Nuzzolo-Shihadeh L, Cruz-Ramos F, Ordaz-Farias A, Benavides-Gonzalez MA, Carranza-Villegas G. Echocardiographic Characteristics of Subjects With COVID-19: A Case Series. Cardiol Res 2020;11:260-5. [PMID: 32595812 DOI: 10.14740/cr1084] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
553 Chen Z, Lv Y, Xu H, Deng L. Herbal Medicine, Gut Microbiota, and COVID-19. Front Pharmacol 2021;12:646560. [PMID: 34305582 DOI: 10.3389/fphar.2021.646560] [Reference Citation Analysis]
554 Bergamaschi L, D'Angelo EC, Paolisso P, Toniolo S, Fabrizio M, Angeli F, Donati F, Magnani I, Rinaldi A, Bartoli L, Chiti C, Biffi M, Pizzi C, Viale P, Galié N. The value of ECG changes in risk stratification of COVID-19 patients. Ann Noninvasive Electrocardiol 2021;26:e12815. [PMID: 33512742 DOI: 10.1111/anec.12815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
555 Atemnkeng F, Alataby H, Demirjian J, Kenne FM, Nfonoyim J. A Novel Report on the Compassionate Use of Baricitinib in Treating a Pediatric Patient With Severe Symptoms of COVID-19 Infection. J Med Cases 2021;12:94-8. [PMID: 33984091 DOI: 10.14740/jmc3629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
556 Maab H, Mustafa F, Shabbir SJ. Cardiovascular impact of COVID-19: an array of presentations. Acta Biomed 2021;92:e2021021. [PMID: 33988162 DOI: 10.23750/abm.v92i2.10299] [Reference Citation Analysis]
557 Ammirati E, Wang DW. SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patients. Int J Cardiol 2020;311:122-3. [PMID: 32276774 DOI: 10.1016/j.ijcard.2020.03.086] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
558 Yasuhara J, Watanabe K, Takagi H, Sumitomo N, Kuno T. COVID-19 and multisystem inflammatory syndrome in children: A systematic review and meta-analysis. Pediatr Pulmonol 2021;56:837-48. [PMID: 33428826 DOI: 10.1002/ppul.25245] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
559 Mumoli N, Cei M, Mazzone A, Conte G. Cardiac injury as prognostic value in COVID-19: more remains to be clarified. Intern Emerg Med 2021;16:267-8. [PMID: 33113079 DOI: 10.1007/s11739-020-02540-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
560 Deng YP, Xie W, Liu T, Wang SY, Wang MR, Zan YX, Meng XB, Deng YQ, Xiong HR, Fu XD. Association of Hypertension with Severity and Mortality in Hospitalized Patients with COVID-19 in Wuhan, China: A Single-centered, Retrospective Study. Arq Bras Cardiol 2021:S0066-782X2021005010205. [PMID: 34287571 DOI: 10.36660/abc.20200733] [Reference Citation Analysis]
561 Cunningham JW, Claggett BL, Jering KS, Vaduganathan M, Bhatt AS, Rosenthal N, Solomon SD. Prognostic Value of Natriuretic Peptides and Cardiac Troponins in COVID-19. Circulation 2021;144:177-9. [PMID: 33999648 DOI: 10.1161/CIRCULATIONAHA.121.054969] [Reference Citation Analysis]
562 Fuentes-Prior P. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection. J Biol Chem 2021;296:100135. [PMID: 33268377 DOI: 10.1074/jbc.REV120.015980] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
563 Han T, Yuan H, Ye L, Jiang X, Bai L, Wang C. [Impact of cardiovascular metabolic diseases on COVID-19: review of recent progress]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:628-32. [PMID: 33963726 DOI: 10.12122/j.issn.1673-4254.2021.04.22] [Reference Citation Analysis]
564 Kozlov IA, Tyurin IN. Cardiovascular complications of COVID-19. Vestn anesteziol reanimatol 2020;17:14-22. [DOI: 10.21292/2078-5658-2020-17-4-14-22] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
565 Araújo NMD, Oliveira EDS, Silva BVSD, Melo EBBD, Dantas RAN, Dantas DV. AUDIOVISUAL AIDS IN PREOPERATIVE CARDIAC SURGERY EDUCATION: A SCOPING REVIEW. Texto contexto - enferm 2022;31:e20210334. [DOI: 10.1590/1980-265x-tce-2021-0334] [Reference Citation Analysis]
566 Huang S, Vignon P, Mekontso-Dessap A, Tran S, Prat G, Chew M, Balik M, Sanfilippo F, Banauch G, Clau-Terre F, Morelli A, De Backer D, Cholley B, Slama M, Charron C, Goudelin M, Bagate F, Bailly P, Blixt PJ, Masi P, Evrard B, Orde S, Mayo P, McLean AS, Vieillard-Baron A; ECHO-COVID research group. Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study). Intensive Care Med 2022. [PMID: 35445822 DOI: 10.1007/s00134-022-06685-2] [Reference Citation Analysis]
567 Fisher M. Cardiovascular disease and cardiovascular outcomes in COVID ‐19. Pract Diab 2020;37:191. [DOI: 10.1002/pdi.2294] [Cited by in Crossref: 6] [Article Influence: 3.0] [Reference Citation Analysis]
568 Gagarkin DA, Dombrowski KE, Thakar KB, DePetrillo JC. Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome associated with COVID-19: a case report. J Med Case Rep 2021;15:219. [PMID: 33910640 DOI: 10.1186/s13256-021-02831-4] [Reference Citation Analysis]
569 Shaghee F, Nafakhi H, Alareedh M, Nafakhi A, Al-Buthabhak K. ECG markers of malignant arrhythmias and in-hospital outcome of COVID-19 pneumonia. J Arrhythm 2021. [PMID: 33821177 DOI: 10.1002/joa3.12506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
570 Khinda J, Janjua NZ, Cheng S, van den Heuvel ER, Bhatti P, Darvishian M. Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression. J Med Virol 2021;93:1078-98. [PMID: 32776551 DOI: 10.1002/jmv.26411] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
571 Busana M, Schiavone M, Lanfranchi A, Battista Forleo G, Ceriani E, Beatrice Cogliati C, Gasperetti A. Non-invasive hemodynamic profile of early COVID-19 infection. Physiol Rep 2020;8:e14628. [PMID: 33113285 DOI: 10.14814/phy2.14628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
572 Berenguer J, Borobia AM, Ryan P, Rodríguez-Baño J, Bellón JM, Jarrín I, Carratalà J, Pachón J, Carcas AJ, Yllescas M, Arribas JR; COVID-19@Spain and COVID@HULP Study Groups. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. Thorax 2021;76:920-9. [PMID: 33632764 DOI: 10.1136/thoraxjnl-2020-216001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
573 Sharma S, Mishra A, Ashraf Z. COVID-19 Induced Coagulopathy (CIC): Thrombotic Manifestations of Viral Infection. TH Open 2022;6:e70-9. [PMID: 35280973 DOI: 10.1055/s-0042-1744185] [Reference Citation Analysis]
574 Randhawa PK, Scanlon K, Rappaport J, Gupta MK. Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular System. Front Physiol 2020;11:611275. [PMID: 33329064 DOI: 10.3389/fphys.2020.611275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
575 Zhou J, Sun Y, Huang W, Ye K. Altered Blood Cell Traits Underlie a Major Genetic Locus of Severe COVID-19. J Gerontol A Biol Sci Med Sci 2021;76:e147-54. [PMID: 33530099 DOI: 10.1093/gerona/glab035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
576 Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT. Liver Biochemistries in Hospitalized Patients With COVID-19. Hepatology. 2021;73:890-900. [PMID: 32415860 DOI: 10.1002/hep.31326] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 31.0] [Reference Citation Analysis]
577 Morelli C, Francavilla M, Stabile Ianora AA, Cozzolino M, Gualano A, Stellacci G, Sacco A, Lorusso F, Pedote P, De Ceglie M, Scardapane A. The Multifaceted COVID-19: CT Aspects of Its Atypical Pulmonary and Abdominal Manifestations and Complications in Adults and Children. A Pictorial Review. Microorganisms 2021;9:2037. [PMID: 34683358 DOI: 10.3390/microorganisms9102037] [Reference Citation Analysis]
578 Bonnet G, Weizman O, Trimaille A, Pommier T, Cellier J, Geneste L, Panagides V, Marsou W, Deney A, Attou S, Delmotte T, Ribeyrolles S, Chemaly P, Karsenty C, Giordano G, Gautier A, Chaumont C, Guilleminot P, Sagnard A, Pastiero J, Ezzouhairi N, Perin B, Zakine C, Levasseur T, Ma I, Chavignier D, Noirclerc N, Darmon A, Mevelec M, Duceau B, Sutter W, Mika D, Fauvel C, Pezel T, Waldmann V, Cohen A; Critical COVID-19 France Investigators. Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study. Arch Cardiovasc Dis 2021;114:352-63. [PMID: 34154953 DOI: 10.1016/j.acvd.2021.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
579 Chazova IE, Mironova OI. [COVID-19 and cardiovascular diseases]. Ter Arkh 2020;92:4-7. [PMID: 33346424 DOI: 10.26442/00403660.2020.09.000742] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
580 Wilson MG, Hull JH, Rogers J, Pollock N, Dodd M, Haines J, Harris S, Loosemore M, Malhotra A, Pieles G, Shah A, Taylor L, Vyas A, Haddad FS, Sharma S. Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. Br J Sports Med 2020;54:1157-61. [PMID: 32878870 DOI: 10.1136/bjsports-2020-102710] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 16.5] [Reference Citation Analysis]
581 Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med 2020;382:e102. [PMID: 32356626 DOI: 10.1056/NEJMoa2007621] [Reference Citation Analysis]
582 Aralova NI; V. M. Glushkov Institute of Cybernetics of National Academy of Sciences of Ukraine, Kyiv. MATHEMATICAL MODEL FOR THE INVESTIGATION OF HYPOXIC STATES IN THE HEART MUSCLE AT VIRAL DAMAGE. Biotechnol acta 2021;14:38-52. [DOI: 10.15407/biotech14.04.038] [Reference Citation Analysis]
583 Raad M, Gorgis S, Dabbagh M, Chehab O, Parikh S, Singh G. Right Heart Strain on Presenting 12-Lead Electrocardiogram Predicts Critical Illness in COVID-19. JACC Clin Electrophysiol 2021;7:485-93. [PMID: 33358667 DOI: 10.1016/j.jacep.2020.09.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
584 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
585 Xu D, Zhou F, Sun W, Chen L, Lan L, Li H, Xiao F, Li Y, Kolachalama VB, Wang X, Xu H. Relationship Between serum SARS-CoV-2 nucleic acid(RNAemia) and Organ Damage in COVID-19 Patients: A Cohort Study. Clin Infect Dis. 2020;epub ahead of print. [PMID: 32720678 DOI: 10.1093/cid/ciaa1085] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
586 Fauvel C, Trimaille A, Weizman O, Pezel T, Mika D, Waldmann V, Cohen A, Bonnet G. Cardiovascular manifestations secondary to COVID-19: A narrative review. Respir Med Res 2022;81:100904. [PMID: 35525097 DOI: 10.1016/j.resmer.2022.100904] [Reference Citation Analysis]
587 Bioh G, Botrous C, Howard E, Patel A, Hampson R, Senior R. Prevalence of cardiac pathology and relation to mortality in a multiethnic population hospitalised with COVID-19. Open Heart 2021;8:e001833. [PMID: 34782369 DOI: 10.1136/openhrt-2021-001833] [Reference Citation Analysis]
588 Karaismailoglu E, Karaismailoglu S. Two novel nomograms for predicting the risk of hospitalization or mortality due to COVID-19 by the naïve Bayesian classifier method. J Med Virol 2021;93:3194-201. [PMID: 33599308 DOI: 10.1002/jmv.26890] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
589 Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;. [PMID: 32450107 DOI: 10.1016/s0140-6736(20)31180-6] [Cited by in Crossref: 267] [Cited by in F6Publishing: 259] [Article Influence: 133.5] [Reference Citation Analysis]
590 [DOI: 10.1101/2020.06.24.150326] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
591 Citro R, Pontone G, Bellino M, Silverio A, Iuliano G, Baggiano A, Manka R, Iesu S, Vecchione C, Asch FM, Ghadri JR, Templin C. Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19. Trends Cardiovasc Med. 2021;31:8-16. [PMID: 33065315 DOI: 10.1016/j.tcm.2020.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
592 Gioia MA, Okunade A, Friedman A, Ahmed MF, Syed RA. A Case of Myopericarditis and Cardiac Tamponade as the Initial Presentation of COVID-19 Infection. Cureus 2021;13:e12967. [PMID: 33654630 DOI: 10.7759/cureus.12967] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
593 Singhvi A, Barghash M, Lala A, Mitter SS, Parikh A, Oliveros E, Rollins BM, Brunjes DL, Alvarez-Garcia J, Johnston E, Ryan K, Itagaki S, Moss N, Pinney SP, Anyanwu A, Mancini D. Challenges in heart transplantation during COVID-19: A single-center experience. J Heart Lung Transplant 2020;39:894-903. [PMID: 32891266 DOI: 10.1016/j.healun.2020.06.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
594 Chen LQ, Burdowski J, Marfatia R, Weber J, Gliganic K, Diaz N, Ramjattan N, Zheng H, Mihalatos D, Wang L, Barasch E, Leung A, Gopal A, Craft J, Ren X, Stergiopoulos K, Jeremias A, Petrossian G, Robinson N, Levine J, Shlofmitz RA, Gulotta RJ, Muehlbauer SM, Lucore CL, Cao JJ. Reduced cardiac function is associated with cardiac injury and mortality risk in hospitalized COVID-19 Patients. Clin Cardiol 2020;43:1547-54. [PMID: 33280140 DOI: 10.1002/clc.23479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
595 Su YB, Kuo MJ, Lin TY, Chien CS, Yang YP, Chou SJ, Leu HB. Cardiovascular manifestation and treatment in COVID-19. J Chin Med Assoc 2020;83:704-9. [PMID: 32433342 DOI: 10.1097/JCMA.0000000000000352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
596 Kosiborod M, Berwanger O, Koch GG, Martinez F, Mukhtar O, Verma S, Chopra V, Javaheri A, Ambery P, Gasparyan SB, Buenconsejo J, Sjöström CD, Langkilde AM, Oscarsson J, Esterline R. Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. Diabetes Obes Metab 2021;23:886-96. [PMID: 33319454 DOI: 10.1111/dom.14296] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
597 Bristow MR, Zisman LS, Altman NL, Gilbert EM, Lowes BD, Minobe WA, Slavov D, Schwisow JA, Rodriguez EM, Carroll IA, Keuer TA, Buttrick PM, Kao DP. Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium. JACC Basic Transl Sci 2020;5:871-83. [PMID: 32838074 DOI: 10.1016/j.jacbts.2020.06.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
598 Janda L, Mihalčin M, Šťastná M. Is a healthy microbiome responsible for lower mortality in COVID-19? Biologia (Bratisl) 2020;:1-11. [PMID: 33078028 DOI: 10.2478/s11756-020-00614-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
599 Ryan PM, Caplice N. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response. Open Heart 2020;7:e001302. [PMID: 32532804 DOI: 10.1136/openhrt-2020-001302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
600 Bonow RO, O'Gara PT, Yancy CW. Cardiology and COVID-19. JAMA 2020;324:1131-2. [PMID: 32960249 DOI: 10.1001/jama.2020.15088] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
601 Yu JS, Pan NN, Chen RD, Zeng LC, Yang HK, Li H. Cardiac Biomarker Levels and Their Prognostic Values in COVID-19 Patients With or Without Concomitant Cardiac Disease. Front Cardiovasc Med 2020;7:599096. [PMID: 33553255 DOI: 10.3389/fcvm.2020.599096] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
602 Castiello T, Georgiopoulos G, Finocchiaro G, Claudia M, Gianatti A, Delialis D, Aimo A, Prasad S. COVID-19 and myocarditis: a systematic review and overview of current challenges. Heart Fail Rev 2021. [PMID: 33761041 DOI: 10.1007/s10741-021-10087-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
603 Jutzeler CR, Bourguignon L, Weis CV, Tong B, Wong C, Rieck B, Pargger H, Tschudin-Sutter S, Egli A, Borgwardt K, Walter M. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;37:101825. [PMID: 32763496 DOI: 10.1016/j.tmaid.2020.101825] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 23.5] [Reference Citation Analysis]
604 Kogan EA, Kukleva AD, Berezovskiy YS, Blagova OV, Zharkov NV, Ainetdinova DK, Demyashkin GA. [Clinical and morphological characteristics of SARS-CoV-2-related myocarditis proven by the presence of viral RNA and proteins in myocardial tissue]. Arkh Patol 2021;83:5-13. [PMID: 34278755 DOI: 10.17116/patol2021830415] [Reference Citation Analysis]
605 Khismatullin RR, Ponomareva AA, Nagaswami C, Ivaeva RA, Montone KT, Weisel JW, Litvinov RI. Pathology of lung-specific thrombosis and inflammation in COVID-19. J Thromb Haemost 2021. [PMID: 34538029 DOI: 10.1111/jth.15532] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
606 Thomas KE, Karamanis A, Dauchy E, Chapple AG, Loch MM. Assessing the effect of blood type on death and a novel scoring system to assess clinical course in patients with COVID-19. Am J Med Sci 2022:S0002-9629(21)00432-8. [PMID: 34986364 DOI: 10.1016/j.amjms.2021.12.006] [Reference Citation Analysis]
607 Zhang C, Verma A, Feng Y, Melo MCR, McQuillan M, Hansen M, Lucas A, Park J, Ranciaro A, Thompson S, Rubel MA, Campbell MC, Beggs W, Hirbo J, Mpoloka SW, Mokone GG, Nyambo T, Meskel DW, Belay G, Fokunang C, Njamnshi AK, Omar SA, Williams SM, Rader D, Ritchie MD, de la Fuente Nunez C, Sirugo G, Tishkoff S; Regeneron Genetic Center. Impact of natural selection on global patterns of genetic variation, and association with clinical phenotypes, at genes involved in SARS-CoV-2 infection. medRxiv 2021:2021. [PMID: 34230933 DOI: 10.1101/2021.06.28.21259529] [Reference Citation Analysis]
608 Alzoughool F, Alanagreh L, Abumweis S, Atoum M. Cerebrovascular comorbidity, high blood levels of C-reactive protein and D-dimer are associated with disease outcomes in COVID-19 patients. Clin Hemorheol Microcirc 2021;77:311-22. [PMID: 33185593 DOI: 10.3233/CH-201002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
609 Verhoef PA, Kannan S, Sturgill JL, Tucker EW, Morris PE, Miller AC, Sexton TR, Koyner JL, Hejal R, Brakenridge SC, Moldawer LL, Hotchkiss RS, Blood TM, Mazer MB, Bolesta S, Alexander SA, Armaignac DL, Shein SL, Jones C, Hoemann CD, Doctor A, Friess SH, Parker RI, Rotta AT, Remy KE. Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research. Crit Care Explor 2021;3:e0374. [PMID: 33786450 DOI: 10.1097/CCE.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
610 Kong X, Qi Y, Huang J, Zhao Y, Zhan Y, Qin X, Qi Z, Atanda AJ, Zhang L, Wang J, Fang Y, Jia P, Golozar A, Zhang L, Jiang Y. Epidemiological and clinical characteristics of cancer patients with COVID-19: A systematic review and meta-analysis of global data. Cancer Lett 2021;508:30-46. [PMID: 33757803 DOI: 10.1016/j.canlet.2021.02.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
611 Mu S, Wei W, Jin C, Pu N, Yu K, Gu G, Luo Z, Tong C, Han Y. Risk factors for COVID-19 patients with cardiac injury: pulmonary ventilation dysfunction and oxygen inhalation insufficiency are not the direct causes. Aging (Albany NY) 2020;12:23464-77. [PMID: 33226958 DOI: 10.18632/aging.104148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
612 Wungu CDK, Khaerunnisa S, Putri EAC, Hidayati HB, Qurnianingsih E, Lukitasari L, Humairah I, Soetjipto. Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19. Int J Infect Dis 2021;105:551-9. [PMID: 33711519 DOI: 10.1016/j.ijid.2021.03.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
613 Jaiswal V, Sarfraz Z, Sarfraz A, Mukherjee D, Batra N, Hitawala G, Yaqoob S, Patel A, Agarwala P, Ruchika, Sarfraz M, Bano S, Azeem N, Naz S, Jaiswal A, Sharma P, Chaudhary G. COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review. J Prim Care Community Health 2021;12:21501327211056800. [PMID: 34854348 DOI: 10.1177/21501327211056800] [Reference Citation Analysis]
614 Siddiq MM, Chan AT, Miorin L, Yadaw AS, Beaumont KG, Kehrer T, Cupic A, White KM, Tolentino RE, Hu B, Stern AD, Tavassoly I, Hansen J, Sebra R, Martinez P, Prabha S, Dubois N, Schaniel C, Iyengar-Kapuganti R, Kukar N, Giustino G, Sud K, Nirenberg S, Kovatch P, Albrecht RA, Goldfarb J, Croft L, McLaughlin MA, Argulian E, Lerakis S, Narula J, García-Sastre A, Iyengar R. Functional Effects of Cardiomyocyte Injury in COVID-19. J Virol 2021;:JVI0106321. [PMID: 34669512 DOI: 10.1128/JVI.01063-21] [Reference Citation Analysis]
615 Elrobaa IH, New KJ. COVID-19: Pulmonary and Extra Pulmonary Manifestations. Front Public Health 2021;9:711616. [PMID: 34650947 DOI: 10.3389/fpubh.2021.711616] [Reference Citation Analysis]
616 Changal K, Veria S, Mack S, Paternite D, Sheikh SA, Patel M, Mir T, Sheikh M, Ramanathan PK. Myocardial injury in hospitalized COVID-19 patients: a retrospective study, systematic review, and meta-analysis. BMC Cardiovasc Disord 2021;21:626. [PMID: 34972516 DOI: 10.1186/s12872-021-02450-3] [Reference Citation Analysis]
617 Dherange P, Lang J, Qian P, Oberfeld B, Sauer WH, Koplan B, Tedrow U. Arrhythmias and COVID-19: A Review. JACC Clin Electrophysiol 2020;6:1193-204. [PMID: 32972561 DOI: 10.1016/j.jacep.2020.08.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
618 Schukraft S, Magnin JL, Cook S. Cardiovascular Manifestations of COVID-19: Insights into a Single-Center Experience. TH Open 2021;5:e329-34. [PMID: 34568743 DOI: 10.1055/s-0041-1731775] [Reference Citation Analysis]
619 Zholinsky AV, Kruglova IV, Feshchenko VS, Risukhina YV, Fomin AV, Galaktionova NM, Pavlova AA, Mitin IN, Parastayev SA, Bezuglov EN, Fyodorov AN, Barshak SI. Federal medical biological agency of Russia's efforts to support Russian athletes during COVID-19 outbreak. Sport Sci Health 2021;:1-7. [PMID: 34777596 DOI: 10.1007/s11332-021-00861-5] [Reference Citation Analysis]
620 Smith SW, Strobel AM, Saenger AK, Apple FS. Laboratory findings in a child with SARS-CoV-2 (COVID-19) multisystem inflammatory syndrome. Clin Chem Lab Med 2021;59:e259-61. [PMID: 33554562 DOI: 10.1515/cclm-2020-1699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
621 Núñez-Gil IJ, Fernández-Ortiz A, Maroud Eid C, Huang J, Romero R, Becerra-Muñoz VM, Uribarri A, Feltes G, Trabatoni D, Fernandez-Rozas I, Viana-Llamas MC, Pepe M, Cerrato E, Bertaina M, Capel Astrua T, Alfonso E, Castro-Mejía AF, Raposeiras-Roubin S, D'Ascenzo F, Espejo Paeres C, Signes-Costa J, Bardaji A, Fernandez-Pérez C, Marin F, Fabregat-Andres O, Akin I, Estrada V, Macaya C. Underlying heart diseases and acute COVID-19 outcomes. Cardiol J 2021;28:202-14. [PMID: 33346365 DOI: 10.5603/CJ.a2020.0183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
622 Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, Wang F. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Research (Wash D C) 2020;2020:2402961. [PMID: 32377638 DOI: 10.34133/2020/2402961] [Cited by in Crossref: 71] [Cited by in F6Publishing: 89] [Article Influence: 35.5] [Reference Citation Analysis]
623 Li JW, Han TW, Woodward M, Anderson CS, Zhou H, Chen YD, Neal B. The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis. Prog Cardiovasc Dis. 2020;63:518-524. [PMID: 32305557 DOI: 10.1016/j.pcad.2020.04.008] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 43.5] [Reference Citation Analysis]
624 Abizaid A, Campos CM, Guimarães PO, Costa JR Jr, Falcão BAA, Mangione F, Caixeta A, Lemos PA, de Brito FS Jr, Cavalcante R, Bezerra CG, Cortes L, Ribeiro HB, de Souza FR, Huemer N, do Val RM, Caramelli B, Calderaro D, Lima FG, Hajjar LA, Mehran R, Filho RK; COVID MI investigators. Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study. Catheter Cardiovasc Interv 2021;98:E370-8. [PMID: 33904638 DOI: 10.1002/ccd.29709] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
625 Yitao Z, Mu C, Ling Z, Shiyao C, Jiaojie X, Zhichong C, Huajing P, Maode O, Kanglin C, Mao OY, Xiaoneng M, Weijie Z. Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study. Curr Med Res Opin 2021;37:385-91. [PMID: 33459077 DOI: 10.1080/03007995.2021.1876005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
626 Maximous S, Brotherton BJ, Achilleos A, Akrami KM, Barros LM, Cobb N, Misango D, Papali A, Park C, Shetty VU, Schultz MJ, Taran S, Lee BW, For The Covid-Lmic Task Force And The Mahidol-Oxford Research Unit Moru Bangkok Thailand. Pragmatic Recommendations for the Management of COVID-19 Patients with Shock in Low- and Middle-Income Countries. Am J Trop Med Hyg 2020. [PMID: 33350378 DOI: 10.4269/ajtmh.20-1105] [Reference Citation Analysis]
627 Capone V, Cuomo V, Esposito R, Canonico ME, Ilardi F, Prastaro M, Esposito G, Santoro C. Epidemiology, prognosis, and clinical manifestation of cardiovascular disease in COVID-19. Expert Rev Cardiovasc Ther 2020;18:531-9. [PMID: 32672482 DOI: 10.1080/14779072.2020.1797491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
628 Tardiolo G, Brianti P, Sapienza D, dell'Utri P, Dio VD, Rao G, Calabrò RS. Are We Paving the Way to Dig Out of the "Pandemic Hole"? A Narrative Review on SARS-CoV-2 Vaccination: From Animal Models to Human Immunization. Med Sci (Basel) 2021;9:53. [PMID: 34449681 DOI: 10.3390/medsci9030053] [Reference Citation Analysis]
629 Luo L, Fu M, Li Y, Hu S, Luo J, Chen Z, Yu J, Li W, Dong R, Yang Y, Tu L, Xu X. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis. Clin Cardiol 2020;43:1478-93. [PMID: 33026120 DOI: 10.1002/clc.23465] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
630 Cai Y, Chen Y, Xiao L, Khor S, Liu T, Han Y, Yuan Y, Cai L, Zeng G, Wang X. The health and economic impact of constructing temporary field hospitals to meet the COVID-19 pandemic surge: Wuhan Leishenshan Hospital in China as a case study. J Glob Health 2021;11:05023. [PMID: 34912549 DOI: 10.7189/jogh.11.05023] [Reference Citation Analysis]
631 Fan ZX, Yang J, Zhang J, He C, Wu H, Yang CJ, Zheng T, Ma C, Xiang ZJ, Zhai YH, Jiang J, Qiu SQ. Analysis of influencing factors related to elevated serum troponin I level for COVID-19 patients in Yichang, China.Cardiovasc Diagn Ther. 2020;10:678-686. [PMID: 32968624 DOI: 10.21037/cdt-20-510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
632 McKinney J, Connelly KA, Dorian P, Fournier A, Goodman JM, Grubic N, Isserow S, Moulson N, Philippon F, Pipe A, Poirier P, Taylor T, Thornton J, Wilkinson M, Johri AM. COVID-19-Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group. Can J Cardiol 2021;37:1165-74. [PMID: 33248208 DOI: 10.1016/j.cjca.2020.11.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
633 Sardu C, Marfella R, Maggi P, Messina V, Cirillo P, Codella V, Gambardella J, Sardu A, Gatta G, Santulli G, Paolisso G. Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovasc Disord 2020;20:373. [PMID: 32799852 DOI: 10.1186/s12872-020-01658-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
634 Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, Salazar-Mather TP, Dumenco L, Savaria MC, Aung SN, Flanigan T, Michelow IC. Predictors of COVID-19 severity: A literature review. Rev Med Virol 2021;31:1-10. [PMID: 32845042 DOI: 10.1002/rmv.2146] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 20.0] [Reference Citation Analysis]
635 Prasitlumkum N, Chokesuwattanaskul R, Thongprayoon C, Bathini T, Vallabhajosyula S, Cheungpasitporn W. Incidence of Myocardial Injury in COVID-19-Infected Patients: A Systematic Review and Meta-Analysis. Diseases 2020;8:E40. [PMID: 33120956 DOI: 10.3390/diseases8040040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
636 Kim MS, Frenkel SL, Hayden SR. Fever Unmasking Brugada-Pattern Electrocardiogram in Patient With Coronavirus Disease 2019 (COVID-19). J Emerg Med 2020;59:439-41. [PMID: 32739128 DOI: 10.1016/j.jemermed.2020.06.053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
637 Drapkina OM, Karpov OE, Lukyanov MM, Martsevich SY, Pulin AA, Kutishenko NP, Akimkin VG, Andrenko EY, Voronina VP, Dindikova VA, Dmitrieva NA, Zagrebelny AV, Lerman OV, Makoveeva AN, Okshina EY, Kudryashov EV, Klyashtorny VG, Smirnov AA, Fomina VS. Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes. Cardiovasc Ther Prev 2020;19:2727. [DOI: 10.15829/1728-8800-2020-2727] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
638 Henein MY, Bytyçi I, Nicoll R, Shenouda R, Ayad S, Cameli M, Vancheri F. Combined Cardiac Risk Factors Predict COVID-19 Related Mortality and the Need for Mechanical Ventilation in Coptic Clergy. J Clin Med 2021;10:2066. [PMID: 34065902 DOI: 10.3390/jcm10102066] [Reference Citation Analysis]
639 Hajjar LA, Costa IBSDS, Rizk SI, Biselli B, Gomes BR, Bittar CS, de Oliveira GQ, de Almeida JP, de Oliveira Bello MV, Garzillo C, Leme AC, Elena M, Val F, de Almeida Lopes M, Lacerda MVG, Ramires JAF, Kalil Filho R, Teboul JL, Landoni G. Intensive care management of patients with COVID-19: a practical approach. Ann Intensive Care 2021;11:36. [PMID: 33604873 DOI: 10.1186/s13613-021-00820-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
640 Sadler C, Alvarez Villela M, Van Hoesen K, Grover I, Lang M, Neuman T, Lindholm P. Diving after SARS-CoV-2 (COVID-19) infection: Fitness to dive assessment and medical guidance. Diving Hyperb Med 2020;50:278-87. [PMID: 32957131 DOI: 10.28920/dhm50.3.278-287] [Reference Citation Analysis]
641 Mishra AK, Sahu KK, George AA, Lal A. A review of cardiac manifestations and predictors of outcome in patients with COVID - 19. Heart Lung 2020;49:848-52. [PMID: 32593418 DOI: 10.1016/j.hrtlng.2020.04.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
642 Sokolski M, Trenson S, Sokolska JM, D'Amario D, Meyer P, Poku NK, Biering-Sørensen T, Højbjerg Lassen MC, Skaarup KG, Barge-Caballero E, Pouleur AC, Stolfo D, Sinagra G, Ablasser K, Muster V, Rainer PP, Wallner M, Chiodini A, Heiniger PS, Mikulicic F, Schwaiger J, Winnik S, Cakmak HA, Gaudenzi M, Mapelli M, Mattavelli I, Paul M, Cabac-Pogorevici I, Bouleti C, Lilliu M, Minoia C, Dauw J, Costa J, Celik A, Mewton N, Montenegro CEL, Matsue Y, Loncar G, Marchel M, Bechlioulis A, Michalis L, Dörr M, Prihadi E, Schoenrath F, Messroghli DR, Mullens W, Lund LH, Rosano GMC, Ponikowski P, Ruschitzka F, Flammer AJ. Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry. ESC Heart Fail 2021. [PMID: 34533287 DOI: 10.1002/ehf2.13549] [Reference Citation Analysis]
643 Sheehan MM, Saijo Y, Popovic ZB, Faulx MD. Echocardiography in suspected coronavirus infection: indications, limitations and impact on clinical management. Open Heart 2021;8:e001702. [PMID: 34376573 DOI: 10.1136/openhrt-2021-001702] [Reference Citation Analysis]
644 He DD, Zhang XK, Zhu XY, Huang FF, Wang Z, Tu JC. Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction. Comput Biol Med 2021;131:104293. [PMID: 33662681 DOI: 10.1016/j.compbiomed.2021.104293] [Reference Citation Analysis]
645 Rapkiewicz AV, Mai X, Carsons SE, Pittaluga S, Kleiner DE, Berger JS, Thomas S, Adler NM, Charytan DM, Gasmi B, Hochman JS, Reynolds HR. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine 2020;24:100434. [PMID: 32766543 DOI: 10.1016/j.eclinm.2020.100434] [Cited by in Crossref: 180] [Cited by in F6Publishing: 172] [Article Influence: 90.0] [Reference Citation Analysis]
646 Saeed S, Rajani R. The cardiovascular complications in COVID-19: Focus on acute cardiac injury. Pak J Med Sci 2021;37:908-12. [PMID: 34104187 DOI: 10.12669/pjms.37.3.4063] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
647 [DOI: 10.1101/2020.05.18.20066902] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
648 Mihalick VL, Canada JM, Arena R, Abbate A, Kirkman DL. Cardiopulmonary exercise testing during the COVID-19 pandemic. Prog Cardiovasc Dis 2021;67:35-9. [PMID: 33964290 DOI: 10.1016/j.pcad.2021.04.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
649 Cordero A, Santos García-gallego C, Bertomeu-gonzález V, Fácila L, Rodríguez-mañero M, Escribano D, Castellano JM, Zuazola P, Núñez J, Badimón JJ, González-juanatey JR. Mortality associated with cardiovascular disease in patients with COVID-19. REC: CardioClinics 2021;56:30-8. [DOI: 10.1016/j.rccl.2020.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
650 Huang W, Li C, Wang Z, Wang H, Zhou N, Jiang J, Ni L, Zhang XA, Wang DW. Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases. Sci China Life Sci. 2020;63:1678-1687. [PMID: 32567003 DOI: 10.1007/s11427-020-1733-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 21.0] [Reference Citation Analysis]
651 Ferrari F, Martins VM, Teixeira M, Santos RD, Stein R. COVID-19 and Thromboinflammation: Is There a Role for Statins? Clinics (Sao Paulo) 2021;76:e2518. [PMID: 33787678 DOI: 10.6061/clinics/2021/e2518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
652 Bonnemain J, Ltaief Z, Liaudet L. The Right Ventricle in COVID-19. J Clin Med 2021;10:2535. [PMID: 34200990 DOI: 10.3390/jcm10122535] [Reference Citation Analysis]
653 Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, Mohan S. Outcomes for Patients with COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. Kidney Int Rep. 2020;5:1149-1160. [PMID: 32775814 DOI: 10.1016/j.ekir.2020.06.013] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 27.5] [Reference Citation Analysis]
654 Hakim R, Motreff P, Rangé G. [COVID-19 and STEMI]. Ann Cardiol Angeiol (Paris) 2020;69:355-9. [PMID: 33069381 DOI: 10.1016/j.ancard.2020.09.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
655 Wang D, Gee GC, Bahiru E, Yang EH, Hsu JJ. Asian-Americans and Pacific Islanders in COVID-19: Emerging Disparities Amid Discrimination. J Gen Intern Med 2020;35:3685-8. [PMID: 33009656 DOI: 10.1007/s11606-020-06264-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
656 Bao J, Li C, Zhang K, Kang H, Chen W, Gu B. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta 2020;509:180-94. [PMID: 32511971 DOI: 10.1016/j.cca.2020.06.009] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 17.0] [Reference Citation Analysis]
657 Mirmoeeni S, Azari Jafari A, Hashemi SZ, Angouraj Taghavi E, Azani A, Ghasrsaz H, Angouraj Taghavi A, Niksima SH, Rashidi S, Kazemi E, Sheibani H, Naghibi Irvani SS, Dalvand S. Cardiovascular manifestations in COVID-19 patients: A systematic review and meta-analysis. J Cardiovasc Thorac Res 2021;13:181-9. [PMID: 34630964 DOI: 10.34172/jcvtr.2021.30] [Reference Citation Analysis]
658 Satterfield BA, Dikilitas O, Kullo IJ. Leveraging the Electronic Health Record to Address the COVID-19 Pandemic. Mayo Clin Proc 2021;96:1592-608. [PMID: 34088418 DOI: 10.1016/j.mayocp.2021.04.008] [Reference Citation Analysis]
659 Bollavaram K, Leeman TH, Lee MW, Kulkarni A, Upshaw SG, Yang J, Song H, Platt MO. Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V. Protein Sci 2021;30:1131-43. [PMID: 33786919 DOI: 10.1002/pro.4073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
660 Kumar R, Kumar J, Daly C, Edroos SA. Acute pericarditis as a primary presentation of COVID-19. BMJ Case Rep 2020;13:e237617. [PMID: 32816925 DOI: 10.1136/bcr-2020-237617] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
661 Blagova O, Varionchik N, Zaidenov V, Savina P, Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur J Immunol 2021;51:893-902. [PMID: 33368288 DOI: 10.1002/eji.202048930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
662 Zhang Q, Zheng Z, Zhang Y. Association of Myocardial Enzyme Abnormality with Clinical Outcomes of Patients with COVID-19: A Retrospective Study. Dis Markers 2021;2021:3440714. [PMID: 34725560 DOI: 10.1155/2021/3440714] [Reference Citation Analysis]
663 Ali L, Mohammed I, Janjua I, Naeem M, Adeli G, Elalamy O, Alhatou M, Akhtar N, Canibano B, Iqrar A. Acute Myocardial Injury and Rhabdomyolysis in COVID-19 Patients: Incidence and Mortality. Cureus 2021;13:e18899. [PMID: 34804738 DOI: 10.7759/cureus.18899] [Reference Citation Analysis]
664 Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, Penso L, Herlemont P, Sbidian E, Weill A, Dray-Spira R, Zureik M. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients. Hypertension 2021;77:833-42. [PMID: 33423528 DOI: 10.1161/HYPERTENSIONAHA.120.16314] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 21.0] [Reference Citation Analysis]
665 Ciaccio M, Agnello L. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19). Diagnosis (Berl) 2020;7:365-72. [PMID: 32589600 DOI: 10.1515/dx-2020-0057] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
666 Yuan X, Xu J, Hussain S, Wang H, Gao N, Zhang L. Trends and Prediction in Daily New Cases and Deaths of COVID-19 in the United States: An Internet Search-Interest Based Model. Explor Res Hypothesis Med 2020;5:1-6. [PMID: 32348380 DOI: 10.14218/ERHM.2020.00023] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
667 Bansal A, Kumar A, Patel D, Puri R, Kalra A, Kapadia SR, Reed GW. Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19). Am J Cardiol 2021;141:140-6. [PMID: 33217345 DOI: 10.1016/j.amjcard.2020.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
668 Fischer Q, Brillat-Savarin N, Ducrocq G, Ou P. Case report of an isolated myocarditis due to COVID-19 infection in a paediatric patient. Eur Heart J Case Rep 2020;4:1-5. [PMID: 33117957 DOI: 10.1093/ehjcr/ytaa180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
669 Mori M, Ikeda N, Taketomi A, Asahi Y, Takesue Y, Orimo T, Ono M, Kuwayama T, Nakamura S, Yamada Y, Kuroda T, Yuzawa K, Hibi T, Nagano H, Unno M, Kitagawa Y. COVID-19: clinical issues from the Japan Surgical Society. Surg Today 2020;50:794-808. [PMID: 32651686 DOI: 10.1007/s00595-020-02047-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
670 Nassar M, Nso N, Gonzalez C, Lakhdar S, Alshamam M, Elshafey M, Abdalazeem Y, Nyein A, Punzalan B, Durrance RJ, Alfishawy M, Bakshi S, Rizzo V. COVID-19 vaccine-induced myocarditis: Case report with literature review. Diabetes Metab Syndr 2021;15:102205. [PMID: 34293552 DOI: 10.1016/j.dsx.2021.102205] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
671 Maurus S, Weckbach LT, Marschner C, Kunz WG, Ricke J, Kazmierczak PM, Bieber S, Brado J, Kraechan A, Hellmuth JC, Hausleiter J, Massberg S, Grabmaier U, Curta A. Differences in Cardiac Magnetic Resonance Imaging Markers Between Patients With COVID-19-associated Myocardial Injury and Patients With Clinically Suspected Myocarditis. J Thorac Imaging 2021;36:279-85. [PMID: 34108409 DOI: 10.1097/RTI.0000000000000599] [Reference Citation Analysis]
672 Obukhov AG, Stevens BR, Prasad R, Li Calzi S, Boulton ME, Raizada MK, Oudit GY, Grant MB. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes. Diabetes. 2020;69:1875-1886. [PMID: 32669391 DOI: 10.2337/dbi20-0019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
673 Bader F, Manla Y, Atallah B, Starling RC. Heart failure and COVID-19. Heart Fail Rev. 2021;26:1-10. [PMID: 32720082 DOI: 10.1007/s10741-020-10008-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]
674 Rattanawong P, Shen W, El Masry H, Sorajja D, Srivathsan K, Valverde A, Scott LR. Guidance on Short-Term Management of Atrial Fibrillation in Coronavirus Disease 2019. J Am Heart Assoc 2020;9:e017529. [PMID: 32515253 DOI: 10.1161/JAHA.120.017529] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
675 Khan S, Rasool ST, Ahmed SI. Role of Cardiac Biomarkers in COVID-19: What Recent Investigations Tell Us? Curr Probl Cardiol 2021;:100842. [PMID: 33994028 DOI: 10.1016/j.cpcardiol.2021.100842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
676 Lusczek ER, Ingraham NE, Karam B, Proper J, Siegel L, Helgeson E, Lotfi-Emran S, Zolfaghari EJ, Jones E, Usher M, Chipman J, Dudley RA, Benson B, Melton GB, Charles A, Lupei MI, Tignanelli CJ. Characterizing COVID-19 Clinical Phenotypes and Associated Comorbidities and Complication Profiles. medRxiv 2020:2020. [PMID: 32995813 DOI: 10.1101/2020.09.12.20193391] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
677 Polito MV, Silverio A, Bellino M, Iuliano G, Di Maio M, Alfano C, Iannece P, Esposito N, Galasso G. Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? Cardiol Ther 2021. [PMID: 34191268 DOI: 10.1007/s40119-021-00232-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
678 Waleed RM, Sehar I, Iftikhar W, Khan HS. Hematologic parameters in coronavirus infection (COVID-19) and their clinical implications. Discoveries (Craiova) 2020;8:e117. [PMID: 33110936 DOI: 10.15190/d.2020.14] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
679 Popov AF, Berger R, Schlensak C, Bongers MN, Haeberle H, Acharya M, Lausberg HF. Mechanical circulatory support for cardiovascular complications in a young COVID-19 patient. J Card Surg 2020;35:3173-5. [PMID: 32740953 DOI: 10.1111/jocs.14916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
680 Varney JA, Dong VS, Tsao T, Sabir MS, Rivera AT, Ghula S, Moriles KE, Cherukuri ML, Fazal R, Azevedo CB, Mohamed RM, Jackson GR, Fleming SE, Rochez DE, Abbas KS, Shah JH, Minh LHN, Osman F, Rafla SM, Huy NT. COVID-19 and arrhythmia: An overview. Journal of Cardiology 2021. [DOI: 10.1016/j.jjcc.2021.11.019] [Reference Citation Analysis]
681 Cho J, Lee YJ, Kim JH, Kim SI, Kim SS, Choi BS, Choi JH. Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19. Sci Rep 2020;10:16200. [PMID: 33004837 DOI: 10.1038/s41598-020-72879-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
682 Filardo S, Di Pietro M, Diaco F, Romano S, Sessa R. Oxidative Stress and Inflammation in SARS-CoV-2- and Chlamydia pneumoniae-Associated Cardiovascular Diseases. Biomedicines 2021;9:723. [PMID: 34202515 DOI: 10.3390/biomedicines9070723] [Reference Citation Analysis]
683 De Michieli L, Jaffe AS, Sandoval Y. Use and Prognostic Implications of Cardiac Troponin in COVID-19. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.03.005] [Reference Citation Analysis]
684 La Colla L, Bronshteyn YS, Mark JB. Respiratory Variation in Central Venous Pressure (CVP) to Guide Ventilatory Support in Coronavirus Disease 2019 (COVID-19)-Related Lung Injury. J Cardiothorac Vasc Anesth 2021;35:345-7. [PMID: 32732100 DOI: 10.1053/j.jvca.2020.06.043] [Reference Citation Analysis]
685 Kitakata H, Kohsaka S, Kuroda S, Nomura A, Kitai T, Yonetsu T, Torii S, Matsue Y, Matsumoto S. Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients. J Clin Med 2021;10:3086. [PMID: 34300252 DOI: 10.3390/jcm10143086] [Reference Citation Analysis]
686 Pérez-Bermejo JA, Kang S, Rockwood SJ, Simoneau CR, Joy DA, Ramadoss GN, Silva AC, Flanigan WR, Li H, Nakamura K, Whitman JD, Ott M, Conklin BR, McDevitt TC. SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients. bioRxiv 2020:2020. [PMID: 32935097 DOI: 10.1101/2020.08.25.265561] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 19.5] [Reference Citation Analysis]
687 Papageorgiou N, Sohrabi C, Prieto Merino D, Tyrlis A, Atieh AE, Saberwal B, Lim WY, Creta A, Khanji M, Rusinova R, Chooneea B, Khiani R, Wijesuriya N, Chow A, Butt H, Browne S, Joshi N, Kay J, Ahsan S, Providencia R. High sensitivity troponin and COVID-19 outcomes. Acta Cardiol 2021;:1-8. [PMID: 33685354 DOI: 10.1080/00015385.2021.1887586] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
688 Tryfou ES, Kostakou PM, Chasikidis CG, Kostopoulos VS, Serafetinidis II, Ferdianaki EK, Mihas C, Olympios CD, Kouris NT. Biventricular myocardial function in Covid-19 recovered patients assessed by speckle tracking echocardiography: a prospective cohort echocardiography study. Int J Cardiovasc Imaging 2021. [PMID: 34940941 DOI: 10.1007/s10554-021-02498-4] [Reference Citation Analysis]
689 Kandasamy M. Perspectives for the use of therapeutic Botulinum toxin as a multifaceted candidate drug to attenuate COVID-19. Med Drug Discov 2020;6:100042. [PMID: 32352081 DOI: 10.1016/j.medidd.2020.100042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
690 Ashraf H, Soleimani A, Kazemi saeid A, Sadat Naseri A, Majidi F, Peirovi N, Karbalai Saleh S. Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review. World J Meta-Anal 2021; 9(4): 342-352 [DOI: 10.13105/wjma.v9.i4.342] [Reference Citation Analysis]
691 Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Scherrer-Crosbie M, Chen Y, Han Y. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106:1132-1141. [PMID: 32354800 DOI: 10.1136/heartjnl-2020-317056] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 60.5] [Reference Citation Analysis]
692 Demidova TY, Lobanova KG, Perekhodov SN, Antsiferov MB, Oynotkinova OS. Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy. Terapevticheskii arkhiv 2021;93:1193-202. [DOI: 10.26442/00403660.2021.10.201072] [Reference Citation Analysis]
693 McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res. 2020;127:571-587. [PMID: 32586214 DOI: 10.1161/circresaha.120.317447] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 71.5] [Reference Citation Analysis]
694 Das D, Podder S. Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity. Comput Biol Med 2021;134:104459. [PMID: 34020127 DOI: 10.1016/j.compbiomed.2021.104459] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
695 Do BN, Nguyen PA, Pham KM, Nguyen HC, Nguyen MH, Tran CQ, Nguyen TTP, Tran TV, Pham LV, Tran KV, Duong TT, Duong TH, Nguyen KT, Pham TTM, Hsu MH, Duong TV. Determinants of Health Literacy and Its Associations With Health-Related Behaviors, Depression Among the Older People With and Without Suspected COVID-19 Symptoms: A Multi-Institutional Study. Front Public Health 2020;8:581746. [PMID: 33313037 DOI: 10.3389/fpubh.2020.581746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
696 Perkin MR, Heap S, Crerar-Gilbert A, Albuquerque W, Haywood S, Avila Z, Hartopp R, Ball J, Hutt K, Kennea N. Deaths in people from Black, Asian and minority ethnic communities from both COVID-19 and non-COVID causes in the first weeks of the pandemic in London: a hospital case note review. BMJ Open 2020;10:e040638. [PMID: 33067300 DOI: 10.1136/bmjopen-2020-040638] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
697 Qin W, Chen S, Zhang Y, Dong F, Zhang Z, Hu B, Zhu Z, Li F, Wang X, Wang Y, Zhen K, Wang J, Wan Y, Li H, Elalamy I, Li C, Zhai Z, Wang C. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J 2021;58:2003677. [PMID: 33574077 DOI: 10.1183/13993003.03677-2020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
698 King JT Jr, Yoon JS, Rentsch CT, Tate JP, Park LS, Kidwai-Khan F, Skanderson M, Hauser RG, Jacobson DA, Erdos J, Cho K, Ramoni R, Gagnon DR, Justice AC. Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: The Veterans Health Administration COVID-19 (VACO) Index. PLoS One 2020;15:e0241825. [PMID: 33175863 DOI: 10.1371/journal.pone.0241825] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
699 Turagam MK, Musikantow D, Goldman ME, Bassily-Marcus A, Chu E, Shivamurthy P, Lampert J, Kawamura I, Bokhari M, Whang W, Bier BA, Malick W, Hashemi H, Miller MA, Choudry S, Pumill C, Ruiz-Maya T, Hadley M, Giustino G, Koruth JS, Langan N, Sofi A, Dukkipati SR, Halperin JL, Fuster V, Kohli-Seth R, Reddy VY. Malignant Arrhythmias in Patients With COVID-19: Incidence, Mechanisms, and Outcomes. Circ Arrhythm Electrophysiol 2020;13:e008920. [PMID: 33026892 DOI: 10.1161/CIRCEP.120.008920] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
700 Atri D, Siddiqi HK, Lang J, Nauffal V, Morrow DA, Bohula EA. COVID-19 for the Cardiologist: A current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies. JACC Basic Transl Sci. 2020;. [PMID: 32292848 DOI: 10.1016/j.jacbts.2020.04.002] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 53.5] [Reference Citation Analysis]
701 Goud PT, Bai D, Abu-Soud HM. A Multiple-Hit Hypothesis Involving Reactive Oxygen Species and Myeloperoxidase Explains Clinical Deterioration and Fatality in COVID-19. Int J Biol Sci 2021;17:62-72. [PMID: 33390833 DOI: 10.7150/ijbs.51811] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
702 Reiken S, Dridi H, Sittenfeld L, Liu X, Marks AR. Alzheimer's-like remodeling of neuronal ryanodine receptor in COVID-19. bioRxiv 2021:2021. [PMID: 33619477 DOI: 10.1101/2021.02.18.431811] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
703 Ziadi A, Hachimi A, Admou B, Hazime R, Brahim I, Douirek F, Zarrouki Y, El Adib AR, Younous S, Samkaoui AM. Lymphopenia in critically ill COVID-19 patients: A predictor factor of severity and mortality. Int J Lab Hematol 2021;43:e38-40. [PMID: 32996680 DOI: 10.1111/ijlh.13351] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
704 Ozer KB, Sakin O, Koyuncu K, Cimenoglu B, Demirhan R. Comparison of Laboratory and Radiological Findings of Pregnant and Non-Pregnant Women with Covid-19. Rev Bras Ginecol Obstet 2021;43:200-6. [PMID: 33860503 DOI: 10.1055/s-0041-1726054] [Reference Citation Analysis]
705 Gao P, Wu W, Tian R, Yan X, Qian H, Guo F, Li T, Liu Z, Wang J, Zhou X, Qin Y, Zhao D, Bian X, Lin X, Zhang S. Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19). Ann Transl Med 2021;9:883. [PMID: 34164517 DOI: 10.21037/atm-21-2282] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
706 Soulat-Dufour L, Lang S, Ederhy S, Adavane-Scheuble S, Chauvet-Droit M, Nhan P, Jean ML, Ben Said R, Issaurat P, Boccara F, Cohen A. Left ventricular ejection fraction: An additional risk marker in COVID-19. Arch Cardiovasc Dis 2020;113:760-2. [PMID: 33187875 DOI: 10.1016/j.acvd.2020.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
707 Dawson D, Dominic P, Sheth A, Modi M. Prognostic value of Cardiac Biomarkers in COVID-19 Infection: A Meta-analysis. Res Sq 2020:rs. [PMID: 32702736 DOI: 10.21203/rs.3.rs-34729/v1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
708 Awasthi M, Gulati S, Sarkar DP, Tiwari S, Kateriya S, Ranjan P, Verma SK. The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV. Viruses 2020;12:E909. [PMID: 32825063 DOI: 10.3390/v12090909] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
709 Hebbard C, Lee B, Katare R, Garikipati VNS. Diabetes, Heart Failure, and COVID-19: An Update. Front Physiol 2021;12:706185. [PMID: 34721055 DOI: 10.3389/fphys.2021.706185] [Reference Citation Analysis]
710 Geng YJ, Wei ZY, Qian HY, Huang J, Lodato R, Castriotta RJ. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol. 2020;47:107228. [PMID: 32375085 DOI: 10.1016/j.carpath.2020.107228] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 23.5] [Reference Citation Analysis]
711 Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, B Pearson CA, Group CW, Jombart T, Procter SR, Knight GM. COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med 2020;18:270. [PMID: 32878619 DOI: 10.1186/s12916-020-01726-3] [Cited by in Crossref: 95] [Cited by in F6Publishing: 101] [Article Influence: 47.5] [Reference Citation Analysis]
712 Buckley LF, Wohlford GF, Ting C, Alahmed A, Van Tassell BW, Abbate A, Devlin JW, Libby P. Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019. Crit Care Explor 2020;2:e0178. [PMID: 32832913 DOI: 10.1097/CCE.0000000000000178] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
713 Nalugo M, Schulte LJ, Masood MF, Zayed MA. Microvascular Angiopathic Consequences of COVID-19. Front Cardiovasc Med 2021;8:636843. [PMID: 33604359 DOI: 10.3389/fcvm.2021.636843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
714 de la Guía-Galipienso F, García-González P, Fabregat-Andrés O, Quesada-Dorador A, Meyer-Josten C, Lavie CJ, Morin DP, Sanchis-Gomar F. Cardiac magnetic resonance in the diagnosis of the unusually detected acute myocarditis in the young people: a case report. AME Case Rep 2021;5:35. [PMID: 34805754 DOI: 10.21037/acr-21-24] [Reference Citation Analysis]
715 Vitiello A, Ferrara F. Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients. Wien Klin Wochenschr 2021. [PMID: 33877436 DOI: 10.1007/s00508-021-01855-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
716 Chatterjee A, Wu G, Primakov S, Oberije C, Woodruff H, Kubben P, Henry R, Aries MJH, Beudel M, Noordzij PG, Dormans T, Gritters van den Oever NC, van den Bergh JP, Wyers CE, Simsek S, Douma R, Reidinga AC, de Kruif MD, Guiot J, Frix AN, Louis R, Moutschen M, Lovinfosse P, Lambin P. Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study. PLoS One 2021;16:e0249920. [PMID: 33857224 DOI: 10.1371/journal.pone.0249920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
717 Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, Wooster L, Rotter JI, Guo X, Malhotra R. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol 2020;92:1875-83. [PMID: 32441789 DOI: 10.1002/jmv.26050] [Cited by in Crossref: 164] [Cited by in F6Publishing: 149] [Article Influence: 82.0] [Reference Citation Analysis]
718 Zagidullin NS, Motloch LJ, Musin TI, Bagmanova ZA, Lakman IA, Tyurin AV, Gumerov RM, Enikeev D, Cai B, Gareeva DF, Davtyan PA, Gareev DA, Talipova HM, Badykov MR, Jirak P, Kopp K, Hoppe UC, Pistulli R, Pavlov VN. J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality? PLoS One 2021;16:e0257982. [PMID: 34648510 DOI: 10.1371/journal.pone.0257982] [Reference Citation Analysis]
719 Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul 2020;77:100741. [PMID: 32773102 DOI: 10.1016/j.jbior.2020.100741] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 31.5] [Reference Citation Analysis]
720 Singh M, Bansal V, Feschotte C. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors. SSRN 2020;:3611279. [PMID: 32714119 DOI: 10.2139/ssrn.3611279] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
721 Poterucha TJ, Elias P, Jain SS, Sayer G, Redfors B, Burkhoff D, Rosenblum H, DeFilippis EM, Gupta A, Lawlor M, Madhavan MV, Griffin J, Raikhelkar J, Fried J, Clerkin KJ, Kim A, Perotte A, Maurer MS, Saluja D, Dizon J, Ehlert FA, Morrow JP, Yarmohammadi H, Biviano AB, Garan H, Rabbani L, Leon MB, Schwartz A, Uriel N, Wan EY. Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30-Day Mortality in COVID-19. J Am Heart Assoc 2021;10:e018476. [PMID: 33169643 DOI: 10.1161/JAHA.120.018476] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
722 Faria AVS, Andrade SS, Peppelenbosch MP, Ferreira-Halder CV, Fuhler GM. Platelets in aging and cancer-"double-edged sword". Cancer Metastasis Rev 2020;39:1205-21. [PMID: 32869161 DOI: 10.1007/s10555-020-09926-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
723 Tavazzi G, Corradi F, Mojoli F, Forfori F, Via G. Contextualizing cardiac dysfunction in critically ill patients with COVID-19. Minerva Anestesiol 2020;86:1340-5. [PMID: 33174406 DOI: 10.23736/S0375-9393.20.14859-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
724 D'Andrea A, Russo V, Manzo G, Giordano V, Di Maio M, Crescibene F, D'Alto M, Bossone E. Association of atrial fibrillation and left atrial volume index with mortality in patients with COVID-19 pneumonia. Eur J Prev Cardiol 2020:zwaa138. [PMID: 33624089 DOI: 10.1093/eurjpc/zwaa138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
725 Zhao M, Lu J, Tang Y, Dai Y, Zhou J, Wu Y. Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies. Eur J Clin Pharmacol. 2021;77:311-319. [PMID: 33051695 DOI: 10.1007/s00228-020-03017-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
726 Ramadan MS, Bertolino L, Marrazzo T, Florio MT, Durante-Mangoni E; The Monaldi Hospital Cardiovascular Infection Study Group. Cardiac complications during the active phase of COVID-19: review of the current evidence. Intern Emerg Med 2021. [PMID: 34046852 DOI: 10.1007/s11739-021-02763-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
727 Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond) 2020;57:236-43. [PMID: 32802325 DOI: 10.1016/j.amsu.2020.07.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
728 Sahin B, Kose S, Eren G, Yoruk G. Clinical features, management, and outcome of hemodialysis patients with SARS-CoV-2. Ther Apher Dial 2021. [PMID: 34076947 DOI: 10.1111/1744-9987.13696] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
729 Saha AK, Podder CN, Niger AM. Dynamics of novel COVID-19 in the presence of Co-morbidity. Infect Dis Model 2022. [PMID: 35530528 DOI: 10.1016/j.idm.2022.04.005] [Reference Citation Analysis]
730 Younis NK, Zareef RO, Al Hassan SN, Bitar F, Eid AH, Arabi M. Hydroxychloroquine in COVID-19 Patients: Pros and Cons. Front Pharmacol 2020;11:597985. [PMID: 33364965 DOI: 10.3389/fphar.2020.597985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
731 McCarthy CG, Saha P, Golonka RM, Wenceslau CF, Joe B, Vijay-Kumar M. Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs). Compr Physiol 2021;11:1575-89. [PMID: 33577121 DOI: 10.1002/cphy.c200020] [Reference Citation Analysis]
732 Salimi-Jeda A, Abbassi S, Mousavizadeh A, Esghaie M, Bokharaei-Salim F, Jeddi F, Shafaati M, Abdoli A. SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies. Int Immunopharmacol 2021;101:108232. [PMID: 34673335 DOI: 10.1016/j.intimp.2021.108232] [Reference Citation Analysis]
733 Rey JR, Caro-Codón J, Poveda Pineda D, Merino JL, Iniesta ÁM, López-Sendón JL; CARD-COVID investigators. Arterial thrombotic complications in hospitalized patients with COVID-19. Rev Esp Cardiol (Engl Ed) 2020;73:769-71. [PMID: 32499015 DOI: 10.1016/j.rec.2020.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
734 Hu B, Deng Q, Zhou Q. Cardiac involvement of COVID-19: Looking forward to novel discoveries and clinically valuable evidence. Int J Cardiol 2020;314:95. [PMID: 32560765 DOI: 10.1016/j.ijcard.2020.05.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
735 Almanza-hurtado A, Martínez-ávila MC, Rodríguez-yánez T, Paternina-mendoza MC, Gutiérrez-ariza JC, Gómez-arroyo G. Viral Cardiomyopathies Associated With SARS-CoV-2 Infection. Clin Med Insights Case Rep 2022;15:117954762210881. [DOI: 10.1177/11795476221088140] [Reference Citation Analysis]
736 Siddiqi HK, Neilan TG. COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection. J Cardiovasc Transl Res 2020;13:347-8. [PMID: 32367343 DOI: 10.1007/s12265-020-10013-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
737 Nascimento JHP, Costa RLD, Simvoulidis LFN, Pinho JC, Pereira RS, Porto AD, Silva ECF, Oliveira LP, Ramos MRF, Oliveira GMM. COVID-19 and Myocardial Injury in a Brazilian ICU: High Incidence and Higher Risk of In-Hospital Mortality. Arq Bras Cardiol 2021;116:275-82. [PMID: 33470333 DOI: 10.36660/abc.20200671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
738 St John MH, Barry AR. COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Can Pharm J (Ott) 2020;153:193-7. [PMID: 33193917 DOI: 10.1177/1715163520929373] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
739 Hosseinzadeh R, Goharrizi MASB, Bahardoust M, Alvanegh AG, Ataee MR, Bagheri M, Navidiyan ES, Zijoud SRH, Heiat M. Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)? Clin Hypertens 2021;27:3. [PMID: 33451360 DOI: 10.1186/s40885-021-00161-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
740 Nakano H, Shiina K, Tomiyama H. Cardiovascular Outcomes in the Acute Phase of COVID-19. Int J Mol Sci 2021;22:4071. [PMID: 33920790 DOI: 10.3390/ijms22084071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0